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Abstract 
Govemmenta1 concem for the effective utilization of limited health care resources 
has necessitated the development of standardized, objective tools to measure and 
document changes within the health care system. The use of coronary artery bypass 
grafting surgery (CABGS), like all other health procedures, has high public cost and must 
be perfom1ed appropriately, when necessary, efficiently, and with high quality of care. 
Establishing the required frequency of a procedure, CABGS, in a population 
(benchmarking) is vital to ensure adequate allocation of resources. In 1995 researchers 
found that CABG surgery in Newfoundland and Labrador (NL) was being appropriately 
applied but that access to the service was far less than ideal. The authors benchmarked 
the need for CABGS. The current investigation was designed to reassess the need for 
CABGS in this province and to provide revised benchmarks. The analysis compared data 
between study periods and addressed the following areas: the current need for CABGS in 
L, the appropriateness of utilization, the necessity of utilization, the waiting times, the 
quality of care delivered with this service, and the future need ofCABGS in NL. 
All patients identified with critical coronary mtery disease (CAD) through 
coronary angiography (CA) between August 18, 1998 and August 13, 1999 were 
included in the study. In addition, all patients who received CABGS during the same 
study period were followed for quality of care. Findings were then compared with a 
previous study ( 1994/95). 
In 1998/99, 1625 patients had critical coronary artery disease and were 
characterized by late stage angina symptoms and multi-vessel disease. The average age 
was 62 years and 75% were male. Four hundred thitty-fom patients (434) underwent 
lV 
CABGS during the study period while 517 patients were referred for surgery. Thus, the 
waitlist increased by ~ 30% throughout the year. Only 40% of patients received surgery 
within the recommended waiting time. Over 94% of the referrals were deemed 
necessary. There was an excellent correlation between the cardiovascular team and the 
objective RA D criterion in decision-making (Kappa=0.86). We identified an additional 
91 patients for whom surgery was recommended, according to RAND criteria, but who 
did not receive a referral. Eighty-six percent (86%; n=78) of this group were actually 
treated with percutaneous transluminal coronary angioplasty (PTCA). 
Since 1994/95, the number of diagnostic catheterizations has increased by 37%. 
In addition, there was a 50% increase in critical coronary artery disease diagnosis (1 082-
1625). ln both studies, the proportion of patients with critical CAD diagnosed by 
angiography was similar. Although age and gender remained stable throughout the study 
periods, the latter ( 1999) cohort was characterized by a higher proportion of Class III 
angina, a lower proportion of positive exercise stress testing results, and less patients with 
a very low ejection fraction. Yet, the proportion ofpatients with critical CAD referred 
for CABGS remained stable (36%). Whilst there has been a dramatic increase in 
referrals for angioplasty (137%), there has been a relative decline in medical therapy as a 
means of treatment for these patients (-18%). Compared to 1995, increased utilization of 
CABGS was related to the diagnosis of patients at an earlier symptomatic phase of 
coronary artery disease (CAD) and to increased access to coronary catheterization. In 
addition, increased use ofPTCA and changes in health care altered demand. 
We concluded that physician clinical decision-making was an appropriate way by 
which to measure need for CABGS. The authors have noted an increase in utilization of 
v 
cardiac catheterization, which resulted in an increase in refen-als for CABGS (8% per 
annum). Thus, allowing for growth in access to coronary angiography, and change in 
case mix as well as the need to reduce the waiting list, we estimated annual need to be 
1.72 surgeries/ 1,000 population> 20 yrs of age in 200112002. However, predictions 
proved unreliable and need was underestimated. 
ln times of continual fluctuation in rate and changing assumptions between 1994 
and 1999, it is difficult to provide a confident estimation of future need. Research should 
instead aim to identify stability. Persistent monitoring should recognize this period of 
stability and researchers will be better able to estimate future trends at that time. 
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CHAPTER I 
Introduction 
1.1 CABGS in Newfoundland and Labrador 
In the Canadian Health Care System, a third party, the Provincial Government, pays for 
services rendered to the population at large. Being a publicly funded system, its primary goal is 
to facilitate reasonable access and delivery ofhealth services without incuning economic barriers 
to its citizens. Therefore an appropriate allotment of funding should be achieved via accurate 
and monitored establishment ofthe required frequency of procedures in the population 
(benchmarking data). The success of coronary bypass surgery in the management of 
symptomatic coronary artery disease has increased the demand for this revascularization 
technique. The health care system has failed to meet this demand. Gauging a community's need 
lor C ABG surgery should provide feedback to all parties involved and place necessary restraints 
on the provision of this service in the event of over utilization and increased funding, human 
resources, and technical support in the event ofunderutilization. 
The province of Newfoundland and Labrador, like many other health care jurisdictions, is 
faced with widening gaps between the demands for health care and the ability to supply these 
resources ( 6 7). In times of fiscal restraint, there is need for the effective utilization of severely 
limited resources to protect patients, service providers, and the payer. Cardiac care places a 
substantial burden on the health care system with a provincial operating budget over $10 million 
(25). Each coronary artery bypass grafting (CABG) procedure costs between $11,000 and 
$34,000 (in 1988 Canadian dollars; with improved equipment, teclu1ological advances, and 
inflation, it is likely this figure has increased) (73,88, 116, 136). Unfortunately, Newfoundland 
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and Labrador has a high prevalence of coronary artery disease (CAD), with 82% of its people 
possessing at least one major risk factor, excluding family history (128). 
Jn early 1990's, the wait-list for CABGS in NL was 18/100,000. There was higher output 
per surgeon as compared to the rest of Canada (24,25,58). Nevertheless, the wait list has 
continued to increase by approximately 20% per annum since that time (25). This excessive 
demand on resources was associated with difficulty in providing emergent care (84, 1 05). Thus, 
in 1994/95 researchers sought to assess the Cardiac Care Program and found that despite 
c ABGS being appropriately and necessarily applied, the access to this service was limited ( 42). 
At that time, the authors predicted the consequent need for CABGS and a substantial increase in 
funding for the cardiac program was approved. 
Since that time, NL' s Health Care Boards have been regionalized and efforts to expand 
the cardiac programs capacity have been implemented. However, indications for coronary 
rcvascularization have expanded, and changing fertility trends and mortality levels in Canada 
and L alike have resulted in an age structure in which an increasing proportion of the 
population are elderly and at risk for CAD. Furthem1ore, the number of cardiac catheterizations 
perf01med has increased. This will also increase demand for CABGS (137). This is not 
surprising as angiography is the current means by which we can diagnose and hence, treat CAD. 
Historically, a ratio of3.5:1 catheterizations to CABGS has occurred (133) . In NL, the recent 
addition in 2002 of a second catheterization laboratory ensures that the referral rate for coronary 
angiography will continue to increase. Finally, the advent of angioplasty + stenting has 
increased the indications for PTCA, a change in practice which could alter the need for CABGS. 
The benchmark for CABG surgery, as determined by the 1994/95 study, now appears 
inadequate, given that the assumptions on which it was based have changed dramatically. 
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Erfcctive delivery of CABGS to the community implies that surgery be undertaken for 
appropriate patients, that reasonable waiting periods occur, and that those patients who need the 
procedure receive it (1 08). Therefore, a revisiting of current benchmarking data for CABGS is 
vital to ensure appropriate and reasonable allocation of resources. 
1.2 Purpose of Study 
The primary objective ofthe current investigation was to review the need for CABGS. 
Consensus guidelines were utilized to objectively ascertain the appropriateness, necessity, 
efficiency, and quality of care for CABGS in 199811999. The original benchmarks from 1994/95 
were revisited and current and future need for CABGS in the province were predicted. By 
comparing both study periods, the findings have numerous implications for government policy 
and can be used as a guideline for resource management in the Cardiac Care Program. 
1.3 Introduction to Coronary Artery Disease 
As the second leading cause of death, cardiovascular disease accounts for approximately 
27% of Canadian mortality (129) and ischemic heart disease (IHD) accounts for almost 90% of 
heat1 disease ( 120). The disease is a direct consequence of inadequate supply (perfusion) 
relative to the demand for oxygenated blood in the heat1, resulting in a state of myocardial 
ischemia. Although initially reversible, longer periods of ischemia cause increased amounts of 
necrotic myocardium. When demand exceeds supply, it is also characterized by reduced 
availability of nutrient substrates and inadequate removal of metabolites (120). Atherosclerosis 
and thrombosis, causing narrowing and hardening of coronary arteries, are the most imp011a11t 
pathogenic mechanisms leading to ischemia (120). For this reason, it is often termed coronary 
artery disease or coronary heart disease, and is considered to reflect critical stenosis of the major 
coronary arteries. In most cases, it results from decades of silent, slowly progressive coronary 
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atherosclerosis, manifesting in late adulthood (over 40 years of age) (42,75). 
Major risk factors for CAD include increased age, smoking, diabetes, hypertension, 
dyslipidemia, and a positive family history. Females demonstrate a protective effect during 
reproductive years due to hom1one production (120). Minor risk factors identified consist of 
obesity (> 30% above ideal weight), sedentary lifestyle, and major depression. 
1.4 Treatment of CAD 
Lifestyle changes are recommended, most specifically, dietary modifications to reduce fat 
intake and, in turn, atherosclerotic accumulation. Exercise can improve weight control, reduce 
hypertension and dyslipidemia, and help maintain glycemic control. Lipid modifying therapy 
and blood pressure control are considered vital preventative measures to minimize risk factors 
for CAD. Smoking cessation reduces risk of death by 50% (52). 
Medical therapy is conunonly used to alleviate symptoms and complications of CAD. 
itrates are used for symptomatic control of acute symptoms (27). Beta-blockers, considered a 
first line therapy, reduce mortality by reducing heart rate, contractility, and blood pressure, 
thereby maintaining low oxygen demands. In addition, maximal medical therapy usually 
includes calcium channel blockers, which reduce left ventricular afterload via arteriolar dilation. 
By blocking calcium channels, heart contractility is also reduced. Triple combination drug 
therapy enhances perfusion while decreasing demand, enabling adequate oxygen and nutrient 
deli\ ery to this vital organ (27). 
Finally, treatment of CAD can also include coronary revascularization. 
Revascularization may be undertaken by surgery or by balloon angioplasty. The need for these 
procedures is detem1ined by coronary angiography (CA) (137). Albeit non-permanent solutions, 
revascularization is often offered to relieve symptoms and to prolong life. Percutaneous 
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transluminal coronary angioplasty (PTCA) with stenting, a stabilized balloon that inflates the 
_ .0 .. ,ed artery so as to allow greater perfusion to the myocardial muscle, is widely used for nat t vv 
single, double, and triple vessel artery disease. The addition of stenting has greatly expanded the 
inJications for PTCA and likely, decreased the demand for CABGS. 
1.5 Coronary Artery Bypass Grafting Surge1·y 
Coronary artery bypass grafting surgery is now an established treatment for CAD. In 
1 ()69 Richard Lower demonstrated possible anastomosis between coronary arteries (122). 
However, it wasn't until 1968 that Bailey and Hirose perfonned the first experimental surgery in 
humans (1 0). Since that time, the techniques for CABGS have greatly improved (122). CABGS 
provides newly grafted vasculature to the heart so that old, atherosclerotic vessels are bypassed. 
It has been shown to prolong survival and improve the quality of life for many patients (117). 
Like other surgeries, CABGS can have serious complications. Although advanced 
techniques and familiarity have reduced operative mortality and morbidity, the surgery is still 
reported to have a risk of death ranging from 1-5% (117). Other cardiac complications include 
arrhythmias (10-40% of patients) and myocardial infarctions (MI's) (6-8%) (117). Some, (10-
20%) of patients experience complications that require extended hospital stay. Frequently, 
infections are the cause of prolonged length of stay. Stroke occurs more often in older patients 
(1-5%). Significant neurological abnonnalities have been found in as many as 61% of patients 
(I 17). Furthem1ore, cognitive function is sometimes reduced following surgery and psychiatric 
complications have been reported (117). Numerous other complications have been detailed 
( rractures, pericardia} effusions, anemia, etc), but risk for an individual patient is very low (117). 
cvertheless, patients most often feel the surgery was beneficial, as it dramatically improved 
quality of life (1 05,117). 
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While CABGS is neither appropriate nor necessary in every patient with CAD, it is often 
utilized for symptom control. Ultimately, clinical decision-making and an educated judg1nent 
are required. While the evidence base is incomplete, CABG surgery has been shown to be 
superior to angioplasty and/or medical therapy for some patients. It has a survival benefit for 
patients suffering from stable angina with left main coronary disease, three-vessel disease with 
depressed left ventricular function, or multi-vessel disease with significant proximal left anterior 
descending (LAD) stenosis (24,75). It is also indicated for patients with unstable angina who 
continue to have pain despite aggressive medical therapy, who have an evolving MI, or who 
have complications of a failed PTCA. 
Table 1.1 Indications for CABGS 
Indications Coronary artery stenosis 
Stab 1 e Angina Left n1ain 
3-vessels ±reduced ejection fraction 
Multi-vessel with proximal LAD affected 
Unstable angina Evolving myocardial infarction 
Failed medical therapy 
Failed PTCA 
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CHAPTER II 
Review of the Literature 
2.1 Introduction 
Coronary artery bypass grafting surgery has been used in Canada for over 30 years; yet, 
extensive waiting lists have continued to mount since the early 1980's (104). Public polls show 
that nearly 2/3rds of Canadians believe that waiting lists, particularly for CABGS, have 
increased substantially in recent years (33). It may be hypothesized that in times of financial 
restraint, under utilization of a necessary intervention would be detrimental to the health of the 
community; conversely in times of easy access to a procedure, over utilization would occur with 
an associated loss of effective care being provided. Hence, there is considerable demand for this 
service to be used at an appropriate rate and therefore an enhanced interest in assuring effective 
delivery of the service for the payer, the provider, and the patients. It is thus necessary to 
uetermine optimum rates of utilization to ensure appropriate delivery of care. 
Appropriate CABGS usage should ensure that only necessary surgeries are perfo1med 
with good outcomes and within a reasonable period of time. Assessment of the optimal annual 
utilization rate depends on the ability to determine appropriate use in the population. It should 
be based on objective, reproducible guidelines using available client assessments and 
documentation. It is also dependent on setting reasonable criteria for the assumptions on which 
the rate is based. The rate of CABGS will be influenced by: 1) the rate of cardiac 
catheterization, 2) the rate ofPTCA utilization, 3) development of new technologies, 4) 
demographic change in the population, and 5) indications for CABGS. 
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Figure 2.1 Flow Diagram To CABGS 
I Community Population I 
I 
I Persons with CAD I 
I 
I Persons receiving Angiography I 
I 
I I J 
CABGS PTCA Medical Therapy 
I I I 
Failed; Repeat CA Failed; CABGS or Failed; PTCA or CABGS 
Repeat CA Or Repeat CA 
2.2 Benchmarking the Need for CABG Surgery 
[n order to determine the appropriate allotment of resources, need may be defined as a 
population-based rate. Benchmarking data aim to provide a guideline, which allows the service 
provider a means to satisfy need and monitor productivity. Benchmarking the need for CABG 
surgery must consider the availability of coronary catheterization, which ultimately controls the 
now to the operating room. However, simply supplying service at this rate is not assurance that 
all clients who need the service receive it. It is anticipated that criteria must also determine that 
the procedure is applied appropriately and prioritized effectively. Finally, the quality of service 
delivery should be high. Thus, an accurate benchmark requires that these conditions are met. 
Since the rate of cardiac catheterization is the limiting factor in identifying patients who need 
C ABGS, it is hypothesized that access to coronary angiography will predict need. Whilst the 
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researchers have utilized this changing access to predict increasing demand, it is essential first to 
document the appropriateness and necessity of current utilization. 
2.3 Assessment Tools for Measuring the Necessity of CA and CABGS 
1 n an attempt to define the right rate, researchers have focused on identifying underuse 
and overuse of procedures. Almost all objective tools were designed with the intention of aiding 
physician/surgeon decision-making (87, 138). Ben1stein et al., compared 3 methods designed to 
aid in the decision making process (19). Two of these were consensus procedures while the third 
method used a decision algorithm model. They found that although the panels (Dutch and 
American) had high agreement, the algorithm model was not consistent with the panels and did 
not accurately reflect physician practice. In Newfoundland and Labrador, like other Canadian 
settings, the decision to refer patients for CABG surgery is one of consensus. The cardiovascular 
team, comprising of cardiologists, surgeons, and other relevant physicians, discuss the patient's 
indication and history and decide on the treatment plan. Because Canadian practice utilizes tean1 
management, it is not surprising that the more valid assessment tools use a consensus procedure 
(6,11,40,74,86,126,142). 
The RAND Corporation, a nonprofit institution based in the United States, attempts to 
improve policy and decision-making through research and analysis. They have devised a 
methodology that has been applied in the benchmarking debate (20,64). Six frequently 
perfom1ed and resource intensive procedures, including CA and CABGS were examined. The 
researchers used a consensus process to synthesize expert opinion. The cardiovascular panel 
consisted of l family physician, 2 internists, 3 cardiologists, 2 cardiothoracic surgeons, and 1 
radiologist. Project staff organized a comprehensive and thorough review of the literature and 
clinical definitions were established. Indications were then organized into chapters of clinical 
9 
similarity (stable angina, unstable angina, etc). Panel members were asked to rate each 
indication on appropriateness and necessity on a scale of 1 through 9 (1 being inappropriate or 
not necessary). Appropriateness of the procedure was defined to mean that the expected health 
benefit exceeded the expected negative consequences by a sufficiently wide margin so that the 
procedure was considered worth doing, exclusive of monetary costs. Necessity, in contrast, was 
applied only to those indications deemed appropriate and its definition was more stringent. A 
procedure was considered necessary only if the physician felt obliged to reconunend it to the 
patient as being the best clinical option available. Mean ratings were then accrued and the panel 
convened for 2 days. Project staff led discussions and all indications were revised when 
required. 
While numerous manipulations can be construed from the data, the panel's findings 
enable researchers to utilize various definitions according to their own local practice. The 
authors have deemed the procedure appropriate or necessary if the median rating was between 7-
9 without disagreement between panel members, inappropriate or not necessary if the median 
was 1-3 without disagreement, and equivocal if there was disagreement or the median rating was 
4-6. The RAND method has been used by other panels, who created their own ratings to apply 
to local practice ( 12,4 7 ,50,64, 119). Appendix A provides a sample of necessity ratings for 
CABGS. The remainder of the literature review will address the use ofthese CABGS ratings. 
2.4 Review of the RAND Technique 
The RAND teclu1ique has been extensively used and validated (1,31,42,93,94,97,98, 
100,102,103,125). Based on a comprehensive review ofthe literature, the procedure applies both 
accrued infonnation and experience in its application. The ability to apply various definitions of 
agreement and disagreement provide flexibility for future researchers to use as needed. 
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Furthem1ore, clinical definitions can be altered to allow application to various settings (11 0). 
The authors have provided ratings in a relatively short time period and at a limited cost. 
2.41 Limitations of the RAND Methodology 
The use of an evidence based consensus procedure does have some serious concerns. 
First, the inherent usefulness is questioned (65). Next, the effect of the rater (expert-specific 
deviation) has limitations (114). Finally, there is a measurement error component (132). 
Current ratings, based on the 1991 ratings, may be outdated. There has been considerable 
advancement in technique and equipment since that time, as well as substantial changes in the 
surgical procedure. For instance, off-pump CABGS, which reduces the need for ventilatory 
assistance and decreases length of stay, mortality, as well as morbidity, has decreased the cost 
per procedure and has become almost routine (43,88,116). Indications for coronary angioplasty 
have greatly expanded and outcomes have continued to improve (23,37, 118). A revised 
literature review and renewed application would yield more precise ratings. The RAND 
corporation did not clarify which risks or benefits it has considered in its deliberations (57). 
Further, it did not make the intended outcome of care explicit, a problem because different 
people may have different aims and expectations for care. Moreover, it has been criticized for 
ignoring patients' preferences and trivializing the visceral judgments doctors reach during 
consultation (57). Finally, although content validity is assured via consensus, sensitivity and 
specificity cannot be deten11ined due to the lack of a gold standard. The inherent usefulness of 
the RAND technique to identify over and under use remains controversial (2). 
2.42 Definitions 
Under the RAND schemata, a procedure is deem_ed appropriate when the expected health 
benefits exceed the expected negative consequences. This rating tends to err on the side of 
11 
. t ·ve11tion as it is derived following assessment of net potential gain (64). Conversely, 1n Cl 
necessity was ascertained only when the physician felt obliged to recommend CABGS as the 
best clinical option available. Further, indications given a high necessity rating were generally 
those for which surgery was expected to improve life expectancy. However, from a meta-
analysis of randomized trials comparing early surgery to initial medical therapy, researchers have 
derived a model showing that the magnitude of life expectancy gains from CABGS has a 
complex relationship to multiple factors, which were not considered by the expert panel 
(93,141 ). 
Jn the application of the RAND method, clinical definitions were the same as those 
previously used by numerous researchers in addressing the question of varying rates 
( 4,42,44,54,93, 1 00,1 05). Of course, reliability was enhanced in this manner. Nevertheless, the 
technique has been criticized because these definitions considered neither resources (monetary 
costs and restraints) nor patient objectives or preferences (57). For the present study, these 
definitions were an accurate detem1ination of need since the Canadian health care system does 
not assess the financial considerations of treatment The application of medical procedures has 
always been highly debated and perfect agreement is rarely achieved. 
2.43 Internal and External Validity 
Based on clinical scenarios, the RAND indications have high content validity (20). 
Internal consistency was enhanced by discussion and feedback (111). Disagreement was found 
on approximately 17% of indications, which may have reflected accurate discrepancies in 
clinical practice or may have been indicative ofbias in the methodology (111). However, it is 
likely that this instead reflects a lack of available concrete evidence, and hence, the lack of 
consensus regarding efficacy, highlighting areas wherein knowledge was inconclusive (111 ). 
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. k t al conducted a review of the literature to determine evidence available to the average Ftn · e · 
physician (39). The findings supported levels of disagreement in the RAND method, signifying 
the need for more clinical evidence regarding some indications. Shekelle et al. documented the 
reproducibility ofthe method (125). Panelists were nominated by a variety of organizations and 
randomized to 1 of 3 panels. For CABGS there was moderate to high levels of agreement on 
appropriateness and necessity with approximately 95% agreement between panels (125). This 
suggests the teclmique is a valid and reliable tool for assessing under use of this procedure. 
In response to criticisms regarding lack of extemal validity for necessity scores, Kravitz 
and colleagues assessed outcome measures for patients receiving recommended surgeries as 
compared to those for whom surgery was not suggested (70, 71 ). Death and frequency of chest 
pain were examined. Adjusting for the degree of coronary artery stenosis (70% of proximal 
LAD), risk factors, and ejection fraction, patients who received surgery within 1 year had a 50% 
reduction in mortality and had a significant reduc6on in chest pain as compared to those who did 
not receive surgery (70) . 
2.44 Inter-Rater Variability 
The rater effect varies depending upon regional affiliation as well as on person specialty. 
Ratings vary between nations even when presented with the same research evidence and when 
asked to ignore economic considerations (21). Nevertheless, Shekelle demonstrated that 
Canadian panels showed high levels of agreement on necessity ratings (95%). It was noted 
however, that disagreement was substantial for appropriateness ratings (125). Panel members 
displayed systematic and random variation in rating indications. Member specialty contributed 
to judgments of efficacy; for example, surgeons deemed the service more appropriate as 
compared to family physicians. But, the literature was less revealing about the size or the extent 
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. 1 · dt. fference (57). Furthem1ore, surgeons were also less likely to confonn to the panel ol t liS 
median as compared to primary care givers (80). Primary care physicians were most likely to 
confonn following discussion, while cardiologists were most accurate when considering the 
median rating as gold standard. Yet, these differences affected less than 116 of clinical cases 
e\amined (63, 80). Discussions were led by a chairperson, which may have imposed value 
judgments and influenced panel discussions. 
2.45 The Canadian Model 
In 1994, in conjunction with the original investigators, Canadian researchers sought to 
replicate RAND findings using Canadian definitions and panel members. In "Coronary 
angiography and revascularization: defining procedural indications through formal group 
processes," Kahan et al. investigated interphysician agreement within and between 2 panels (64). 
The Canadian criteria used a stringent disagreement definition and defined disagreement to be 
when 3 or more ratings were in the lowest 3-point range and 3 or more ratings were in the 
highest 3-point range, a demanding definition using only 9 panel members. It was likely that 
this definition over-estimated the appropriateness of surgical procedures by assuming agreement 
\\hen the panel was, instead, largely in contention. Clinical definitions were altered to suit 
Canadian practice. Again, investigators found that agreement was enhanced through the 
consensus procedure and was dependent upon the composition ofthe panel (80,101). However, 
there were no significant differences between either of the Canadian panels in tenns of their 
agreement or disagreement. 
2.46 Conclusion 
Although criteria should now be updated to include relevant medical literature, the 
RAND method of rating appropriateness and necessity is cost effective and generalizable. It has 
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been successful in aiding physician judgment, identifying areas of concem, dete1mining over 
utilization and benclm1arking the need for CABGS. Although it was subjective, it combined the 
expertise of experienced physicians and the knowledge of existing clinical literature. This seems 
to be a reasonable design when considering the imprecise nature of medical science and the 
subjectivity of everyday clinical decision-making. Based on the deliberations of expert panels, 
the technique blends evidence with inference, melding facts and values without delineating the 
degree of net benefit for specific indications (92). The APPROACH study, recently published 
from Alberta and now initiated in BC and other provinces, also uses these techniques and hence, 
this may indeed be the best method for comparative data in the Canadian system at this time 
(37). In the cunent NL investigation, use of RAND criteria permitted comparison of clinical 
practice from 1994-1999. Expert opinion can provide valuable infonnation when there is 
conf1icting or incomplete knowledge in the literature regarding the efficacy of any medical 
procedure, as is the case for CABG surgery (2). While no global standard has yet been 
established, the RAND technique has persisted in dominating medical literature on 
appropriateness of coronary revascularization (57). 
2.5 Application of the RAND Methodology 
Researchers have utilized RAND criteria to assess appropriateness of utilization in an 
attempt to identify over use of CABG surgery (77,85, 140). Rates of inappropriate use in Canada 
ranged from 1 through 4% using the Canadian criteria (18,42, 78), while American studies have 
found rates of inappropriate use from 4 to 17% (17,28). Publications from the United Kingdom 
have reported rates of inappropriateness as high as 16% while Sweden have demonstrated rates 
as low as 2% (11 ,16). High inappropriate use implies excessive application of this procedure, 
"ithout incurring much likely benefit. Mcglynn and colleagues found evidence to suggest that 
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. _ . tJ·onal variations in definitions and practice standards strongly influenced these rates and 
111 tcJ na 
Sl1ould be taken to ensure appropriate guidelines are applied (85). care 
In efforts to detem1ine under utilization, the scenario becomes much more complex. It 
requires assessment of all patients with critical coronary artery disease. This assumes that all 
S) mptomatic patients deemed likely to benefit from CABGS receive a catheterization, a difficult 
assumption to test In effect, the cardiac catheterization laboratory is the site that controls the 
!low to the CABGS operating room (137). Approximately 30% of catheterized individuals will 
require CABGS (133). Thus, under use of this laboratory is indicative of a shortfall in 
identifying patients. Asymptomatic patients do not present to the health care system, resulting in 
the failure to identify persons for whom surgery might be deemed necessary. Additionally, all 
surgeries completed should be necessary and patients should receive the service efficiently. A 
breakdown in either of these components would likely indicate ineffective use of this procedure. 
Although much less has been published regarding the application of necessity measures 
for CABGS, some studies have looked at necessity in detennining disparity in access. Gender, 
race, age, income, geographical location, and size of Cardiac centre have all been examined to 
determine biases in the refenal ofnecessary surgeries (3,28,40,47,50,70,74,76). Fox et aL, again 
using Canadian criteria, assessed all patients diagnosed from the cardiac catheterization lab with 
critical coronary artery disease and demonstrated high necessity scores for CABGS in 
ewfoundland and Labrador (94%); suggesting that the vast majority of surgeries completed 
were required ( 42). However, they also identified an additional 31 patients with critical CAD 
(9°1o) for whom surgery was recommended according to the necessity scores but who were not 
rcfen·ed for CABGS. Moreover, they demonstrated that the difference between the number 
refetTed for CABG surgery and the number performed was substantiaL Kravitz et aL concluded 
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I t Patients who received necessary surgery within a 1-yr period had lower mortality as tHI 
compared to those who did not (8.7 vs. 15.8%, p=O.Ol), indicating that necessity score has 
external validity in determining under use as demonstrated by a survival advantage (71). 
2.6 Utilization Rates of CABGS 
In addressing cunent capacity, researchers have noted considerable variation in rates of 
uti 1 ization. ln 1 986, Wennberg commented on the ubiquity of variations in population-based 
rates of surgery (138). CABG surgery proves to be no exception. There is an abundance of 
1 i terature targeted towards identifying these geographical variations and deten11ining which rate 
is right (3,4,28,105,121,133). Previous research has found considerably higher rates of 
utilization in the United States as compared to Canada (3,48). However, Canadian rates of 
cardiovascular procedures are in the moderate to high range when compared with nations other 
than United States (16,38,81). Complicating the matter, there continues to be local discrepancy 
in rates (58,90). In a national comparison of cardiovascular rates in 1991, the Canadian average 
\\as 50 CABGS I 1 00,000 population. While provincial rates ranged from 25 through 78/ 
100,000, NL was perfmming 47/100,000 population CABG surgeries at that time (59). 
Whilst this has been the focus of research for numerous years, it has been presumed that 
these variations reflect local practice variations and differences in the application of 
methodology. Furthennore, health care policies influence access and thus, population rate. 
While there are no clear explanations, it emphasizes the importance of defining local need and 
using consistent methodology. 
2. 7 Consensus Based Priority Scores 
Prioritizing patients for care in a queue-based system is a complex task. Priority scores 
for C !\ BGS have also been established using an evidence-based consensus method. However, as 
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. 511-ategies for action, they do not consider patient request or circumstances such as nlel c L 
araphical or financial restraints. Furthermore, the literature on this topic remains uncertain as geo,::. 
to the precise benefits of faster wait-times to CABG surgery, and variations are easily detected in 
the scoring system. Priority scores for CABGS depend on the presence of angina symptoms. 
This likely results in an underestimate of priority for patients, as some patients who require 
c ABGS are asymptomatic or have chronic heart failure. 
Naylor has utilized regression to identify the variables that most consistently reflect 
priority scores and has devised a simple and short method by which to estimate a patient's 
appropriate wait time (95). The variables included are based on coronary anatomy, clinical 
presentation, response to medical therapy, and the results of non-invasive tests of ischemic risk 
(05 ). Ranks ranging from 1 -7 can be computed for each patient and are associated with a 
maximum recommended wait time. Recommended wait times progressed through emergency 
revascularization (immediate), very urgent(< 24 hours), urgent (<72 hours), semi-urgent (prior 
to discharge, within 2 weeks of referral), short elective (6 weeks), delayed elective (3 months), 
and finally, marked delay (6 months). Initially, there was panel agreement for only 60% of 
cases. Another study found that for 48/49 scenarios, 75% of urgency ratings fell within 2 
contiguous points on the scale (98). However, Naylor and colleagues found that physicians did 
benefit fi·om feedback and the use of consensus criteria as aids in their decision-making, as 
tndicated by improved agreement (96). Despite its limitations as a consensus procedure, it was 
based on a thorough review of the literature and was representative of Canadian practice and 
beliefs. It too, has been extensively used and validated (1,31,42,93,94,97,98,100,102,103,104, 
125 ). 
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In an effort to appraise the efficacy in NL, Fox et al. retrospectively applied these criteria 
to all patients refened for CABGS (42). They demonstrated that only 46% of patients received 
surgery within the recommended waiting time, with more urgent patients most likely to exceed 
the wait. In comparison, Naylor and investigators revealed that almost 80% of patients in 
Ontario underwent surgery within the proposed wait time (99, 102,1 03). Again, very urgent 
patients were less likely to receive their surgery on time. Such evidence suggests lack of access 
to CABG surgery in Newfoundland and Labrador. 
2.8 Managed Delay 
Under utilization can also be detected by the existence of extensive waiting periods. 
Waiting lists, although not an ideal solution, have become a practical and defendable solution if 
considered a temporary delay in the delivery of a service and if there is no significant adverse 
impact on patient health (30). Indeed, a policy of managed delay has advantages over systems 
based on financial consideration since access to health care can be detem1ined according to 
urgency of clinical need (94). Furthennore, it necessarily limits supply, encouraging optimum 
use and reducing rates of inapprop1iate use. Waiting lists are considered ethical only if they are 
based on medical need, are associated with low risk, and if they are measured, monitored and 
managed in an effective manner so as to provide service within an appropriate period of time 
(91 ,96). Canada's primary goal in health care management is to facilitate reasonable access to 
health services without patients encountering barriers (30). Accordingly, it is of considerable 
importance to optimize queue-based allocation of scarce resources and to ensure safe and fair 
application of these queues (99). 
If not managed properly, prolonged waits for a needed surgery place considerable 
emotional and financial burdens on the patient, the service provider, and the payer. While one of 
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b·ectives of CABG surgery is to improve the quality of life by reducing symptoms and/or the o ~ . 
limitations that result from having CAD, many patients experience heightened anxiety 
throughout the waiting period (127). Extended waiting periods and repeat cancellations 
contribute to a state of uncertainty and fear. In fact, these feelings can be more disturbing than 
the chest pain itself ( 13 ). Patients have expressed dissatisfaction with their lives and health 
status, reporting high frequencies of symptoms of fatigue, shortness of breath, chest pain, 
depression, stress, substance abuse, and sleep disturbances (12,61,134). Likewise, relatives of 
patients have indicated higher levels of anxiety, depression and irritability as compared to control 
groups ( 15). ln addition to this, it has been found that patients have an increased risk of 
psychological disturbances for 2 years following surgery (61). From a biomedical perspective, 
there is risk of an adverse event while awaiting surgery. Canadian estimates suggest that the risk 
of death ranges between 0.4 and 1% while the risk of a non-fatal myocardial infarction (MI) or a 
change in clinical status requiring urgent admission is between 0.1 and 12% 
( 14,26,31 ,89, 102,103 ). However, other studies have found the risk of death to be over 2% and 
the risk of a non-fatal MI or worsening clinical status to be almost 20% (14,34,61). These 
patients are often unable to work and their daily activities are severely minin1ized. Thus, the 
financial burden on families can be taxing (12). Delay in surgery is a very difficult situation for 
the physician as well. Physicians face conflicting responsibilities to both the individual patient 
and to society. They cannot simultaneously be advocates for their patients and also serve as 
linancial guardians of the health care system without incurring divided loyalties and ethical peril 
(82, 131 ). The difficulty with delaying beneficial surgery expands beyond emotional and ethical 
dilemmas; there may also be legal implications for doctors and health care management (91). 
Moreover, changes in clinical status require readmission, and reinvestigation is often necessary 
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following prolonged waits. Cox and colleagues found that almost 9% of patients required 
readmission during the waiting period (31 ). This constitutes considerable additional costs to the 
health care provider and often compromises the health of the patient. Previous investigations 
ha' c also reported that delayed surgeries contribute to prolonged hospital stay, higher drug use 
and more post surgical rehospitalization (26,35). It may decrease the possibility of returning to 
,, ork following surgery, furthering the impact on society (35, 130). Thus, there is economic 
incentive to minimize the risks and burdens associated with these waits. Education and good 
patient-doctor relations may reduce anxiety and contribute to a better experience for the patients, 
families, and medical team. It is of fundamental importance to apply and effectively manage 
patient queues so that access is judged safe, fair, and justifiable, not simply economically but 
medically and ethically as well (30). 
Nonetheless, managed delay helps to control service usage and guarantees at least 
moderate efficiency because it necessarily limits access. Delay may still be beneficial for some 
elective cases. It offers the patient time for sober thoughts and time to prepare for surgery while 
allowing urgent cases immediate attention (91 ). However, the average Canadian waits 149 days 
for surgery (98). Although this occupies middle ground in international comparisons, some have 
suggested that wait time should not exceed 42 days (68). 
2.9 Predicting Future Need 
ln addition to concerns addressing the need for CABGS, there are considerable 
difficulties in extrapolating this data to future years. While the assumptions used to benchmark 
this need must be continuous, the trends must also be stable. In times of fiscal restraint, this 
consistency is almost never attained. Exacerbating this effect, a growth in the proportion of 
elderly people in the population is expected to greatly escalate the need for coronary 
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Jlarization by increasing the population at risk (41). Improvement in techniques, rC\'<!SCL 
I Oloay and physician familiarity permit high-risk patients to be treated and encourages late tee 111 o , 
stage treatment, thereby expanding existing indications for this procedure (36). In contrast, 
patient awareness of risk factors for CAD has risen dramatically. It can be inferred that tlus may 
reduce the incidence of the disease in coming years (60). Yet, it has been found that lifestyle 
adaptation has minimal influence in the development and progression of heart disease (107) . 
Conversely, the advancement of medical therapy and PTCA may diminish the need for CABG 
surgery (37,41 ,60,93, 115, 118). Even so, medications for reducing blood pressure or cholesterol 
arc not optimally used (9, 139). Furthe1more, Serruys and colleagues have found that CABGS 
continues to be the gold standard for treatment and has better outcome statistics for many 
indications as compared to PTCA (23,115,117,124). Increased access to cardiac catheterization 
will undoubtedly lead to more comprehensive and earlier identification of patients with critical 
coronary artery disease and consequently, an increase in the possible candidates who may benefit 
from CABG surgery (137). As a result ofthese varying factors, it would appear necessary to 
continually review the utilization of CABG surgery, taking account of growth in angiography 
access and changing assumptions and thus enabling appropriate benchmarking figures. 
2.10 Summary 
It is acknowledged that, 1) benclm1arking the need for CABGS is useful in the effort to 
contain and appropriately distribute health care resources, 2) the consensus procedure can aid in 
the physician decision-making processes, and 3) an objective and reliable tool designed to 
measure appropriateness, necessity, and priority can provide informative feedback and 
monitoring if applied suitably. The RAND method has proved to be a valid means by which to 
achieve this task. 
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CHAPTER III 
Design and Methods 
3.1 Introduction 
A retrospective cohort study was perfom1ed in a tertiary care hospital in Newfoundland 
<tnd Labrador in 1994/95 in efforts to appraise the need for CABGS. The findings indicated that 
CABGS was being appropriately and necessarily applied; but the access to this service was far 
less than ideal. Following the infusion of$1.5 million and restructuring of the health care system 
after 1995, it is vital to review the assessment of need. This chapter contains the method by 
which we achieved this assessment. 
3.2 Research Design 
The Health Sciences Cardiac Program is the sole source for revascularization services in 
cwfoundland and Labrador, responsible for a population of 402,000 persons over the age of 20 
in 1999. All consecutive patients who underwent coronary catheterization during 1 year (1998-
1999) were prospectively studied, in addition to the cohort of patients who received CABGS 
during the same study year. The waiting list was evaluated prior to the study's inception as well 
as following completion of the study. We evaluated: the current need for CABGS in NL, the 
approp1iateness of utilization, the necessity of utilization, the waiting times for CABGS, the 
quality of care delivered with this service, and the future need for CABGS in NL. 
3.3 Ethics 
The study was granted approval by the Human Investigation Committee at Memorial 
University of Newfoundland and Labrador. Infom1ation was obtained and recorded from patient 
charts. A study number code on each abstraction fom1 was used to maintain confidentiality and 
only the primary investigators had access to the list of subjects and respective codes. The 
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· ian name was not recorded and neither patient nor physician was identified by name in any phYSIC 
·t or publication. Accrued data from the Cardiac Program of the Health Care Corporation of 
repol 
St. .John's was reviewed to determine utilization rates of procedures from 1994-2002 . 
.3.-t Sample Selection 
All patients receiving angiography were assessed for appropriateness using patient 
demographics, indications, and resultant angiographic data. All patients with critical coronary 
artery disease (defined as a stenotic lesion> 50% in either the left, right, or circumflex artery) at 
time of coronary angiography were identified and followed through cardiovascular rounds where 
decisions conceming revascularization were made. Two groups of patients were identified and 
studied; the lirst consisted of all those who received a referral for CABG surgery during the 
study period (August 18, 1998 through August 13, 1999) while the second consisted of those 
clients who received surgery throughout the same period. Two patients were ultimately excluded 
due to missing data. In those patients referred for surgery, we evaluated several key components 
in service delivery. By applying the RAND criteria, we assessed the appropriateness and 
necessity of CABGS utilization. Further, we determined the efficiency of service as indicated by 
the management of the queue-based service. This was accomplished using Naylor's priority 
scoring and following the referred cohort. 
Finally, we detennined the current need for CABGS in Newfoundland and Labrador and 
made predictions for future need based on the compilation of bypass and angiography utilization 
data and demographic population trends. 
3.5 Study Population 
The cardiac booking registry repmied 2196 procedures in the study year, 1625 patients 
\\ere identified to have critical coronary artery disease. Although 578 referrals for CABG 
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l·y were made, many of these were repeat procedures. Only 517 patients were actually surge 
refetTed for de novo surgery during the study period and 434 surgeries were performed. 
Figure 3.1 Study Population 
Coronary Angiography 
2196 
I 
Critical CAD 
1625 (74%) 
I 
I I I I I 
Referred PTCA Treated Medically Referred CABG Contraindicated* Not Included 
631 (J90~) 293 (18%) 578 (35.6%) 117 (7%) 6 (0.4%) 
I 
I I I 
53 Repeat Procedures 8 Patients Re-Presented N = 517 
I 
I Study Population I 
*Contraindicated: Tem1inal illness, such as cancer, AIDS, severe COPD (chronic obstructive 
pulmonary disease), hepatic failure, where a reasonable prognosis is 6 months or less, 
advanced dementia, or severe impairment in ability to perfonn the basic activities of daily 
living because ofnoncardiac disease. Many of these patients ultimately received medical 
therapy. 
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3.6 Research Instruments 
3.61 Data Collection Instrument 
A standardized data collection instrument (Appendix B) was developed for this study. It 
consisted of 3 parts. The first section included demographic information, such as age, sex, 
cardiac risk factors, clinical presentation, angina symptoms, date of coronary angiogram, 
relevant medical history, cardiac medications and response to medical therapy, left ventricular 
ejection fraction, the results of non-invasive and invasive tests of ischemia, and coronary artery 
anatomy. This infonnation was collected on all patients receiving coronary catheterization 
during the study period. Part II was completed on all patients with critical coronary artery 
disease and included infonnation presented to the weekly cardiovascular (CV) conference team, 
including risk stratification information and CV round treatment decisions for patients (i .e. 
CABG surgery, PTCA, or medical therapy). Part III contained infom1ation on the quality of care 
lor those who received revascularization during the study, including post-operative 
complications up until the time of discharge and surgery waiting times. When possible, 
photocopies of the cardiac catheterization, cardiovascular conference, and operative notes for 
each client were obtained and attached to the data abstraction form. In addition, discharge 
summaries, letters of consultation, and other relevant information were attached when the 
researcher felt it was necessary. The information from the 3 fonns was used to determine 
appropriateness, necessity, and priority for CABG surgery. Definitions employed are presented 
in Appendix C. 
3.62 Appropriateness, Necessity, and Priority Scores 
The appropriateness and necessity scores, using RAND Corporation criteria, were 
derived for all charts and applied for both angiography and CABGS (Appendix A). Level of 
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_ tive risk was determined using Parsonnet risk stratification score (Appendix D; 112). This 
opeta 
takes into consideration significant medical history, left ventricular ejection fraction, age and 
Albeit a brief scoring of risk, it has proven to be a reasonable and cost-effective measure of 
sex. 
co-morbidity. RAND ratings are dependent upon this categorization (112, 117). Using the 
scoring system of Naylor et al. (Appendix E), a priority score for queue time for surgery was also 
dcri,ed for each patient referred for CABG surgery (94). 
3.7 Procedure 
Data was collected by a research nurse with extensive experience in cardiology (GK) and 
by a Master of Science Candidate (the author) trained for this purpose. Patient charts were 
utilized. Patients receiving a referral for surgery were followed forward in time until a censor 
point had been reached. Patients were censored when: a) the patient received surgery, b) the 
patient was removed from the waiting list, or c) the last follow-up, being 6 months following the 
end of study date. Critical events (death, MI, change in status) were noted. Patients receiving 
surgery during the study period were followed until time of discharge noting various 
complications and mortality. All definitions were clearly defined and were the same as those 
used by Naylor and colleagues. Abstraction forms were reviewed to ensure consistency and 
completeness and a comprehensive check was made to determine accuracy. In addition, random 
checks were made to ensure correctness. 
Two trained personnel (GK and the author) independently computed appropriateness and 
necessity of angiography and CABGS for all subjects identified with critical coronary artery 
disease and for those who received CABG surgery during the study period. Inter-rater reliability 
"as monitored using the Kappa statistic to ensure high consistency (kappa= 0.92). Scores were 
compared and discrepancies settled by arbitration in consultation with the chief investigator (PP; 
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. ·an) Appropriateness scores evaluated decision-making by the CV conference team and phyStCI · 
., "P'Jlied to all patients referred for CABGS. Using RAND suggestions, necessity ofCABG 
\\ Cl t: u t 
. cJ·y > 7 was considered a recommendation for treatment and these recommendations were 
SLII g -
compared to cardiovascular reports and attendance records to determine agreement in treatment 
decision-making. P1iority scores were determined for all patients referred for CABG surgery 
during the study period. These scores, associated with recommended waiting times, were 
compared to actual time to surgery. 
3.8 Data Analysis 
Data was entered in a Paradox database and analyzed using Statistical Package for Social 
Sciences (SPSS) software. Descriptive statistics were used to describe the samples and 
comparisons between groups were done using a Student's t-test, Pearson chi square statistic, and 
Fisher exact as appropriate. Kaplan Meier distributions of the time to surgery for varying 
priorities of urgency were constructed. Finally, these data were evaluated and used to document 
changes from 1995-1999. Utilization data from 1994 through 2002 were used to compare 
benchmarking predictions with actual need for CABGS. 
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CHAPTER IV 
Results 
.. u Introduction 
Using similar methods as those in the 1999 investigation, Fox et al., (Appendix F) 
retrospectively reviewed hospital records and also identified 2 groups of patients; those 
diagnosed with critical CAD and refened to CABGS between April1, 1994 and March 31, 1995, 
as well as those patients who received CABGS during that period. This chapter will highlight 
the findings of both studies (hereafter refened to as 1995 and 1999 respectively) and note 
changes between time periods. The comparison findings have been published in The Canadian 
.lou mal of Cardiology (2004) and can be found in Appendix G. 
4.2 Corona•·y Angiography 
Despite increased utilization of CA' s between time periods, patients waited an average of 
5 days for cardiac angiography and 90% possessed at least 1 risk factor. A high level of 
appropriate usage was observed. Of2071 CA's assessed for appropriateness using the RAND 
criteria in 1999, 74% (N=l534) were appropriate, 22% (N=457) were uncertain, and 4% (N=80) 
\\ere inappropriate. ln the inappropriate group, the majority (60%) were for chest pain of 
uncertain etiology. Cases in the uncetiain group, compared with the appropriate group, were 
more likely to be over 75 years of age, less likely to have unstable angina, more likely to have 
other reasons (particularly heart failure) as the indication, and less likely to have a very positive 
exercise stress test (Table 4.1). 
The proportion of patients diagnosed with critical CAD was slightly higher in the 1999 
cohort compared to the 1995 cohort (from 68% to 74%). Although age and gender remained 
consistent throughout the 2 study periods, the later cohort was characterized by a significantly 
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. 1 . pr·oportion of class III angina (33 vs 14%), a lower proportion of very positive exercise 111g lCI 
tests (71 vs 40%), and less patients with ejection fraction less than 0.35 (14 vs 25%). By :;tress -
1999, the threshold for CA had been lowered to include more patients with Class I-III angina 
(Table 4.2). Since 1995, the number of diagnostic coronary angiographies (CA) increased by 
3 7<!,0 (from 1604 to 2196). The waiting list for CA' s was 134 at the end of September, 1999. 
Angiography utilization increased by only 2.8% in the coming year while the waitlist increased 
to 343 by 2001. This implies that the catheterization laboratory was working at full capacity in 
1999. A second catheterization laboratory was opened in 2002 due to the expanding waitlist. 
-'.3 Management of Critical Coronary Artery Disease 
Table 4.3 shows a summary oftreatment decisions in 1995 and 1999. The proportion of 
patients with critical CAD who were referred for CABGS remained relatively stable (36%), 
despite absolute CABG surgery referrals increasing from 391 to 578 (48%). While PTCA 
referrals increased by 137% (266 to 631 referrals), its propmiion ofthose with critical coronary 
artery disease increased from 26 to 3 9%. Yet, medical therapy as a means of treatment 
decreased in absolute refen·als from 358 patients to 293 (-18%). Tables 4.4 and 4 .5 demonstrate 
the clinical characteristics of patients by treatment category. 
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Table 4.1 Characteristics of Patients who Underwent Diagnostic Coronary Angiography (CA), Characterized by Appropriateness; 1999 
---- --- - -- -- ... -----Appropriate Uncertain Inappropriate 
Characteristic (n=l534) (n=457) (n=80) 
N(%) N(%) N(%) 
·--------
Age> 75 57 (4) 126 (28) 2 (3) 
Max medical therapy 1236 (80) 198 (43) 34 (43) 
Exercise Stress Test 
Very Positive 335 (22) 31 (7) 0 (0) 
Positive 550 (36) 194 (42) 8 (11) 
Indication for CA 
Chronic stable angina 472(31) 174 (38) 27 (34) 
Unstable angina 642 (42) 117 (26) 2 (3) 
Acute MI/Post MI angina 321 (21) 49 (11) 2 (3) 
Chest pain (uncertain origin) 24 (2) 24 (5) 48 (60) 
Silent ischemia 25 (2) 4 ( 1) 0 (0) 
Other 50 (3) 89 (19) 1 ( 1) 
Ejection fraction 
> 35% 1216 (88) 331 (79) 70 (95) 
15-35% 143 (10) 63 (14) 3 (4) 
< 35% 23 (2) 23 (6) 1 ( 1) 
Coronary Anatomy 
Protected left main 7 (1) 6 (1) 0 (0) 
Unprotected left main 83 (5) 18 (4) 0 (0) 
3-vessel disease 417 (27) 108 (24) 6 (8) 
2-vessel disease + PLAD* 125 (8) 34 (7) 2 (3) 
2 vessels 194 (13) 60 (13) 3 (4) 
1 vessel with PLAD 129 (8) 20 (4) 1 ( 1) 
1 vessel 269 (18) 63 (14) 8 (10) 
No critical CAD 309 (20) 147 (32) 60 (75) 
* Proximal left anterior descending 
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Table 4.2 Comparison of Clinical Characteristics of Patients Diagnosed with Critical 
Coronary Artery Disease (CAD) 
1995 (N= 1073) 1999 (N=1625) 
Characteristic p 
N (0/o) N ( 0/o) 
-·----- ·-- ---·-
Age, years (mean, SD) 60 (±11) 61 (±11) NS 
Male 760 (71) 1152 (71) NS 
Angina Class 
No angina/Uncertain 69 (6.4) 117 (7) NS 
Class I-II 108 (11.9) 131 (8) NS 
Class III 146 (13.5) 534 (33) < 0.0001 
Class IV 750 (69 .3) 843 (52) < 0.0001 
V c1·y positive stress test 436 (40) 326 (20) < 0 .0001 
Ejection fraction <35% 268 (25) 226 (14) < 0.0001 
Corona1·y anatomy 
Left main 72 (7) 119 (7) NS 
3 vessels 328 (30) 568 (35) NS 
2 vessels 314 (29) 438 (27) NS 
1 vessel 359 (33) 500 (31) NS 
32 
Table 4.3 Changes in the Study Populations 
- 1995 Investigation 1999 Investigation %Change inN variable 
rota! N 1857 2454 32.1% 
-R~pcat Procedures 253 322 27.3% 
-
Coronary Angiography 1604 2196 37% 
Cntical Coronary 1082 (68%) 1625 (74%) 50.2% 
.-\rtcry Disease 
Referred CABG 391 (36%) 578 (36%) 47.8% 
Referred PTCA 266 (26%) 631 (39%) 137.2% 
Treated Medically 358 (33%) 293 (18%) -18.2% 
Contraindicated 58 (5%) 117 (7%) 101.7% 
Not Included 10 (3%) 6 (0.4%) -40.0% 
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Table 4.4 Demographic and Cardiac Characteristics of Persons with Critical Coronary Aa·tery Disease by Treatment Decision; 1995* 
~ble Medical therapy PTCA Contraindicated CABGS 
~ 358 (33.1 %) 266 (24.6%) 58 (5.4%) 391 (36.0%) 
j\ 
~Age, yr (SD) 57.6 ± 11.2 59± 10.1 65.6 ± 9.8 61.9 ± 10.2 
:--:-
l\1ak 252 (70.4%) 186 (70%) 43 (74.1 %) 279 (71.4%) 
~~!ina Class 
54 (15.1%) 3 (1.0%) 3 (5.2%) 9 (2.3%) No angina/uncertain 
Class I 54 (15.1%) 3 (1.0%) 0 2 (0.5%) 
Class II 35 (9.8%) 4(1.1%) 2 (3.4%) 8 (2.0%) 
Class Ill 42 (11.7%) 28 (10.7%) 5 (8.6%) 71 (18.2%) 
Class IVA 136 (37.9%) 61 (22.8%) 18 (31.0%) 77 (19.7%) 
Class !VB 26 (7.3%) 28 (10.7%) 17 (29.3%) 81 (20.7%) 
Class IVC 11(3.1%) 139 (52.6%) 13 (22.4%) 143 (36.6%) 
[ oron:..~ry Anatomy 
Protected Left Main 2 (0.6%) 2 (0.7%) 1 (1.7%) 1 (0.2%) 
L'nprotcctcd Left I (0.3%) 5 (8.6%) 60 (15.4%) 
3-Vcsscl Disease 48 (13.4%) 30(11.1%) 28 (48.3%) 222 (56.8%) 
2-Vcsscl + PLAD 46 (12.8%) 50 (19%) 8 (13.8%) 52 (13.3%) 
2-Vcsscl- PLAD 67 (18.7%) 47 (18%) 9 (15.5%) 35 (9%) 
1-\'csscl + PLAD 46 (12.8%) 53 (19.7%) 3 (5.2%) 15 (3.8%) 
I-V esse! - PLAD 148 (41.4%) 84 (31.5%) 4 (6.9%) 6 (1.5%) 
Ejection Fraction NA 
No Data 2 (0.6%) 0 4 (1.0%) 
"'-u 
, .1) 'o 285 (79.6%) 29 (50.0%) 287 (73.4%) 
15-J5°~, 63 (17.6%) 21 (36.2%) 80 (20.5%) 
15 11 'o 8 (2.2%) 8 (13.8%) 20 (5.1%) 
Exercise Stress Test NA 
V!.!ry Positive 113 (31.6%) 17 (36.2%) 198 (50.6%) 
Positive 105 (29.3%) 10 (17.2%) 34 (8.7%) 
Indeterminate NA NA NA 
Nc~ativc 
'- NA NA NA 
-Not done/No data 105 (29.3%) 31 (53.4%) 159 (40.7%) 
\1ax Medical Therapy 
YL'S NA 229 (86%) NA 289 (85.5%) 
-
* I 082 patients; 9 missing data 
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Table 4.5 Demographic and Cardiac Characteristics of Persons with Critical Coronary 
Artery Disease by Treatment Decision; 1999* 
~able Medical therapy PTCA Contraindicated CABGS 
I\ (o;,) 293 (18%) 631 (39%) 117 (7%) 578 (36%) 
I-- 60 (sd=11) 59 (sd=ll) 64 (sd=12) 62 (sd=9) \1can Age, yr 
1-- 69.3% 66.9% 66.7% 77.0% \1alc 
:Mgina Class . 
43 (14.8%) 22 (3.5%) 14 (12.0%) 37 (6.4%) No angina/uncertam 
Class I 1 (0.3%) 0 1 (0.9%) 1 (0 .2%) 
Class ll 45 ( 15.5%) 48 (7.6%) 6 (5.1%) 29 (5.0%) 
Class Ill 87 (29.9%) 157 (24.9%) 39 (33.3%) 248 (42.9%) 
Class IVA 24 (8.2%) 23 (3.6%) 5 (4.3%) 24 (4.2%) 
Class !VB 40 (13.7%) 120(19.1%) 18 (15.4%) 101 (17.5%) 
Class IVC 51 (17.5%) 261 (41.4%) 34 (29 .1 %) 138 (23 .9%) 
Coronary Anatomy 
Protected Left Main 4 (1.4%) 7(1.1%) 2 (1.7%) 0 
Unprotected Left 1 (0.3%) 1 (0.2%) 6 (5.1%) 97 (16.8%) 
3-V esse) Disease 48 (16.4%) 94 (14.9%) 75 (64.1 %) 348 (60.2%) 
2-V esse) + PLAD 22 (7.5%) 68 (10.8%) 9 (7 .7%) 71 (12.3%) 
2-Vcssel- PLAD 64 (21.8%) 149 (23.6%) 15 (12.8%) 39 (6.7%) 
1-Vcsscl + PLAD 23 (7.8%) 118 (18.7%) 2 (1.7%) 11 (1.9%) 
1-\'csscl- PLAD 131 (44.7%) 194 (30.7%) 8 (6.8%) 12 (2.1%) 
Ejection Fraction 
~o Data 15 (5.2%) 92 (15.0%) 5 (4.3%) 13 (2 .3%) 
')50~) 221 (76.7%) 481 (78.6%) 67 (57.8%) 473 (82 .1 %) 
15-35° 0 46 (16.0%) 36 (5.9%) 31 (26.7%) 78 (13.5%) 
< l5°'o 6 (2.1%) 3 (0.5%) 13 (11.2%) 12 (2.1 %) 
Exercise Stress Test 
Vcry Positive 36 (12.3%) 112 (17.7%) 21 (17.9%) 154 (26.6%) 
Positi\c 113 (38.6%) 233 (36.9%) 33 (28.2%) 219 (37.9%) 
Indeterminate 10 (3.4%) 8 (1.3%) 0 8 (1.4%) 
. cgati\e 18 (6.1%) 25 (4.0%) 2 (1.7%) 15 (2.6%) 
\lot done/No data 116 (39.6%) 253 (40.1 %) 61 (52.1 %) 182 (31.5%) 
Max Medical Therapy 
_Yes 194 (66.2%) 494 (78.3%) 94 (80.3%) 439 (76.0%) 
* 1625 patients; 2 missing data, 4 received another therapy 
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ln 1999, unstable angina was the most common indication for surgery (56%), stable 
. followed with 24%. Sixty (60)% had triple vessel disease and over 82% had ejection 
ang111a 
fractions greater than 35. Most were on maximum medical therapy (76%) at the time of surgery. 
The operative risk was relatively low with 66% of patients at low risk while only 4.1% were 
deemed to be high risk. This represents a shift towards patients who were less acutely ill 
compared to 1995 data. The proportion of patients in the 1999 cohort with class III angina was 
higher (43% vs 18%), the proportion on maximal medical therapy was lower (76% vs 86%), and 
the propotiion considered elective (prioritized between 6 weeks and 6 months wait-time), was 
higher (41 % vs. 14%). The increase in the number of patients referred for CABGS could be 
solely attributed to the increase in the number of patients recommended for elective surgery. 
(Table 4.6). 
This shift towards the less ill was facilitated by the growth in PTCA (refer to Table 4.1 ). 
In 1999, PTCA was predominantly used to treat the more acutely ill; 64% of those referred for 
PTCA had unstable angina and 78% were on maximum medical therapy. Twenty-six (26)% of 
patients had severe coronary miery disease; left main, triple vessel, or two vessel with proximal 
left anterior descending (LAD) disease. The comparable figures in 1995 were as follows: 86% 
\\'ho had a PTCA procedure had unstable angina, 86% were on maximum medical therapy, and 
31% had severe coronary artery disease (Table 4.4 and Table 4.5). 
36 
Table 4.6 Changes in the CABGS Referral Cohort 
Variable 1995 1999 Probability 
N 391 517 
Mean Age, yr 61.9 ± 10.2 62.2 ± 9.4 NS 
Male 70.4% 77% 0.05 
Angina Class 
No angina, Class 1 or II 19 (4.9%) 57 (11.0%) 0.05 
Class Ill 71 (18.2%) 205 (39.7%) <0.0001 
Class IVA 77 (19.7%) 24 (4.6%) <0.0001 
Class lVB/C 224 (57.3%) 215 (41.6%) <0.0001 
Coronary Anatomy 
Protected Left Main 1 (0.2%) NA NS 
Unprotected Left 60 (15.4%) 87 (16.8%) NS 
3-Vessel Disease 222 (56.8%) 307 (59.4%) NS 
2-Vessel + PLAD 52 (13.3%) 62 (12.0%) NS 
2-V esse! - PLAD 35 (9.0%) 37 (7.2%) NS 
1-Vessel + PLAD 15 (3.8%) 13 (2.5%) NS 
1-Vessel - PLAD 6 (1.5%) 11 (2.1 %) 
Indication for Surgery 
Stable Angina 49 (12.5%) 123 (23.8%) <0.0001 
Unstable Angina 275 (70.4%) 288 (55.8%) NS 
Acute MI 4 (1.0%) 2 (0.4%) NS 
Post MI 43 (11.0%) 82 (15.9%) NS 
Other 20 (5.1%) 22 (4.3%) NS 
Ejection Fraction 
o Data 4 (1.0%) NA NA 
> 35% 287 (73.4%) 434 (84%) <0.0001 
15-35% 80 (20.5%) 67 (13%) <0.0001 
< 15% 20 (5.1 %) 16 (3%) NS 
Operative Risk 
Low Risk 250 (64.0%) 341 (66.0%) NS 
Moderate Risk 101 (25.8%) 140 (27.1 %) NS 
High Risk 40 (10.2%) 21 (4.1 %) NS 
Max Medical Therapy 289 (85.6%) 383 (74.7%) <0.0001 Yes 
Delayed Elective Priority 53 (13.6%) 201 (38.9%) <0.0001 
----
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Refened for CABGS Cohort 
In 1995, 39I of I073 patients with critical CAD were recommended for CABG surgery 
(J6%). By 1999, of 1625 patients, 578 were referred for CABGS (35%). However, repeat 
patients accounted for 61 of these patients; 53 patients received repeat angiography because they 
had ,, aited over 6 months, and another 8 patients were presented again to cardiovascular rounds 
due to changing indications. Despite an increase in surgical procedures from 338 to 434 (28%), 
the cardiac unit was not able to meet the increase in demand. Over the same period of time, the 
waitlist bad increased from I90 to 267 (49%). 
In 1995, almost 99% of referrals for CABGS were considered appropriate with 1.2% 
judged uncertain. Necessity scores were also high, as 94% were deemed necessary. Only I% of 
cases were considered not necessary for surgery, while 5% were rated uncertain. The situation 
''as similar in 1999; the decision to refer for CABGS was considered appropriate in all but one 
case. Again, 95% of patients referred for surgery were considered to be necessary recipients of 
C ABGS, in 3% the decision was tenned uncertain, and 2% of cases were deemed unnecessary 
(Table 4. 7). 
In 1999, we sought to evaluate those who received necessity scores< 7; three patients 
had contraindications for surgery and II had chest pain of uncertain origin or congestive heart 
failure. Most patients had 2 vessel or diffuse disease. Further, this population was significantly 
older as compared to those patients deemed to be necessary recipients (Table 4.8). 
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Table 4.7 Changes in the Appropriateness/Necessity 1995/1999 
'ippropriateu ess CABGS Referred 1995 CABGS Referred 1999 
(N=391) (N= 517) 
S ·ore 7-9 (Appropriate) 
,c 
384 (98.2%) 488 (98.3%) 
Score 4-6 (Indetenninate) 7 (1.8%) 8 (1.5%) 
Score J-3 (Not Appropriate) 0 1 (0.2) 
Necessity 
Score 7-9 (Necessary) 368 (94.2%) 491 (94.9%) 
Score 4-6 (Indeterminate) 17(4.3%) 17 (3.3%) 
Score 1-3 (Not Necessary) 6 (1.5%) 9 (1.7%) 
Table 4.8 Clinical Characteristics of CABGS Referral Cohort by RAND Necessity, 
1999 
. Rand Criteria for Necessary for Indete1minate for Not Necessary 
CABGS CABGS Therapy CABGS forCABGS 
I 
(7-9) (4-6) (1-3 or no code) 
(n=491) (n=17) (n=9) 
I Aue ;::, 62.1 61.8 71.6 
1 
Sex (Male) 376 (76.6%) 15 (88.2%) 8 (88.9%) 
' Angina Class 
I 
2 16 (3.3%) 3 (17.6%) 6 (66.7%) 
, 192 (39.1 %) 10 (58.8%) 1 (11.1%) ..) 
4A 23 (4.7%) 2 (24.5%) 
48 98 (20.0%) 1 (0.2%) 
-lC 130 (26.5%) 
Other 32 (6.5%) 1 (5.9%) 2 (22.2%) 
Coronary Anatomy 
Left Main 95 (19.3%) 
3-vessel disease 324 (66.0%) 3 (17.6%) 6 (66.7%) 
2-VD +PLAD 55 (11.2%) 6 (35.3%) 1 (11.1%) 
2-VD - PLAD 16(3.3%) 5 (29.4%) 2 (22.2%) 
1-VD +PLAD 
1-YD - PLAD 
1 (0.2%) 1 (5.9%) 
Other 2 (11.8%) 
Maximum Medical 386 (78.6%) 9 (52.9%) 0 
Thera_py (Yes) 
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To exan1ine underutilization of CABGS, in 1995 Fox et al. identified an additional 31 
patients for whom CABGS was considered necessary according to RAND criteria but who were 
not referred. In 1999 researchers identified an additional 91 patients deemed necessary. In the 
1 ()09 cohort. 78 of these patients received coronary angioplasty. Technological advancement in 
the application of percutaneous transluminal coronary angioplasty (PTCA) now allows a more 
\·ariable patient selection. Although PTCA is beyond the scope of this paper, a review of the 
literature and analyis of this patient population suggests that treatment with PTCA for these 
patients was an acceptable alternative. A comparison between the cardiovascular team and the 
research team decisions are presented in Table 4.9. Level of agreement was assessed using 
Cohen's Kappa Statistic and indicated good agreement (0.86). 
Table 4.9 
PANEL 
Comparison of Decisions Between Cardiovascular Team and the 
Research Team for Annual Incidence Cohort of Coronary Artery 
Disease (n=1625); 1999 
Cardiovascular Team 
CABG Surgery No CABG Surgery TOTAL 
RAND Criteria CABG Surgery 508 
No CABG Surgery 9 
TOTAL 
Pair ll'ise comparisons 
(CV Team vs. Research) 
517 
Kappa (CJ) 
0.86 (0.84-0.88) 
91 599 
1017 1026 
1108 1625 
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..t.5 CABGS Wait-times 
In 1995, 338 CABG surgeries were completed, but 391 patients were referred for the 
service. Thus, the Cardiac Care Progrmn operated on an annual deficit of 53 surgeries. The 
"aiting Jist increased by 20% throughout the study year. The average waiting time for CABGS 
among the patients referred for surgery during the study period was 33 days (SD=63.5). Using 
Naylor's priority scores, Table 4.10 documents the priority scores for these patients and 
corresponding proportions waiting less than maximum suggested time; indicating that 47% of all 
patients received surgery within recommended waiting ti1ne. However, it is of interest to note 
that patients prioritized to delayed elective (6 months) were most likely to receive surgery within 
a recommended time frame (75°/o). Fifty percent of patients in the elective category (6 weeks) 
received surgery within the recommended wait time while 64% of patients in the semi-urgent 
category ( 14 days) were promptly treated. However, those in emergent or very urgent categories 
\\ere not likely to receive surgery in time (23 and 24o/o respectively). Figures 4.1 and 4.2 present 
Kaplan Meier life plots for this population demonstrating this trend. 
In the later cohort, 1999, 517 patients were referred for revascularization and 434 CABG 
surgeries were undertaken. Thi1iy-nine (39)% of all clients received service within 
recommended wait time. Only 20% of24 patients in the emergent priority received surgery 
within the recommended 24 hours. Thirty (30)% of clients in the very urgent category (less than 
72 hours), whilst 49o/o of those in the urgent category(< 2 weeks) received surgery within the 
recommended waiting time. Seventy-one (71)% of patients in the semi-urgent group underwent 
CABGS within the recommended time frame. In the short-elective class (n=160), 55 patients 
(34.4%) had CABGS within the recommended 3 month waiting period. Finally, 17 of 41 (41 %) 
patients in the delayed elective category underwent CABGS within the advised 6 months. 
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Patients were most likely to receive service on time in the urgent and semi-urgent category and 
were )east likely to be done on time when asigned to the immediate or very urgent categories. 
Although patients differed in waiting times, there were no other statistically significant 
distinctions between those receiving surgery and those who remained waiting in tenus of 
demographics, symptoms, or outcomes (Figures 4.3 and 4.4). 
ln 1999, the average waiting time for surgery was 86.9 days following refeiTal (sd=156.5) 
while the median waiting time was 17 days. The g1·eatest deterioration in waiting times occulTed 
in those patients desig11ated to the delayed elective priority. In consideration of utilization data, 
it is likely that the lowered threshold for CA access, has resulted in decreased efficiency in the 
clecti ve category of patients. 
Table 4.10 Changes in the Priorities 1995/1999 
Priority Waiting Time N- 1995 Received 
Surgery Within 
N -1999 Received 
Surgery Within 
Recommended Recommended 
Waiting Time Waiting Time 
(o/o) (%) 
< 24 hours 31 7 (23%) 24 5 (20.8%) 
2 < 72 hours 122 30 (24%) 141 42 (29.8%) 
3 < 2 weeks 87 56 (64%) 68 33 (48.5%) 
4 < 6 weeks 98 49 (50%) 59 42 (71.2%) 
5 < 6 months 53 40 (75%) 201 71 (35.3%) 
TOTAL 391 182 (46.5%) 493* 193 (39.1 %) 
* 24 patients did not receive a priority score; they did not have angina 
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Figure 4.1 Kaplan-Meier Life Plot A; 1995 
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Figure 4.2 Kaplan-Meier Life Plot B; 1995 
Time to CABG for Patients Requiring 
·Elective Surgery 
1.0-------------------
c 
0 
:e 
0 
c. · 
.9 
.8 
.7 
.6 
.5 
.4 
e .3 
D.. . 
Q) 
> .2 
:;::; 
_!Q 
::J 
E 
::J 
.1 
Priority 
., 
• Delayed wait list 
between 6 wks-6 m ths 
• Short wait list 
0 0.0 +----.--, between 2-6 weeks 
0 20 40 60 80 100 120 140 160 . 180 
Days on the waiting list 
44 
Figure 4.3 Kaplan-Meier Life Plot A; 1999 
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Figure 4.4 Kaplan-Meier Life Plot B; 1999 
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• (j The Waiting List 
-t. ) 
As previously indicated, although 517 patients were referred for CABG surgery in 1999, 
011 ly 434 surgeries were completed, an annual deficit of 83 surgeries. In the latter cohort, 7 
patients died while awaiting surgery and 2 were removed from the list due to worsening clinical 
status. Hence, at the end of the study, 267 patients were on the waiting list for CABG surgery; 
an increase of almost 30% over the study period. Furthennore, it is of interest that researchers 
noted a change in clinical symptom as indicated by increasing severity of angina in another 28 
patients who were waiting for surgery. 
4.7 Quality of Care 
In 1995, the median length of stay was 7 days. Factors influencing length of stay were 
recorded and are reported in Table 4.11. While mortality and morbidity rates were comparable 
to findings of other Canadian studies, ventilation greater than 3 days was the most frequent 
complication (7. 7%). Eleven patients died post-operatively (3.3%). 
In 1999, the post-operative length of stay (LOS) ranged from 1 through 135 days while 
the median LOS was again 7 days. Patients were followed until discharge. Fifteen (3.5%) 
patients died post-operatively (Table 4.11 ). Again, ventilatory assistance greater than 3 days was 
the most common cause with 5.3% of patients having this complication. Many (56%) of patients 
experienced some fonn of morbidity related to the CABG surgery; atrial fibrillation, pleural 
effusion, anemia, and confusion being the most conunon (Table 4.12). 
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Table 4.11 Post-operative Complication Rates 1995/1999 
1995 1999 
Complicatioll N=338 N=434 Probability 
11 (%) 11 (%) 
Re-operation 9 (2.7%) 10 (2.3) NS 
Ventilatory Assistance > 3 days 26 (7.7%) 23 (5 .3) < 0.05 
Cardiac AlTest 8 (2.4%) 1 (0.2) < 0.05 
Myocardial Infarction 4 (1.2%) 9 (2.1) NS 
Sternal Wound Infection 15 (4.4%) 11 (2.5) 0.056 
Groin/Leg Wound Infection 18 (5.3%) 12 (2.8) <0.05 
Mediastinitis 6 (1.8%) 3 (0.7) NS 
Stroke 2 (0.6%) 11 (2.5) < 0.05 
Arrhythmia requiring Pacemaker 10 (3.0%) 4 (0.9) < 0.05 
Arrhythmia 6 (1.8%) 2 (0.5) NS 
Acute Renal Failure requiring Dialysis 8 (2.4%) 3 (0.7) < 0.05 
Death 11 (3.3%) 15 (3.5) NS 
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Table 4.12 Other Common Complications of CABGS Cohort; 1999 
Complication 
Atrial Disturbances 
Ventricular disturbances (arrhythmias) 
Pleural effusion/pericardia} rub 
Post-operative anemia 
Pneumonia 
Pneumothorax 
Pericarditis 
Thromboembolism 
Fluctuating glucose/early onset diabetes 
Edema 
Other respiratory problems 
Signs of infection 
Nausea/weakness/loss of vision 
Seizures 
Gastrointestinal problems 
Urogenital proble1ns 
Hypotension 
Renal insufficiency 
Pain/discomfort 
Confusion/ mental health issues 
Other 
n (%) 
106 (24.4) 
11 (2.5) 
54 (12.4) 
21 (4.8) 
12 (2.8) 
6 (1.4) 
10 (2.3) 
6 (1.4) 
11 (2.5) 
9 (2.1) 
22 (5.1) 
14 (3.2) 
15 (3.5) 
4 (0.9) 
16 (3.7) 
10 (2.3) 
8 (1.8) 
8 (1.8) 
6 (1.4) 
20 (4.6) 
22 (5.1) 
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..t.8 Benchma•·king the Need for CABGS 
4.81 Fluctuation in Utilization 
[n 1999/2000 the annual growth inCA was 3.3% but the growth in those refened for 
CABGS was 6.0% (Table 4.13). This was influenced by inclusion of patients who had repeat 
coronary angiographies while waiting for CABGS and also by a reduction in the rate ofPTCA 
rrom the previous year. The number of CABGS actually performed was less than the number 
reiCrred and the wait list predictably increased. In comparison, in 2000/2001 the number of 
CABGS perfonned exceeded the number refened and the wait list actually decreased. However, 
the following year, refenals rose dramatically (14%) and again exceeded perfonnance. Table 
4.13 documents the 4 year trends in cardiac revascularization and waiting lists. The ability of the 
Cardiac Program to provide effective emergent care is probably influenced by the size of the 
waiting list. Fifty (50) additional CABGS will need to be performed each year to eliminate the 
waiting list within 5 years. 
4.82 Ammal Need and Future Predictions 
From 1995 to 1999, there has been a shift to less acutely ill patients refened for CA and 
lor CABGS. While the procedures were necessary, patients were less symptomatic. This shift to 
the less acutely ill was facilitated by a growth in PTCA. In 1998/99, the volume ofPTCA used 
to treat the less ill patients had been related to the limited availability of revascularization 
surgery. Historically, the ratio of catheterization to CABGS referral has been consistent, 
demonstrating that as access to CA increases, the demand for CABGS also rises. There has been 
an 8% annual growth ofCABGS referrals from 1994-2001. 
Given that the objective criteria and the cardiovascular team decisions were similar, the 
cardiology referal rate for CABGS is a good proxy for the need ofCABGS. Based on the 1999 
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study, we predicted that 691 surgeries/year would be required to meet community demands in 
2001 (Table 4.14). However, 717 surgeries were actually refened and 20 patients were added to 
the waiting list. The diference between actual and predicted need makes benchmarking for the 
future unreliable. Comparison of clinical practice in 1995 and 1999 demonstrated that 
assumptions continue to change. Case mix for CA referral changed and patients with less severe 
symptoms were referred for CABGS. Indications for PTCA + stenting changed and utilization 
for this procedure increased substantially. From 1999, proportions referred for CABGS 
increased from 26% to 30% in 2001 (Table 4.13), while proportions referred for PTCA 
decreased from 29 to 23%. 
Demonstrating continued flux of CABGS in utilization and demand, the researchers fear 
that assumptions catmot be maintained. Benchmarking data in a time of health care instability is 
not appropriate. Instead, the study indicates that physicians are appropriately and necessarily 
applying services. Therefore, it is by this means that govennnent should meet future demand. 
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Table 4.13 Coronary Revascularization Utilization+ 
1998 1999 2000 2001 
Coronary Catheterization 2196 2269 2258 2389 
Refe.-red CABG 0/t, 578 613 628 717 (26) (27) (28) (30) 
PTCA 0/o 631 536 529 550 (29) (24) (23) (23) 
CABG performed 437 473 641 626 
CABG Waiting List 227 308 223 243 
Annual Growth in 
CA ( 0/o) 9.2* 3.3 -0.5 5.8 
CABG (0/o) 12.0* 6.0 2.4 14.2 
PTCA (0/o) 39.0* -15.1 -1.3 4.0 
+ Includes patients who had repeat CA while on CABGS waiting list 
• Derived from increase between 1995 and 1999 
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Table 4.14 Annual Need for CABGS Based on 1999 Data 
-· -· -
1994/95 1998/99 1999/00 2000/01 2001/02 
-··-
RefeiTed for CABGS 391 517 517 517 517 
Annual growth (8o/o) NA NA 41 83 124 
Elimination of waiting list NA 50 50 50 50 
Predicted Need per year 462 567 608* 650* 691* 
Need per 1 000 population+ 1.15 1.41 1.51 1.62 1.72 
* Actual referrals were 613, 628, and 717 respectively 
+ eed/ population ofNewfoundland in 1999 
Calculations derived: 
Using# of Patients referred in 1999 cohort 517 
Increasing by 8% to 1999/00 (517*1.08) 41 
Consideration of the waiting list 50 
Predicted Need 608 
Based on Population in1999 (402,000) 1.5111,000 
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CHAPTERV 
Discussion 
5.1 Introduction 
This study has demonstrated that physician decision-making for CABGS continues to be 
appropriate. We have noted changes in utilization over the study years, making estimation of the 
need for C ABGS in coming years difficult. Despite an increase in resources, access to CABGS 
continues to be inadequate. 
This study has several limitations. Firstly, using an abstraction form compiled from a 
combination of secondary data sets has limitations. The selection of which data to collect and 
the quality of the data gathered was predetennined (53). Furthermore, previously discussed 
problems in the RAND technique and data quality must be considered. 
Two research personnel gathered information prospectively from medical charts, and 
reports using patient and physician clarification when required. Hence, most of the data was 
compiled using information from numerous medical staff persom1el and from a variety of 
disciplines. As a result, the quality of data must be variable and problems are largely 
undetectable (53). Although there were few complications in assessing the information, a 
number of variables were noted to be unreliably reported. For example, tests of ischemic risk 
were necessary in the application of Naylor's priority score. Although a common procedure, 
most cardiac patients did not require the test and if completed, the results were often ambiguous 
or outdated. A further weakness results from evidence suggesting variability in the interpretation 
of coronary angiography (79). 
Scores were easily determined for most patient scenarios, however discrepancies between 
researchers still existed. Nevertheless, inter-rater reliability was high (Kappa statistic=0.92). 
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Using the objective criteria, we have excluded patient preferences, as well as other factors that 
nHIY have been revealed through patient-physician consultations. For example, in 1995, despite 
being offered surgery out of the province, none of the 41 patients who had waited> 12 months 
opted for this management ( 1 08). 
5.2 Limitations of Benchmarking 
Benchmarking the population-based need for CABG surgery is unreliable. There is an 
abundance of medical literature targeted to cardiologists who want clinical benclu11arking data, 
but recent evidence suggests that accurate, real-time, national and regional benchmarks that 
i ntcgrate cost and clinical q uaiity are scarce (132). 
ln order to determine population based need, several assumptions are necessary. It is 
important to quantify what proportion of the population is at risk. Here, we have assumed that 
all patients with critical coronary artery disease are identified. This poses several restrictions. 
Firstly, a prop01iion of patients are asymptomatic and thus, will not present to the hospital 
setting. Furthennore, all patients requiring cardiac catheterizations must be referred to the 
Health Sciences Centre and catheterization should be provided in a timely manner. This requires 
that family physicians promptly and accurately assess prospective patients. The need for CABG 
surgery is based on the identification of critical coronary artery disease through coronary 
angiography, and it is this factor that most accurately reflects the need for CABG surgery. By 
increasing cardiac catheterization capacity, the need for CABG surgery also increases (137). 
Despite increased utilization, inappropriate angiography use remained low and thus, appropriate 
diagnosis of CAD has been assumed. The average patient waited only 7 days for cardiac 
catheterization and the rate of inappropriate use was only 3.9%. As previously indicated, NL has 
a high prevalence of CAD relative to other Canadian provinces and thus, we would expect high 
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rates of angiography in this setting. In addition to this, the identification of CAD may be 
inaccurate. Gould demonstrated up to a 50% error rate in EST (exercise stress testing) and noted 
that 25% of angiographies improperly diagnose CAD (45,46). However, coronary angiography 
remains the gold standard for cardiac diagnostics (124). Leape and colleagues have suggested 
that discrepancies in diagnosing CAD have minimal consequences in the application of RAND 
criteria (79). Entry into the study was detem1ined by diagnosis of critical coronary artery 
disease, which was precisely defined through cardiac angiography. Given that cardiac 
catheterization rep01is include an assessment by a radiologist and cardiologist, the researchers 
had little difficulty in identifying the study population. Moreover, the study sample is quite large 
and it is unlikely that this variable was substantially biased. 
5.21 Will access to CA and CABGS change? 
While inappropriate usage ofCA has remained reasonably low, the proportion of patients 
diagnosed with CAD has remained stable. With the opening of a second catheterization 
laboratory, increased angiography utilization in coming years will occur, which will result in an 
increase in CABGS referral. Using utilization data, we have estimated this increase will be 
approximately 8% per annum. However, continued monitoring will be necessary to ensure 
inappropriate utilization of CA is detected. 
We have identified that CABGS is applied to patients appropriately using the RAND 
criteria. Ninety-five percent (95%) of surgeries performed were necessary and the 
cardiovascular team had almost perfect agreement with the objective scores. This evidence 
implies that current clinical decision-making is indeed a reliable tool by which to benclm1ark 
need. Increasing utilization of CABGS from a relatively low baseline rate would not be expected 
to be associated with a large increase in um1ecessary surgeries. However, when supply equals 
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I alld it is more likely that over utilization will occur and it will be necessary to monitor any t em, , 
inappropriate usage. Further, quality of care may be compromised. Demonstrating good quality 
of care and standard morbidity rates improves satisfaction with the service. We have established 
that L is curTently providing good quality of care, as indicated by length of stay, mortality and 
morbidity. These findings were comparable with other results from Canadian provinces and 
benchmarking studies (44,54,93,104). In the circumstance of restricted access to CABGS in NL, 
over utilization is unlikely whilst under utilization will inevitably occur. However, setting a 
future benchmark is difficult because the degree ofunderutilization is uncertain. Increased 
demand for CA and the advent ofPTCA with stenting further complicates the scenario. In times 
of increasing access to new technologies, it will continue to be difficult to set a benchmarking 
rate. 
5.3 Issues Arising From the Study 
5.31 Newfoundland and Labrador's Cardiac Care Program 
Funding health care places considerable financial burden on govenunent, particularly in a 
nation such as ours, whereby health care is deemed a constitutional right to every citizen. In 
attempts to control increasing financial burden, the health care system in many provinces is faced 
with reduced funding and resource cutbacks. Newfoundland and Labrador is no exception. 
Dispersely populated, it is faced with the overwhelming task of providing health services in a 
reasonably timely and effective mmmer to a scattered population. An investigation completed in 
the United States found that there were no data to indicate that outcomes were related to specific 
surgeon volume. However, centralizing the provision of coronary revascularization is believed 
to enhance perfom1ance and delivery of service due to a best performer model (8). Indeed, 
i\cwfoundland and Labrador's outcome measures have proved comparable to other provinces 
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(..l-L54). This type of system, through a wealth of knowledge and resources, enables the 
d. vascular team to handle more difficult cases, further encouraging increased demand for car JO 
CABGS. 
5.32 The balance between supply and demand 
The current study demonstrated that demand continued to exceed supply. While the CV 
panel rererred 517 patients, only 434 surgeries were completed in 1999; hence, running an 
annual deficit of 83 surgeries. Using RAND criteria, researchers have identified additional 
clients who may have benefited from CABG surgery. With this noted, it is important to 
remember that demand is ultimately based upon the use of the cardiac catheterization laboratory. 
13y enhancing access to this service, it is likely that more patients will be identified to have 
critical coronary artery disease, and in tum, more patients will require CABG surgery. However, 
continued fluctuations in usage are associated with changing referral rates as doctors attempt to 
overcome ban-iers to revascularization. Nonetheless, failure to increase CABGS utilization at a 
time of growth inCA will lead to unacceptable deterioration in waiting times for surgery. 
5.33 Waiting list management 
Using Naylor priority scoring, we have shown that although wait times are often 
exceeded, the time to surgery curves suggest that the CV panel was indeed prioritizing patients 
appropriately. Such evidence implies that clinical practice was appropriate and that the 
cardiovascular team was appropriate in its clinical decision-making. Nevertheless, poor access 
to the service has lengthened wait times particularly for elective patients and demand was not 
being met. ln a system of managed delay such as this, when demand exceeds capacity, it is 
much more likely the more urgent cases are bypassed (66). This is reiterated in other Canadian 
Investigations (66,99, 102,103,1 04). Thus, we have reduced the ability to provide emergent care, 
58 
I tl1is has considerable consequences in a queue-based system. To our knowledge, 28 patients unc 
had worsening symptoms prior to receiving treatment. Further, a total of7 patients died while 
l·t1· 11 a for CABG surgery. Patients who continue to wait for surgery undergo considerable \\ ' i.l b 
physical stress and are usually not able to work. This constitutes both familial and societal 
economic burdens. In addition, bed blocking is of paramount importance since some ofthese 
clients were unable to leave hospital and thus occupied acute care beds. Compounding this 
issue, patients who wait more than 6 months are required to undergo re-catheterization and this, 
of course, occupies the catheterization laboratory unnecessarily. Although such findings are 
similar to previous results (42), this evidence does indicate considerable issues with managed 
delay. Previous attempts at front load reduction of the waiting list or a reduction in the rate of 
referral have had little success due to considerable financial difficulties and ethical concen1s 
(91 ). L bas attempted to resolve this issue by offering candidates financial assistance and 
opportunity to receive surgery in other Canadian provinces. Only 1 of 41 who had waited> 1 
year opted to participate, resulting in a failed campaign (25, 1 08). This undoubtedly leads to 
public concern and angst. With expected increasing demand in the coming years, it is unlikely 
that health care management will be able to provide service to all clients and thus, it becomes 
imperative to provide reasonable and objective wait-time goals. 
5.34 Changing Clinical Practice 
Although the RAND Canadian criteria for necessity identified an additional 91 patients 
lor whom surgery was deemed necessary, 78 of these patients received revascularization in the 
form ofPTCA + stenting. Because the literature base is dated, PTCA may have been appropriate 
treatment for these patients in light of increasing indications for PTCA and improved efficacy 
(5.23,37,41,115,118,124,135). It is the physician decision which most accurately reflects 
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I . ues in resources. This study has demonstrated that the referral rate by cardiologists is very c 1a11::;, 
ll·ate as compared to an objective scoring system. a eeL 
5.35 Predicting Future Need 
There is a steady and linear incline in the growth rate of the Canadian population. 
Statistics Canada estimates a population of almost 36 million by 2010 (52). Simultaneously, 
changing fertility trends and mortality rates have resulted in an increasing growth rate in the 
elderly population. It is important to consider that NL has a significant level of out-migration, 
hut this has comprised mainly of the working young. Furthe1more, it is possible that these 
people retum to NL in their elder years. Utilization rates of coronary revascularization have 
risen in recent years and it is predicted that this trend will continue as the population ages. 
Irrespective of this population shift, speculations by some researchers suggest that the 
need for revascularization should decrease in the coming years. Despite decades of use of 
rcvascularization to treat CAD, this treatment remains a non-pem1anent solution (41). Recent 
e\ idence suggests that CABGS only appears to be effective in patients with 3-vessel disease, 
when analysis is adjusted for other risk factors (83). Furthermore, when patients who had an 
acute Ml are excluded, this benefit almost disappears. An overview ofCABGS's effect on 
survival at I 0 years demonstrated the advantage to be only 4 months, and that this benefit was 
largely confined to patients with left main CAD, a high operative risk score, and abnmmalleft 
ventricular function (141 ). Similarly, PTCA demonstrated no survival advantage compared to 
medical therapy and may have only modest value in symptom relief and patient preference (60). 
In addition, evidence from Holland suggests that the largest benefit can be achieved through 
primary prevention (22). The discovery and implementation of numerous primary preventative 
measures further suggests the need for CABGS should decrease. Public awareness has 
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heightened and it is likely that this should also reduce the prevalence of risk factors in the 
population. However, this may be offset by the increasing prevalence of diabetes, particularly in 
the aboriginal communities. 
Dzavik suggests that the need for CABG will actually increase in the coming 10 years 
(36). Consistent with a growing population and an increasing proportion of the elderly, he 
suggests that this change in demographics will instead increase the prevalence of CAD in a 
proportional manner. Further, the under utilization of preventative pharmacology due to 
physician and patient factors will decrease their relevance. One study of over 3300 patients 
demonstrated a less than 7% rate of medication use. As well, the increasing numbers of 
survivors ofMI's will increase the total number of patients who will eventually require 
revascularization (36). In addition, treatment with CABGS is not a cure, and hence, these 
people are o rten entered into the cyclic pattern of presentation, treatment, relief, and then 
worsening symptoms. Finally, CAD has been considered a disease of the western world. 
Studies in Asia suggest an alam1ing rise in prevalence of CV risk factors (52). It can only be 
anticipated that advancing global economies will heighten this effect (36). 
-
In Newfoundland and Labrador, it is likely that in the next 10 years, improved primary 
prevention will be offset by growth in diabetes, better survival from MI, aging of the population, 
and better detection of critical CAD through increased CA utilization. Moreover, the indications 
ror CABG surgery are expanding. To date, no intervention proves to be as effective for 
" 
improving the quality of life for patients. 
5.4 Comparison of Study Periods 
The findings from the 1995 study completed by Fox et al. demonstrated that the 
appl ication of CABG surgery was indeed appropriate and that the quality of care was good (42). 
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However, it found that wait times were not optimal and that not all necessary surgeries were 
completed. From a review of the population demographics, it became apparent that in the most 
recent study, patients receiving CABG surgery were less symptomatic as compared to previous 
findings (24% Class lYC angina as compared to 42% respectively) and that the indication for 
surgery was no longer overwhelmingly unstable angina (50% as compared to 74% in 1994/5). In 
1999, 60% of patients had triple vessel disease, similar to 57% in 1995. A majority of clients in 
both time periods were in a low operative risk category (64% and 67% respectively), and only 
4% of current cases were considered high risk in 1999 as compared to 10% in the 1995 study. 
These data were consistent with increased access to cathetetization for patients diagnosed with 
stable angina syndromes requiring elective surgery. 
Wait times did not improve over time. In 1995, researchers found that only 47% of 
patients received surgery within the appropriate time. In 1999, only 39% of patients received 
surgery within the recommended time period. Consistent with the hypothesis that demand 
exceeded supply, those patients in the urgent and semi-urgent category were least likely to be 
completed on time. Unfortunately, 107 patients remained on the waiting list throughout the 
study period. 
Following the 1995 study, attempts were made by the Government ofNewfoundland and 
Labrador and the Health Care Corporation of St. Johns to increase the capacity of the cardiac 
program (i.e., from the 1995 average of 10 to 12 procedures per week). Restructuring of the 
Cardiac Care Unit and Cardiovascular Intensive Care Unit have increased the number of 
available beds from 14 to 17 through a provision of capital funds (almost $1 million) and an 
appropriate increase in the atmual operating budget ($2 million per year) (25). These funds 
allowed for the addition of a 2nd operating room in 1997. Eight additional beds were provided to 
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the coronary recovery ward and 3 additional nurse practitioners were hired. However, problems 
,, ith the provision of perfusionists, intensive care unit beds, and adequate number of surgeons 
have prevented NL from achieving the target number ofCABGS. During the 1999 study period, 
a nurse 's strike exacerbated this problem and resulted in over 3 weeks of delayed surgeries. 
Thus, an average of only 8.4 surgeries per week were completed during the study period. These 
issues were addressed and by the end of the study period, new perfusionists were hired and the 
nurses' contract was renegotiated. In 2002, a second catheterization laboratory was opened to 
facilitate access to CA. However, Newfoundland and Labrador continues to combat issues with 
recruitment. 
Predicted need for 2001 was 691 surgeries per year. It is obvious that Newfoundland and 
Labrador was failing to achieve this rate. In addition to this, the assumptions used to predict 
ruture benchmarks were unreliable and predispose to continued failure in matclung supply and 
demand for CABGS. This failure to satisfy increased demand during recent years has continued 
to produce dissatisfied patients, media attention, and political controversy despite substantial 
efforts to alleviate this crisis situation ( 1 08). 
5.5 Summary 
Using similar practice guidelines and research infrastructure over two study periods, 
separated by 4 years, external validity was maximized. We have demonstrated that 
Newfoundland and Labrador was performing appropriate and necessary coronary 
revascularization, but despite prioritizing patients, access was limited. The governmental 
decision to fund the program based on the referral rate by cardiologists has been welcomed by 
the service provider. However, this rate has increased over time because of appropriate 
increased referral of stable angina for elective surgery. From the payer perspective, this 
63 
t. lLted arowth in need induces substantial stress on the provincial budget, and raises questions con 11 ~ 
concerning capacity to pay for this demand. The fact that this growth rate is unpredictable 
creates even greater tensions. While delays in service provision may be a source of persistent 
frustration and dissatisfaction, patients waiting for CABGS are nevertheless at similar or reduced 
risk of morbidity and mortality as compared to other patients with a similar cardiac profile (79, 
104). 
The advent of a second cardiac catheterization laboratory and increased capacity to 
perform CABGS suggests that the rate ofCABGS will continue to increase. This is appropriate 
at present because underutilization of CABGS in evident. Nonetheless, continued monitoring of 
utilization and case mix is necessary to ensme continued funding ofCABGS at a rate appropriate 
to the capacity of the province to pay. 
The government may rely on the cardiology refe1ral rates as a reasonable means by which 
to benchmark need. Thus, interference with clinical decision-making will not be necessary until 
the disparity between objective need and demand widens. 
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CHAPTER VI 
Conclusions and Recommendations 
The govemment of Newfoundland and Labrador agreed to fund CABGS based upon 
predictions estimated from the 1995 study. However, the health care system was slow in 
providing the capacity to meet this demand; failing to achieve benchmarking rates. This resulted 
in continued disparity between supply and demand, leading to increases in the waiting list and 
waiting times. This failure was exacerbated by increased ammal incident cases requiring 
rcvascularization. The current investigation sought to revisit these predictions and the 
assumptions on which they were based. 
The initial benchmarks have proven unreliable due to 1) a growth in coronary 
angiography by higher referral rates and increased access, 2) earlier referrals for CABGS patients 
with less symptomatic disease, and 3) increased utilization ofPTCA. Thus, revised 
benchmarking data must consider these facets in addition to the knowledge that NL has an 
increasing elderly population. 
This repori has demonstrated that a) the proportion ofthose diagnosed with critical CAD 
among those receiving angiography increased from 68% (1994/5) to 74% (1998/9), and b) the 
proportion of inappropriate catheterizations remained low (4%). Thus, increased utilization has 
not resulted in inapproptiate use. CABG surgery had been appropriately and necessarily applied. 
The cardiovascular team had identified almost all patients for whom surgery was deemed 
necessary while almost all the applications of surgery were necessary. This evidence is 
consistent for both time periods under investigation, indicating acceptable clinical decision-
making. Also highlighted in these findings, the identification of critical coronary artery disease 
is dependent upon cardiac catheterization utilization. Hence, it is likely that with an increasing 
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elderly population, and with earlier refenals for catheterization, so, too, the need for CABG 
surgery will increase. Considering the evidence, it is apparent that the refenal rate by the 
cardiovascular team is cunently a reasonable and cost-effective way in which to plan the funding 
ror the CABGS program in NL. Physician decision best considers change in clinical practice and 
access to resources. 
While the cardiovascular team in Newfoundland and Labrador has effectively prioritized 
patients, the demand has exceeded supply. Thus, considerable waiting list issues have resulted. 
lt is apparent that patients deemed most urgent were least likely to receive surgery within the 
appropriate framework of time. However, current findings also suggested that increased need for 
C ABGS was found in elective and more stable cases. This trend will further exacerbate the 
waiting list concerns. 
The quality of care during these investigations has not changed and has been comparable 
to previously demonstrated Canadian findings. It can be inferred that increasing capacity has not 
affected the quality of service delivery in this province. 
The rates of utilization have been dete1111ined and atmual needs have been revised. We 
estimated annual need to be 1.72 surgeries/ 1,000 population> 20 yrs of age in 2001/2002. In 
addition to a reasonable reduction in the waiting list, 691 surgeries were predicted to meet 
demand. However, on review of utilization data, 717 surgeries were referred during this year 
and an additional 20 patients were added to the waiting list. Thus, the benchmarking data was 
unreliable. lt remains questionable whether NL is capable of achieving these benchmarking rates 
in a climate of uncetiainty and high personnel turnover. Utilization rates have continued to 
Ouctuate and thus limit our ability to rely on assumptions. 
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In a climate of increasing demand in a universal health care system with a limited budget, 
it is vital that the health care profession continue to monitor and assess the provision of all 
coronary revascularization services to plan for the future. While continued assessment is 
required, the focus of future research should aim to clarify the appropriate rate of utilization of 
coronary ang iography. A national database would aid in this assessment by reducing manpower 
und financial considerations while broadening possibilities for research and analysis. In a cross-
sectional assessment, only 22% of questioned institutions had comprehensive cardiovascular 
information systems (132). It is imperative that all Canadian provinces follow suit and 
implement complementary databasing systems. 
The issues within a system of care are diverse and complex. Economic, social, and 
political considerations are relevant. Long range planning and research, which provides a solid 
foundation for the decisions of today and tomorrow, are mandatory for the continued sustenance 
of Canada ' s Health Care system. 
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I . l J• ct I on f r• ctlon U · JH 
I . t)octlon ruction <H\ 
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I. t]octton tuctton >)!a\ 
I. I]octlon traction l! - l!6 
) . Election tract ton <l ~n 
.. THOU VtsstL DIJ[AS£ 
I. [joel I on tuct ton >l!6 
I. I)octlon fuctlon U - l!6 
) . t]oct ton ruction <l ~' 
c. TWO V[SS[L DISUSE NITH rao•IIIAL LtfT 
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I. tJocllon fraction >lS\ 
I. t]octton fuctlon l! - l!6 
). E.)octton fuct lon <\)\ 
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I 2 l I ~ 6 7 I 9 
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AI . LtfT HAIN OIStAst (PROTtCTtO LtfT HAINI 
l. EJection tuctlon >lH 
2. Ejection traction U · H\ 
l, Ejection tuctlon <1!1\ 
AJ . LEfT KAIM DIJtASE (UNUOT£CTED LtfT KAJMI 
l, Ejection tract I on >))\ 
J , Ejection traction U-l!l\ 
J. Ejection tuctlon <lU 
I. TH.Et VtsSlL DISEASE 
l. Ejection tuctlon >))\ 
J. Ejection tuctlon U - U\ 
l. Election ruction <l)\ 
C. TWO VUStL DIUAS£ WITH PIIOXIH.\L 
l.tfT AHTU,JOa D£SCUIOINC INVOLVtli£NT 
J. IE'ectlon tuctlon >))\ 
2. Ejection tuctlon U · U\ 
l . tjectlon traction <IS\ 
aOUIIU. c:a LOW Ulll MOO&U.T&Lf ltG• llll vur mea IIlii. 
••oe•dtr of 
CAN 
I 6 
I 1 l 4 ) 6 l I 9 
(9 . 0 , 1.0, " 
I I 1 
I 1 l 4 S 6 l I 
(9.0, 1.2 , "' 
I 1 2 2 
1 l l 4 S 6 1 I t 
(1.0, l.l, II 
I 
I 2 l 4 S 6 l I 
(t . O, 0 . 1, AI 
2 
l l l 4 S 6 1 I 
19 . 0, D.l , AI 
I 2 4 
lll4S6ll 
11 . 0, D. l, AI 
s ) 
lll4S6ll 
(1.0, 0 . 6, "' 
I 2 4 I 
12l4S6l19 
II . 0, 0 . 1, AI 
.. .,. .. tt, ef 
IJI'V&IIft 
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••o.••ltr of 
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I 1 l 4 ) 6 l I 9 
(1 . 0 , l.l , " 
I I l 
2 ) 4 ) 6 l I 
11.0, l.l, AI 
I 6 
• . •• , • , , , 1 1 2 l 4 S 6 l I t 
(t . O, 0 . 4, AI 
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····· ·· ·· tlll4S6ll 
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1 I 1 4 
I I l 4 S 6 l I 
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4 I l 
••••••••••••••• 1 11l4S6ll 
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2 I 1 l I 
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1 . l:)octlon ru c tion ) ]!)' 
l. IIMCLt VUitL DlltAst - PaOXIHAL LtFT 
AHTtUOa OUCtHDIHC 
J. l)octlon lractlon U-JS\ 
r. IJMCLt VtlltL Ollt.Ut • ~NY VUSEL 
OTMU tHA• PI.\D 
1. Ejection ruction >lH 
2. l)octlon luctlon U-j~' 
loa.eeltr ot looeultr ot 
uvurvs rJ'C:A 
tiiJOIIAftLT 11111:1 Ulll 
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AI . LtrT KAIN DlstASt iPA OT£CT£0 LErT KAINI 
2 . t)ecl.lon !uctlon U-lS\ 
l. Ejection traction <lH 
AJ.LErT HAIM DISEASE tUNP.-OTECT£0 LEn KAINJ 
1. Ejection fraction >l~\ 
L E'ect I on tract ton U-lS\ 
J. Ejection traction <1~\ 
I. Ttllltt VUSEL DISEASE 
1 . Ejection tuc:tlon >l,\ 
l . E '•ct l on r ract ton U-lS\ 
l. tjectlon traction <H\ 
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(1 . 0, 1.4 , AI 
I I 2 4 
1114~6719 
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I I 4 I 6 1 I 
(9 . 0, 0.4, AI 
I I I I 
I I I I 6 1 1 
u .o, 1.0, AI 
l I I 
... o. .. ur ot 
nrvurn 
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11 . 0, 0 . 1, II 
I I 4 
I I I I S 6 1 I t .. , ..... . 
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I I 4 5 
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I 2 2 1 
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(l.O, 1.1 , II 
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11115611 
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(6 , 0, 1.0 , ., 
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C. TWO V[SS[L DIStAst WITH PAOlltiAL LtrT 
AHTCIUOfl DUCEHDJ HC I KVOLV[H£HT 
l. Wllh • wuy po1lt.lve eurcl•• [CC 
•· t)ect I on tuct I on >lH 
b. £)ect I on tract ton 1 S-lH 
c . t)ect I on traction <H' 
l . With • •od•nt•lr po1ltlve, 
lnd•te,.ln•t•, or n•o•tl¥• •••rch• 
tee, or uercl .. tee not don• 
1. E)ectlon tuctlon >lH 
b. Elec:tlon Ccactlon 1)-lSt 
c. EJ•cllon traction <Ut 
O, TWO VUStL OIIUst WITHOUT PlOrttiAL LtfT 
ANTUIOl OtsCtNDINC INVOLVtHtNT 
1. Nlth • .,.,, pultl.,. .••ercll• tee 
a. EJection fraction >lH 
b. EJection tuctlon lS - lH 
c. t)ectlon tuctlon <l!»t 
l. With 1 •oderately po•lthe, 
lndeterwln•t•, or n•v•th• •••rei•• 
tee, or ... rclu tee not don• 
1. tJectlon traction >lH 
b. t)ectlon tuctlon U-lH 
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15ll-HOI 
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l. UNCLE VESSEL DISEASE - PROXIMAL LtrT 
AMT£1ll01l OtSCtHOIHC 
1. Wlth • very po1ltlve ue1clae [CG 
• · t)ectlon tuct I on >lH 
b . t~•ctlon tuctlon lS- lH 
Cl . tlectlon traction cU\ 
J. Whh • •oderatelr po•llln, 
Jndet•Oilnate, or n•oallw• •••rei•• 
lCC, or eaucla• tCC not done 
• · llectlon traction >lS\ 
c. ,,,ctlon ruction <1\\ 
r . JINCLt VUUL DIS EAst - ANY VESSEL 
OTHU TIIA• PLAO 
1 . Wllh • urr potltln eauclu tee 
•· l)ectlon traction >lU 
b . l)ectlon traction U-lS\ 
c . t)ectlon tuctlon cUt 
J . iUth • •odeutelr po11tlve , 
lndetel'WIInete, or neQJtha •••rclte 
tee, or uucl•• tee not don• 
b . t Jectlon tuct ton I \-lH 
•OII.IA.L oa s..c:. aua 
hoe••tty of. 
JlrVUift 
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1 
1 1 1 l 
1 l • I 
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16 . 0, I. l , 
• 1 l J • I 6 1 
11 . 0, I.) , 
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• 11 
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1 
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••a.•.tty of 
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1 l • I 6 1 • 11. 0, 1.1, II 
1 ) I I l I 
1 l • I 6 1 I II. D, 1 , 4, II 
YUI UCI8 Ull' 
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1 1 J • I 
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1 • 
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II . 0 , l.l , ll 
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I J l J 
I l J I I 6 1 I t ... .• , , , . 
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DATA ABSTRACTION FORM FOR CABG/PTCA STUDY 
PART I: CARDIAC CATHETERIZATION 
MCP: 
------------------------
ID #: 
------------------------
Hospital: --------------
Date of Birth: ________________ _ Age: Sex: M 
---
Date Entered on Waiting List for Cath: ____________ _ 
Date of Cardiac Cath: 
------------------------
Angina Class at time of Cath: II III IVA IVB IVC 
N Date of Last l\fl: Myocardial Infarct: Y 
-------
Heart Failure Ever: Y N Class of Heart Failure: I II 
(If not documented, code as N) 
Indication for Cath: D 
1. 
2. 
Asymptomatic 
Chest pain uncertain origin 7. Post infarction Angina 
3. Chronic stable angina 8. Near sudden death 
4. Unstable angina now 9. Post CABG 
5. Unstable angina within past 3 months 10. Silent ischemia 
III 
F 
IV 
6. Acute myocardial infarction 11. Miscellaneous : Specify ______ _ 
a) non Q-wave 
b) Q-wave 
Risk Factors for C.A.D.: Yes No No Data 
Diabetes Mellitus D 0 0 
Hypertension D 0 0 
Hyperlipidemia D 0 0 
Smoker 
(within the last 2 years) D 0 0 
Positive Family History D 0 0 
High Risk Occupation: D D D 
(:.-
Drugs at time of Cath: 
Long acting nitrates 
Beta blockers 
Calcitun channel blockers 
IV Nitro 
IV Heparin 
Maximal Medical Therapy: 
Is there any contraindication 
of the above 5 classes of drugs: 
Coronary Anatomy: r==J 
Yes No 
0 D 
0 D 
0 D 
0 D 
0 D 
o ·o 
0 D 
I. Protected (L) main 5. 
2. Unprotected (L) main 6. 
3. Three vessel disease 7. 
4. Two vessel disease with prox LAD 8. 
Ejection fraction: 
I. >35% 
2. 15-35% 
No Data 
D 
D 
D 
0 
0 
0 
Two vessel without prox LAD 
One vessel disease with prox LAD 
One vessel disease other than LAD 
No critical CAD 
3. <15% or severe systolic dysfunction 
Exercise Stress Test: D 
1. Very Positive 
2. Not very positive 
Contraindication to CABG/PTCA: OY ON 
Appropriateness score for Cath: 
Necessity Score for Cath: __ 
IF INITIAL CAD PROCEED TO NEXT SECTION 
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PART II: CARDIOVASCULAR CONFERENCE 
Date of cardiovascular conference: 
--------
Yes No 
Critical C.A.D. D 
Clinical Contraindication for CABO D 
Anatomic Contraindication for CABO 0 
Clinical Contraindication for PTCA D 
Anatomic Contraindication for PTCA D 
Indication for Revascularization: 
1. Chronic stable angina 
2. Unstable angina 
3. Acute myocardial infarction 
a) non Q-waveb) Q-wave 
4. Post infarction angina 
Operative Risk: 
Female 
Weight > 1.5 ideal weight 
Wt: Ht: BMI: 
Diabetes mellitus 
Systolic BP > 140 mmHg 
Ejection fraction mild impairment 
Ejection fraction severe impairment 
Age 70-74 
75-79 
2:80 
First reoperation 
Second reoperation 
Preop intra-aortic balloon pump 
LV aneurysm 
Emergency surgery following cath on PTCA 
Dialysis dependent 
Catastropic state (acute structural defec4 
cardiogenic shock, ARF) 
Rare problem (paraplegia, pacemaker, 
congenital HD, severe asthma) 
Mitral valve surgery 
P A pressure 2: 60 
Aortic valve surgery 
Aortic gradient > 120 
CABO at time of valve surgery 
COPD 
Claudication or amputation for PVD 
Symptomatic carotid artery disease 
Risk Score: 1'-------' 
5. 
6. 
7. 
8. 
D 
D Describe: 
D Describe: 
D Describe: 
D Describe: 
Asymptomatic 
Near sudden death 
+1 
+3 
Complications during PTCA 
Revascularization with valve surgery 
+3 
+3 
+2 
+4 
+7 
+12 
+20 
+5 
+10 
+2 
+5 
+10 
+10 
10-50 
2-10 
+5 
+8 
+5 
+7 
+2 
+4 
+3 
+4 
Risk Group: 
Decision: 
jl. 
'-------J 2 . 
3. 
Normal or low < 9 
Moderately high 9-18 
Very high> 18 
1. Medical therapy 
2. CABG 
3. PTCA 
4. PTCA with stent 
High ischemic risk on noninvasive tests: Y _ N _No data: __ _ 
Date of cath: ______ _ 
Date entered on waiting list for CABG/PTCA: ______ _ 
Date procedure performed: _____ _ 
TO BE COMPLETED BY PHYSICIANS INVOLVED IN THE STUDY 
Priority Score: ._I __ ___,J 
Appropriateness Score: CABG 
CABG 
PTCA 
Necessity Score: CABG 
Invasive 
(i.e., CABG/PTCA) 
PTCA 
not candidate for PTCA 
is candidate for PTCA 
compared to medical therapy 
IF CABG/PTCA UNDERTAKEN PROCEED TO NEXT SECTION 
pART Ill: Invasive Procedure CABG/PTCA 
Procedure performed: Date Perfonned: 
--------
1. PTCA 
2. PTCA + Stent 
3. CABG 
Indication for procedure: D 
1. Asymptomatic 
2. Chest Pain of Uncertain Origin 
3. Chronic Stable Angina 
4. Unstable angina 
5. Unstable angina within the past 3 months 
6. Acute Myocardial Infarction 
7. Post Infarction Angina 
8. Post-CABG 
9. Miscellaneous: 
(a) Near Sudden Death 
(b) life threatening ventricular anythmias 
(c) unexplained cardiomegaly or CHF 
(d) surgical candidate for valvular procedure 
(e) surgical candidate for heart transplant 
(f) congenital heart disease 
(g) renal artery disease 
(b) abdominal aortic aneurysm (asending) 
(i) thoracic aortic aneurysm (descending) 
G) pre-op carotid endarterectomy 
(k) pre-op peripheral vascular surgery 
(I) suspected LV aneurysm 
Complications of PTCA (within 24 hrs): Yes No 
Failed to dilate D 0 
Emergency CABG 0 0 
Cardiac arrest D 0 
Myocardial infarct D 0 
Stroke D 0 
Arrythmia requiring defib D 0 
Insertion of pacemaker D 0 
Death D 0 
Restenosis 0 0 
Complications of CABG (during post-operative stay): Yes No 
Reoperation 
Vent Assistance > 3 days 
Cardiac arrest 
Myocardial infarct 
Sternal wound infection 
Groin!leg wound infection 
Mediastinitis 
Stroke 
Arrhythmia requiring defib 
Arrhythmia requiring pacemaker 
Acute renal failure requiring dialysis 
Death 
Other 
0 
D 
0 
0 
0 
0 
D 
D 
0 
D 
D 
0 
D 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 Specify: 
Date of Admission: _____ _ Date of Discharge: _____ _ 
Length of stay: -------
TO BE COMPLETED BY PHYSICIANS INVOLVED IN THE STUDY 
Priority Score: .__I _ ___. 
Appropriateness Score: CABG 
CABG 
PTCA .__l _ ___. 
Necessity Score: CABG 
Invasive 
(i.e., CABG/PTCA) 
PTCA 
I 
not candidate for PTCA 
is candidate for PTCA 
compared to medical therapy 
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Chapter Three 
DEFINffiONS USED BY PANEL IN FINAL RATINGS OF INDICATIONS 
To use the indications and ratings, the terms used in the indications must be explic-
itly defined. What follows are the definitions agreed to by the panel prior to complet-
ing their final round of ratings. 
1. RISK FACfORS 
The following are six risk factors for coronary artery disease: diabetes mellitus, 
hypertension, hypercholesterolemia or other atherogenic dyslipidernia, smok-
ing, positive family history (history of a myocardial infarction occurring in a 
grandparent, parent, sibling. aunt, or uncle at age less than 50 years), or male 
sex. 
2. HIGH RISK OCCUPATION 
A high risk occupation is one in which a patient developing sudden chest pain 
or sudden death while at work would endanger the lives of others (e.g., truck 
drivers, airplane pilots, bus drivers, and air traffic controllers). 
3. MAXIMUM MEDICAL THERAPY 
The patient has received drugs from at least two of the three major categories of 
anti-anginal medications (nitrates, calcium channel blockers, and beta-block-
ers); or has received one category of medication and has a contraindication 
(e.g., a patient with asthma may not be a candidate for beta-blockers) or intoler-
ance to at least one of the other two categories of medications; or has a con-
traindication or intolerance to all three categories. 
4. EXERCISE STRESS TEST RESULTS 
a. Very positive: during the first 3 minutes of the test [or heart rate is less than 
120 bears/minute (off beta-blockers) or less than 6.5 METS] the patient de-
velops: (1) 1 mm or more of horizontal or downsloping ST segment depres-
sion that is present 80 msec after the J-point or (2) typical angina; or decrease 
in systolic blood pressure of 20 mm mercury or more; or more than 2 mm of 
13 
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~horizontal or downsloping ST depression at any time; or persistence of ST 
depression greater than 6 minutes postexercise. 
b. Positive: after the first 3 minutes of the test the patient develops: (1} 1 mm 
or more of horizontal or downs loping ST segment depression that is present 
80 msec after the J -point or (2) typical angina occurs. 
c. Indeterminate: the absence of a very positive or positive test in a patient 
who fails to reach at least 85 percent of the predicted maximum heart rate or 
a heart rate-blood pressure product (heart rate x systolic arterial pressure + 
100) less than 250 without evidence of a positive test or the presence of con-
duction abnormalities (e.g., Wolff-Parkinson-White syndrome or left bundle 
branch block) that prevent the interpretation of ST segment changes during 
exercise. 
d. Negative: the absence of a very positive, positive, or indeterminate test in a 
patient who achieves at least 85 percent of the predicted maximum heart rate 
or a heart rate-blood pressure product (heart rate x systolic arterial pressure 
+ 100) of250 or greater. 
5. STRESS IMAGING STUDY 
We include a variety of tests in the category of stress imaging study: (1) 
Thallium scintigraphy (exercise or dipyridamole), (2) Echocardiography (exer-
cise, dipyridamole, or dobutamine). (3) Radionuclide ventriculography (ex-
ercise, dipyridamole). These tests are categorized as: (1) very positive, (2) pos-
itive, (3) indeterminate, or (4) negative. Definitions for the results of each test 
are provided below. 
a Thallium Scintigraphy Results 
1. Very Positive: a large anterior wall defect, or multiple defects (more than 
one arterial territory), or increased lung uptake of thallium in the absence 
of depressed left ventricular function at rest (ejection fraction < 35 per-
cent). 
2. Positive: reversible (partial or complete) thallium distribution in one ar-
terial region during exercise. 
3. Indeterminate: nonreversible (fixed) thallium distribution defect or ab-
normal distribution associated with increased lung uptake in the presence 
of depressed left ventricular function at rest (ejection fraction < 35 per-
cent). 
4. Negative: test does not meet the criteria for very positive, positive, or in-
determinate. 
~00 
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b. Echocardlography Results 
J 
1. Very positive: multiple areas of dyskinesia or hypokinesia, or a large an-
terior area change, induced by exercise. 
2. Positive: exercise-induced wall motion abnormality not present at rest or 
induced worsening of wall motion abnormality (e.g., patient has hypoki-
nesia at rest and develops akinesia or dyskinesia) in one arterial region. 
3. Indeterminate: resting wall motion abnormality or lack of a hyperkinetic 
response. 
4. Negative: test does not meet the criteria for very positive, positive, or in· 
determinate. 
c. Radionuclide Ventriculography Results 
1. Very positive: a fall in left ventricular ejection fraction of greater than 15 
percentage points during exercise or multiple exercise-induced areas of 
hypokinesia or alcinesia 
2. 
3. 
Positive: a fall in left ventricular ejection fraction of 5 to 15 percentage 
points during exercise or left ventricular ejection fraction is less than 50 
percent during exercise or exercise-induced wall motion abnormality not 
present at rest or exercise-induced worsening of a wall motion abnormal-
ity (e.g., a patient has hypokinesia at rest and develops akinesia or dyski-
nesia). 
Indeterminate: resting wall motion abnormality or an increase in left 
ventricular ejection fraction by less than 5 percentage points or decrease 
in left ventricular function by less than 5 percentage points or resting 
ejection fraction less than 50 percent. 
4. Negative: test does not meet the criteria for very positive, positive, or in-
determinate. 
6. ASYMPTOMATIC 
Patients with no prior history of ischemic heart disease (e.g., no history of 
angina or myocardial infarction). 
7. SILENT ISCHEMIA 
Electrocardiographic evidence of ischemia may be detected by three methods: 
(1) the standard 12-lead electrocardiogram, (2) an exercise stress test, or (3) 
ambulatory (Holter) electrocardiography. For our definition. we refer only to 
silent ischemia detected by ambulatory (Holter) electrocardiography. 
a Significant silent ischemia: at least 1 mm of downsloping or horizontal ST 
depression that is: (1) one or more episodes lasting longer than 5 minutes, or 
16 Coronary Angiography: Ratings of Appropriateness and Necessity by a Canadian Panel 
(2) two or more episodes lasting 1 or more minutes each, separated by 1 
mi~ute or more, when the cumulative total of episodes is greater than 5 
minutes. 
b. Trivial/no silent ischemia: does not meet the criteria for significant silent is-
chemia. 
8. MET 
A MET unit is equal to an oxygen uptake of 2.5 ml oxygen per kilogram body 
weight per minute at rest. Many exercise tests are standardized in terms of oxy-
gen consumption (i.e., 2 MITS = twice the oxygen consumption at rest). 
9. CONTRAINDICATIONS TO CORONARY ARTERY BYPASS GRAFf 
SURGERY/PERCUTANEOUS TRANSLUMINAL CORONARY 
ANGIOPIASTY 
In patients with other serious illnesses, such as those illustrated here, we gener-
ally assume they would not be presenting for coronary angiography. 
a. Terminal illness, such as cancer, AIDS, severe COPD [chronic obstructive 
pulmonary disease], hepatic failure, where a reasonable prognosis is six 
months or less. 
b. Advanced dementia 
c. Severe impairment in ability to perform the basic activities of daily living 
(i.e., a score of 3/6 or less using the Katz Activities of Daily IJving criteria) be-
cause of non cardiac disease. 
10. ANGINA 
Angina is present if any three of the following four conditions are met: (1) sub-
sternal or left-sided chest pain; (2) radiation of the pain to the left arm, left 
neck, or left jaw; (3) the pain is usually precipitated by exercise; and (4) the 
pain is relieved within 10 minutes by rest or sublingual nitroglycerin. Angina 
class definitions follow: 
a. Angina on mild exertion: includes patients in the Canadian Cardiovascular 
Society Classes III and N: 
i. Class III= angina on walking one or two level blocks. 
ii. Class fV = angina on any physical activity, including angina at rest 
b. Angina on moderate exertion: includes patients in the Canadian Cardio-
vascular Society Classes I and II: 
i. Class I =angina on strenuous exertion. 
l 
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ii. Class IJ = angina on walking or climbing stairs rapidly or in cold or in 
wind or under emotional stress. 
11. CHEST PAIN OF UNCERTAIN ORIGIN (A1YPICALANGINA) 
12. 
13. 
The patient has chest pain and two or fewer of the conditions described for 
angina. 
UNSTABLE ANGINA 
a. In patients with previously stable angina, the angina increases in intensity, 
duration, or frequency or occurs at rest (prolonged duration, not fleeting 
pain). 
b. In patients without previous history of angina, the initial episode occurs at 
rest or if it occurs with exertion it is unrelieved by rest ("acute coronary in· 
sufficiency'"). 
CONGESTIVE HEART FAILURE 
Heart failure diagnosed clinically that is persisting, is associated with a de· 
crease in functional status, and requires ongoing medical treatment. 
Definitions: 
Coronary artery disease: reduction in luminal diameter of l maio coronary artery of 50% 
or greater by visual inspection, or reduction in luminal diameter of one major coronary 
artery of 70% or greater by visual inspection. 
Unstable angina: Chest pain thought to be due to myocardial ischemia, requiring 
hospitalization because of difficulty in control or concern about the possiblity of 
myocardial infarction. This includes: (1) recent increase in the intensity, frequency, or 
duration of chronic angina; (2) the development of angina at rest; or (3) new onset of 
severe chest pain ("acute coronary insufficiency"). Revascularization is carried out while 
the patient is in the hospital or within 4 weeks of admission for unstable angina. 
Angina Class 1: 
II: 
Ill: 
IVa: 
IVb: 
angina on strenuous exertion 
angina on walking or climbing stairs rapidly 
angina on walking one or two level blocks 
unstable angina, pain resolved with intensified medical therapy 
now stable on oral medication 
unstable angina on oral therapy, symptoms improved but angina 
with minimal provocation 
IV c. symptoms not manageable on oral therapy, requires coronary care or 
parenteral medication, may be hemodynamically unstable. 
Significant coronary artery disease: 
a. Left main disease: reduction in the luminal diameter of the left main coronary artery 
of 50 percent or greater by visual inspection or formal calibration of aogiographic 
findings. Protected left main is defined by presence of a patent bypass graft to the LAD 
(left anterior descending) or circumflex arteries or by collateral flows to these arteries 
(orm a patent RCA (right coronary artery). 
tvv\.<A 
b. Three-vessel disease: reduction in the luminal diameter of all three major coronary 
arteries of SO percent or greater by visual inspection or calibration of angiographic 
findings. If measured by visual inspection, at least one vessel must have 80 percent 
stenosis. The panel believed that these represented equivalent assessments of the extent 
of the disease. 
c. Two-vessel disease: reduction in the luminal diameter of two major coronary arteries 
of SO percent or greater by visual inspection or calibration of angiographic findings. If 
measured by visual inspection, at least one vessel must have 70 percent stenosis. 
d. One-vessel disease: reduction in the luminal diameter of one major coronary artery 
(not left main)of 70 percent or greater by visual inspection or SO percent by calibration. 
6 
e. Proximal left anterior descending (PLA.D): Viabili ty of a major amount of the anterior 
wall of the left ventricle is in jeopardy owing to reduct ion in luminal diameter of PLAD 
by 70 percent or greater by visual inspection or SO percent by quantitative analyses. (For 
purposes of chart abstraction and formal utilization analysis, the definition can be 
narrowed to PLAD involvement that is proximal to the first septal perforator). 
Very positive Exercise ECG: Positive Stage I Bruce protocol: (1) During the first 3 minutes 
of the test (or onset at heart rate less than 120 beats/minute off beta-blockers, or less than 
6.5 METS) the patient develops: (a) 1 mm or more of horizontal or downsloping ST 
segment depression that is present 80 msec after the J-point or (b) the occurrence of 
typical angina; or (2) a decrease in systolic blood pressure of 20 mm mercury or more; or 
(3) more than 2 mm of horizontal or downsloping ST depression at any time; or (4) 
persistence of ST depression for greater than 6 minutes post-exercise. 
Operative R jsk Score 
Female + 1 
Weight > 1.5 ideal weight + 3 
Diabetes mellitus +3 
Systolic BP > 140 mmHg + 3 
Ejection fraction mild impairment + 2 
Ejection fraction severe impairment +4 
Age 70-74 + 7 
75-79 + 12 
2.. 80 +20 
First reoperation + 5 
Second reoperation + 1 0 
Preop intra aortic balloon pump + 2 
LV aneurysm + 5 
Emergency surgery following CA 
or PTCA + 10 
Dialysis dependent + 10 
Catastrophic state 10-50 
Rare problem 2-10 
Mitral valve surgery + 5 
PA pressure 2.. 60 +8 
Aortic valve surgery + 5 
Aortic gradient > 1 20 + 7 
CABG at time of valve surgery + 2 
Chronic obstructive lung disease +4 
Peripheral vascular disease with 
claudication or amputation + 3 
Symptomatic carotid artery disease +4 
7 
Maximum Medical Therapy 
a. Chronic stable angina: The patient has received drugs from at least two of the three 
major categories (nitrates, beta-blockers, and calcium antagonists) or the patient has 
received one class of medication, but there is a note in the chart that the patient is 
unable to tolerate the others. 
b. Unstable angina: Must meet one of the following criteria: 
1. The patient has received drugs from at least two of the following major classes of 
drugs: nitrates, beta-blockers, calcium channel antagonists, and intravenous 
heparin (except TKO Hep-lock), or 
2. Receiving intravenous nitroglycerin, or 
3. Receiving one class of drugs in (a) above, with a note in the record that indicates 
the patient is unable to tolerate other drugs. 
Contraindjcatjons to CABG 
a. Terminal illness, such as cancer, AIDS, severe COPD, hepatic failure, where a 
reasonable prognosis is six months or less. 
b. Advanced dementia. 
c. Severe impairment in ability to perform basic activities of daily living (Katz score 
of 3/6 or below) because of noncardiac disease. 
\0 to 
Medication Llat (072) 
~roup 1• NMratee 
Group 2- e.t• blodc.era 
Group 3- C•lclum c::hMnel blodwra 
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Group &- IV heparin 
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Background and Procedures 
A l\tlethod of Uniform Stratification of Risk 
for Evaluating the Results of Surgery in 
Acquired Adult Heart Disease 
Victor P:1rsonnc:r. \ID. FACC. D:1vid Dean. :1nd A.bn D. Bernstein. EngScD. FACC 
The purpose of the study was to devise a method of stratifying open-heart lJperations into Ienis 
of predicted operative mortality. using objective data that are readily available in :my hospital. 
Follo"ing unh:ariate regression :malysis of J.SOO consecutin operations. l~ risk factors \"·ere 
chosen that met these conditions. A few factors were excluded because they were insufficiently 
objectin or not always available . . -\It additive model was constructed. using the factors chosen. 
ro calculate the probability of mortality within 30 da~· s. The method was then tested 
prospecth:ely in L.33.:! open-heart procedures at the :\ewark Beth Isr.1el \ledical Center. 
Patients were categorized in the groups of increasing risk: glJod I He-c). fair I s-qc-c\. poor I l(}-
1~%). high \ l5-11JC"c l. and extremely high \::::: .:!OC7o). The correlation coefficient of :mticipated 
and observed operative mortality. using the addith:e model. was 0.9q. The oper.Itive mortality 
:.llso correlated closely with complic:uion rates and length of hospital stay. The additin~ model 
was compared with :1 second model based on logistic multiple regression: the resulting 
correlation coefficient was O.SS. The method was also tested at two tHher hospitals: although 
their sample sizes were smaller. the outcomes in each risk group were compar.1ble \tith those :lt 
this institution. The collection of data proved to be acceptably simple for :.lll three centers. This 
study demonstntes that it is possible to design :1 simple method of risk srr:uific:.ltion l1f 
open-heart surgery p:1tients that makes it feasible to anaJ~·ze oper:uh·e results by risk groups 
and to compare results in similar groups between institutions. Wider :1pplication of the system 
is recommended. 1 Circulation l9S9: 79(suppl I\:1-J-I-lZ\ 
T hose: who pay for ht:Jlth c:ue. su.:h as ~kdi­care and insurance: .::1rric:rs. h:l\·t: :1 \veil-founded interest in ~he results L)r surgical 
DfL"~Ccdures. The cost of :;;ur~t:rv is inrluenceJ b~ the 
dur:Hion of hospit:llizJtion.- rh.e severity or illness. 
:md rhe complexity J.nd intensity of c:1rc:. For this 
re:1son. rhe results of open-heart sur~cry in the 
\ biic:ue population were: made public in t ~~6 and 
i l)(\-;". : Listed by region and by hospit;J.I. such dar:1 
:ue ::1lso useful in clinic:J.l rese:1rch ro :1ssess the 
pre\·aknce of c:1rdiovasculJr disease. the eifective-
ness of therapy. and trends in medic:1l practice. 
.--\n inherent difficulty in comparing the: results of 
sur£?.erv of one institution (Or individual) \Vith those 
ut another is the Jack of :1 simple :lnd widely 
:.tccepted quantification of risk-one that defines 
rhe severity of disease and identifies the many 
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v:uiabks that .:ontribute I L"~ -1 pr~dicrJt>k l1utcome. 
The: H~J.I!h (J.re F in;:m.:e .-\..:iministr:1tiL"~n. for ~xJm­
ple. c:1n rcbte th~ resu its l)f surg~ry Io .;gc. ~~x. 
f:l.Cc (Whitt! :.lilJ OL"InWhitc . :lOd CcrtJ.in O:ClmL)[(1jJi-
tieS. but 0L1l tO the S~\ ·eriry Of JiS~J.Se. D~CJUSc it 
recc:ives all irs d:J.t::l (rom \kdic:1re [lillin~ which. in 
rum. is usuJlly b:1scJ on the f:lceshcet oi the 
hospitll ch:1rt. :1n unreliable source L)t in!ormJtion.~ 
Physici:1ns :1nd hospit:1is L)ften consider high mor-
talirv ri!Wres Jmon2 rhc:ir Datic:nrs ro be misleJding 
bec;us~ they beli;,.c: rh:1; their patients :1re in a 
higher-risk c:1regorv than uthers. There has bc:en no 
w~v ro resolve -this issue without :1 charr-bv-chart 
re.;iew. obviouslv an imoossible task. · 
Risk-strJtiticJtion methods have bec:n devised in 
the past. .-\!though some have been :lccur:ltdy pre-
dictive of operative monJlity, they are generJ!Iy 
roo complicJted ior prJctical use. often requiring 
derailed data that m:1y be unavailable. Scores quan-
rifving the degree or ventricular dvsfunction or the 
ex'rent of coronarv Jrteriosclerosis. have been useful 
when resources ~nd personnel are available to col-
lect and process such data. but they are roo com-
plex and costly for universal application. (This 
on 
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Results 
Of 17 variabks l Tabk l) subjected ro univariate 
Jnalysis. 15 fulfilled rhe purposes of the srudy (Table 
~l.. The distribution or patients by risk is shown in 
Figure !.. The me:J.n predicted operative mortalit:' 
was 10..-+CC .. The mean observed operative mortality 
was S.9CC .. Figure .: depicts a comparison berween 
predicted :J.nd actual outcomes for each of the five 
risk ran!!es .. Re2:ression analvsis revealed :1 correla-
tion c:oe.i:ticienr -of 0.~9 l Fig~re 3l.. This figure was 
obt:J.ined by comparing the mean predicted operative 
mortality for all patients in each of the five intervals 
with the observed proportion of patients who actu-
ally died within the intervaL A comparison of rhe 
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F lGl"O.E l.. 811r gn1piz uf tilt! disuibwion by preoperarin! 
ns.:..: ~·fJssiricarion o( .. .. _,_;:; putiems :nciuJed ill rile smtiy 
,:; :ht! Ye11·ark St!rh lsra.:i .\ft:!dicJi Center .. 
uniYJri:.lt~ :.1nd multivJriJre models sho\ved :.1 corre· 
!Jri~.'n co~ffici~nt ,,f L1 .. S5 ~ Figure J.). 
T~.' re~t the as::;umptiL,n th3t :my kind of heart 
:.'ur~cry might tit rhc pr~dictivc SCL1f~. three ~enerJI 
t:Te:.' ... ,f L.'pcr:nion:' were compared: aorwcoronJry 
t'Y!-':l:.'S alone. \·aiYeS :!k1ne. Jnd Yal\:~s plus :wrw-
CL'f<.'n:J.ry bypass ; Figure 51. The ... 'pcrJtiv~ mLmJiity 
in >!:Kh sub!ITL'~UD resembled the results of the !:!rouos 
CL'tnbined. -The, JitJer-:nc>!s were not sratis-tic:J.fly 
si!:!nirkJnt. .. --\ CL'mpariSL'~n ot rhc overall results 
~.,;uincd at rhis insthutiL,n \virh those from rhe two 
L'thcr centers resting this mcthl'd is shO\VO in Figur~ 
() ... mci Figure - sh('I\VS J comparis~.1n of rhc r.:sults 
c''~r:.'erYed at the rhrec cenras r:J..ken :1s :1 unit. with 
:he :1wrt:1lit:· r:.ues predicted by rh~ additi\.·c mL1dd. 
F!.lrthcr :maiyses were par"ormcd. comparing rhe 
.:'L'm;:-iicJtions in \. " :lriL'~US risk _:;rL'Ups. Figure S iilus-
:r:lt>!s rhat the inc!Jencc L'~I nonf:1t:.1l complic:HiL'~ns is 
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F !Gl.;<E :. Graph of a comparison of predicted and 
ubsen·ed outcomes ofsurgeryfor 1 .. -~J] consecwil ·e pro· 
cedures .. sho1t-n us a funcrion ofpreoperarive risk classi· 
fi cwwn . .Varrou: 1·enical bars depict the 95':C con_ridence 
limits _(or each obsen ·ed value. !The score is the predicted 
monaliry rare .. 1 .. Vumbers b_v rhe triangles indicare acrual 
monaiiry in the obsen.·ed groups. 
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FIGCRE .3. Graph of the resuits of a linear regression 
complllison ofpredictt!d ,md obst!rYt.:d morralir:y rwes for 
/ . _;_?:>_ cvnsecwil·t! upen-hearr procedures. The correlar:ion 
c:vt!_tficient tnu (i. uQ . • In til is graph. tht! entire culwr7 ~· ·as 
dil ·icfed inro sl(r;izi~Y smuller groups to prot·ide mure data 
points. 1 
dis tinctly r~l:.it~d to th~ s~verity of dis~ast!. (Any 
and all poswpcr:HiYe problems wcr~ countt!d as 
complications. including such relati\·dy common 
:.~nd benign probl~ms .1s ;mial tibrilb.rion. hypo-
kalemia-related arrhythmias. and stitch infections. 
Deaths were excluded fmm the tJbubtions.) .-\ 
similar correbtion w:1s found \Vith th~ duration of 
hospitalization 1 Figure 9). 
Discussion 
Risk Fi.1ctors Included ~ 
Several facrors knL1wn rc1 be re bred ro opcrarive 
mortalirv. such JS )iew YL1rk He an A.ssociarion 
classific;tion Jnd chronic obsrrucriw pulmLmary 
diseas~. \vere excluded i see bell'\\·) because! they 
are subject to L1bserwr bias. Ldt-\·enrricular ejec-
tion fraction. :1dmirredl~· L1t immense predictive 
value. was m1t measured in ~\·ery pJtienr; there-
sor------T------~-----.-------r------~-----, 
;~Hcenl Predicte-d Mortalty 
Mutivan~t• Lo".stu; ""g:rea.SIOll Mooel 
FIGL:RE ~- Scatter ploi of Ihe results of a linear regres-
-sian comparison uf predicted morraliries obtained with 
the additive and muiiimriaie logistic regression models. 
The carrel arion coefficient was. 0. 85 . . -1 regression line is 
supen·mposed. 
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F !GL"RE 5. Grupir or· ,z l·vmpan:,·on of :ht! •'' ·a ,;// pre· 
.iic:~·d monaiitY r.ut.:s 11·itlr ou1comes ohsen·c'i :n three 
suhl·,;tegorit!s .~r.;:,r::;ery ,znd "·itir t~if suhcut~·gc'ries rakt!n 
:vgt!rlrer. prc!C'['t'!".Uil·c ~isk c·iassr:nc.:z tion. D.ll<l from 
F.'gure ~ ,zre incfu,ic:d:(w compan"svn. 'Dzrft!re•:c·c·s among 
, ;f-osen ·<'ci suiy,; :<·gory mon.rli ty ra I c.'S <~n,f .::rj"cn:nces 
.fn'm drt! pre,iic·;c·,f mon,riily nues " ·ere nor ::;.;n:,·ticaf~,. 
s/~ryririt.'t lllL 
:'L~rc .. m estim:.ue wJs Jccepcabk. In ge:1e:-.li. it was 
Licsircd to limit ::h~ numb~r L1t criteria 50 :he colkc-
tiL)n L)f dJta \\\)uid i1ot become burdensL1mc. The 
selected risk racwrs are diSLUSscd below. Jnd th~ 
;1SSi!!ned scores .1rc shown in Table .:. 
-i.J~nder. ,.While rherc has b~cn consi.:lc:-:lble dif-
fc!"cncc of L)DiniL1n rc~Jrdin\! the imJ:'L~ru.nce of 
~ender JS J r'~cdicrive ~Jriable. ir is th~ CL10Scnsus 
th::it females ·ha\-c a higher opcrJtive morr:.liiry than 
m;.tks .. perhaps t>~c:.lU:-;e of smaller arterY size. \Vhar-
c,·er rhe cause. :·em:.lies tend ro f:ue ! ~ss \\:ell than 
ill ;lieS.: !-i, . .=:< •• '~---
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FIGL"RE 6. Graph of a compan"son of predicted and 
obsen·ed owcomes of surgery a I three cenr:ers parrzcipal-
ing in rhe prospeai~ ·e et ·a/uaiion of the addin·,·e model 
1see text for dewiis1. DUferences among obsen ·ed sub-
caregory morraliiy rates and d~fferences from predicted 
mona/if}' rates 11·ere nor: statistical~v signzficant. 
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Preoperative intra-aonic balloon counterpuisa~ 
tivn. When :1n intra-aortic balloon is in place at the 
time of surgery, indications for its use already ar.e 
evident from otber independent factors. Neverthe-
less. it is hard to discount the occasional disastrous 
result of irreversible ischemia of a lower limb. 
whicg_ at rimes contributes to a patient's demise. 
Others -also have found it to be :m indepenoent risk 
factor. IJ. : 6 
Morbid obesit;.~ For the purpose of this study. 
morbid obesirv \vas defined as at le:1st l.5 times 
normal \veight~ The impact of obesity on operative 
mortality after any major oper::nion is well known: 
this was confirmed bv logistic regression analvsis of 
the present series. Thost!" responsible for the ~ollec­
tion of d::na were provided \vith :1 table of normal 
and 1.5 x normal ,...-ei~hts. -~ 
_'vfirrai vah·e surge;-:•: .-\fter considering the many 
v:1riables th:It can affect mortality in \':Jive operations. 
it was concluded th:n. in the conre~--r of this study. 
only the ·pulmonary :.1rtery sysroiic pressure was oh 
critical importance in differenti:Jting between low- J.nd', 
hi!!h-risk siru:nion~ .-\level of 60 mm Hg was chosen "-. 
as- the . value that .:iifferentiated mild -from severe 
pulmonary hypertension. This vaiue is consistent \Vith 
those reponed in the liter:Hure.: :.:o.:-.·:--s 
Aortic \"Llil"l:! Sllr!?t:r\' . . -\pressure difference of r:o, 
mm H2: across th; Jortic ~alve w:Js selected as the . 
value differentiating mild from seYere stenosis. The 
risk inherent in .1onic insufficiency :1lso may be 
retkcted in Yentricu!:J.r jvsfunction :1nd. therefore. 
in the ejectiL1n fraction. The prcdictiL1n of opt!r:ni,·e 
mort::tliry is .:omplcx. because it depends nor only 
on the degree of ,·ah·ul:J.r stenosis ur re~ur~iration 
but on irs chrL1niLitY. on rhe degre~ L~f lefr-
ventricubr hypertrL)phy. :md ~m the- presence of 
LOngesrive he:J.n f:J.ilure. The YJ!ue selected \vas 
obtained from uni, ·ari:He :1n:1iysis L)f the results oi 
isolated :J.Ortic-,·alve replacement :md from :1 review 
of rhe pertinent recent literarure.=--~---~·-6 · 7 -
Combint!d 1·ah·e replacemem ami coronary aner:-; 
b,_lpass. If rwo vJh·es were ~)per:ned oa. the : 
values \Vere :1dded. lf .:oncomitanr aonocoronary 
b:_v'Passes were pcriormed. 2 more points "vere :1dded. 
For three ,·alves 1 r:trely seen in this series l or for 
tricuspid or pulmonary valve surgery. the surgeon 
was asked ro estimate the surgic:1J risk. In reviewing 
the literature. it is Jifficult to arrive Jt a consensus 
on the risk oi :1dding bypass grJfting to valve 
replacement. The -analysis of r.his series sh-owed a 
small additive effect. as have other analvses.II.-12..72..77.:-s 
So~e--~orkers. however, have found little or no 
difference in operative mortality.:-.-~ 
Failed angioplasr;.· or aczcre cardiac carhereri.za-
tion emergency. In an earlier study of 67 operations 
for acute -angioplasry failures at this institution. 
there was an 11 CC oper~nive mortality rate. similar 
to some rates reponed in the available literature. -q 
There was little information on the outcome of 
similar emergencies after cardiac catheterization. 
but the clinical features are so similar that the 
uutcome of emergency aonocorona~- bypass sur-
;;ery is assum~d :o be the same. 
R_Ef!p~r{l[ion.s. The yresepc- analysis showed that 1 
reoper~Hion represents a distfnd andjmportant f.ac- · 
rof"Tri predicting operative mortality~ .-\.I though th~re 
is some difference of opinion on this issue in the 
!iter~lture. with some authors reporting no impact of 
reoper:nion. -~. -., most reports tend to support this 
evaluation. :.: . .:.:.:.,.-'1·-'-'·"""- -.~ 
C:ara:srroplzlc-s!a!es. -A catastrophic state was 
de!in~ · is major :1cute structural Jamage to the 
hearrL~uch J.S :.1n :.lCute ve mricular septal defect or 
JCUte :nitra( V3.l\·e regurgitation. fn SUCh instanceS. 
an estimate of risk was made bv the surgical resi-
jent. and :1 space \vas provided -on rhe J::iia collec-
tion \vorksheet to permit justific.:uion ~..1f the value 
..:hosen. 
.-\n effort ,,·:1s made to avoid bias t--,- iimitinQ. the 
need for the sur£:eon or his associJte-s to :J.ssfgn .1 
\":J.lue. rn rhis instance. howe\'c!L it made Uttk 
Jiilcrence in the SLOrin~ outcome. becJuse the need 
fL1f :o;uch eStlffiJtion USUal(\· was .lSS0Ciated \Vith 
..:L1incidenral :nderendent risk factors th<>t alre:1dv 
had rendered the. rinal comoosite :-;Lore extremel~­
hi.=:h .. -\.lso. these procedure~ \vere s0 ~·ew th:H the~· 
h:1d little dfect on the c:1icul::ltion '-'I indi,idu;1l 
'wi.=:hrs useli in the additive model. 
'fJttft._~4m;~:circumsrazzces.· Other r:1re risk factors 
· T:1ble :) cerr:1inh· l)iav a rok in the ~'ut.::ome oi the 
surgery. In these.si'ru~tions. as \Veil :.1s in the pre,·i-
.._,us .:::.uegL)J.Y _ rhe surgical res idem w:1s :1sked to 
;:'fl1Yide :ln ~p~wpri:lte- value. 
R.f ... s.'-\ F,zcrors E..xc:'udcd 
C crt:lin f:1c:._1r5 known 1..1r susrec:ed tO aJlect 
:1wrralii'· "·e:-e ~)mirred from rhe SLL'rin~ svstem. 
Bec:1us_; J pre.::onJition L1f the study ,,·as- the iden-
~itic:ltion L1f c;iteri:.t rh:u were easii,· JUJntiried :1nd 
:-~:1dily availabie. some factors knL~,,~ :o represent 
:moL1rt:mt risks h:1J to be omined.;!Qif'0nic-obstruc--: 
riY~ pulmoti:uy dise:1se. for example. ~~·hTc_h_ts ci~ariy. 
.m important dement in survival. is :ilinost inderia-
..lbie unkss Lkt:likd pulmonary iuncrion studies are 
periormedf.:.:--.1 Tne pulmonologist .:ouid not select 
:1 single quanritati,·e clinical fearure rh:1t ,...-ould be of 
!..!Se in comoar:ing one patient 'vith another. Further-
more. for 'ob' ious !ogistic and pracrical reasons. 
many patients ne\·er receive a specinc preoperative 
pulmonary workup. 
Some facrors were excluded as roo subjective, or 
\vere available only after an operation. or were 
!nderinable. or were nor universally available. These 
include rhe number of bypasses. the use of the 
internal mammary anery. the presence :mt.l degree 
of mainstem stenosis. left ventricular end-diastolic 
?ressure. extracranial cerebrovascular disease, c::u-
diopulmonary bypass time, and operative prioriry·. 
The distribution of atherosclerotic lesions through-
our the coronary rree is also a troublesome factor ro 
the surgeon \vho must decide operability. In this 
particular matter there is great interobserver vari-
\ \ ~ 
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CLINICAL PRACTICE 
Assessment of priority for coronary 
revascula risation procedures 
C. DAVID NAYLOR RONALD S. B.-\IGRIE BER.'-:ARD S. GoLDMAN 
A.."-r"J'ONI B.'\Sl~SKI 
REVASCUU.RJSATJON PA!':ELA.-...:0 Co~SEt-ISt.:S METHODS GROUP 
To develop guidelines for ranking the urgency with 
which patients with angiographically proven 
coronary disease need revascularisation 
procedures. factors that a panel of cardiac 
specialists agreed were likely to affect urgency 
were incorporated into 438 fictitious case-
histories. Each panelist then rated the cases on a 
7-point scale based on maximum acceptable 
waiting time for surgery; 1 on the scale 
represented emergency surgery and 7 delays of up 
to 6 months. For only 1% of cases was there 
agreement on a single rating..py at least 12/16 
panelists. Results of this ranking exercise were 
used by the panel to draw up triage guidelines. The 
three main urgency determinants were<ZSeverity 
and stability of symptoms of angina"G:coronary 
anatomy from ang•ographic studies, ancPr~f 
non-invasive tests for risk of ischaemia. Together 
ttiese three factors generally gave an urgency 
rating for any given case to within less than 0·25 
scale points of the value predicted with all factors. 
A numerical scoring system was derived to permit 
rapid estimation of the panel's recommended 
ratings. 
Lancet1990;335: 1070-73. 
Introduction 
Limited medical facilities and man~wer often mean that 
patients .,.,;th coronary heart disease (CHD) have: to walt for 
~lansation procCdurcs.lnTOimafCnten.a are therdorc 
used by doctors to 1dennfy patients who deserve prioriry for 
-trt.:auncnt lx'C2usr of scvcn.rv of S'y11JP.to~Jikc_hhood of 
~.:arly ischa..:mic l!n:ms--a sorting pn>eL'SS somctimL-s termed 
triage. In Ontario (population 9·5 million), the wa1Ung tlines 
otscveraJ months for coronary artery bypass surgery 
(CABS) in some prO\-incial hospitals and institutional 
variations in a~ignm<!nt of surgical priorities• kd to the 
setting up of a panel of II cardiologists and 5 cardiac 
surgeons to develop criteria for allocating priority to 
patienrs. This report summarises the panel's con sen sus 
methods ::.'1d recommendations, and sets out a simple 
scoring system to assess patients' priorities for surgery. 
Methods 
Consensus methods 
~~--maL.b); 
r=rchcn \l.ith the RAND Corporation~• 211d the Cana~ 
}\):IOonal c:onsm5us COnferen~ on Aspects of Ccsare:an Birth. '-' 
Faaors that panclisu agrffil might be important m dmmurung 
urgL-nC)· of nffil for reva.scularisation were taken into account to 
cn:ate 438 casc-hiswries. Most of these: cases were suiuble for 
CABS rather than for pacut.aneous tr.lrulu.minal coronary 
an!,:ioplasry (PTCAl. An urgenC)· rating scale, based on maximum 
n::a~nable dclay before TC"\45Ctllaris.ation, v.-as adopted :.ubk II. 
Two appropriatc:nt:!>s nodc:s were added to the scale for p211elisu to 
indicate c:asc:s for o,a.·hich they thC"Iught rcva.scularisation seemed 
questiC"Inable or contraindica1ed (ublc: I); no urgency ratings o,a.·ere 
gj ven if one or th= nodes was chOSO"l. 
Each panelist was pro,ided ...,;th a revi~:"w (s....--:: below) on the 
potential risks of delayed surgery, and then asked to indepcndc:nt..ly 
rank the 438 c:asc:s in questionnaire form. The maximum acapuble 
waiting period \1.0!.5 to be measured from the rime thai results of 
angiographic in,·c:sti!;'ltion of anginal symptoms (table 11) became 
3\d.ilablc. 
Piiilclist~' am we~; were :~n:~lyscd, and each panelist rccei~·cd an 
anonymous rcr<'n showinc hi~ r.uing; in relation 10 lhC"I...: of the 
othr:n. ,\\:ijor pamms of disagrctment wc:re addressed 211d resolved 
at a ~nd panel m~ting, v;herc comcnsus principles for tri:lgc 
were un.anirnc>ll!>ly adnpted. 
Review of published work 
The tc\iew •. copi~ from C D. ~. on rnJu~~t : drrw un all 
publi~hcd randomiscrl uials of ml-d.ical ,·c:rsus surgial thrrapy for 
sul:>le 211d uns1.1l:>lc angina, and on some nb!.c:r..,.ational dau frnm 
registry rep:ms 10 appraise sub~roups not included in uial.s. In 
c:r>ntrast to other rC"\icv•s dclinating appropriateness of surgery, .. 
the analysis doll srccifiolly v.ith urgcnC)·. Fnr cxJmpk. if a trial 
~h,,wcd that suq:cry did mll sun h> Cllnfcr a ~urvi,·:Jl ad1·ant.Jgl· cn·a 
medic:allh<!T.!py WlW 12 months after randomisation, thcn mL-dial 
therapy for the r:-r-e of patient in the uial was judged to be safe for 
sc-n:ral months. This judgmc:nl entails an assumrnion that there is 
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:! Extn:mdy urgcnl 
L:rgml 
Sc-.m-urgent 
Sh<>n h"-1 
b Dd~yed 
.\ \.arkl-d dc~y 
lnvn<"\Ja•lt r< ..... ,,... .... Ltn.o11UC\ 
'IX"athm :!~ houn 
:!~;:! hou~ 
7:! houn to I~ ..Uy• ~t aJm'"'"" 
· 1 wcci;s to b u. cod:• 
I> -.·e-el.< to l m.>nths 
1 months to b m. .... rns 
Que">tl<>r~bk wh<1h<r n:no,culuis.:aion ~lwuiJ tx- undm.:U.en. 
lrurrrorrut< for m4>C\J~ri!'.alion to b<- und~-r..>..k.:n. 
E.~ch urgenC'f ra1.n9 lt"Vel tept'~IS tht peuod w•thtn whi'C.h lhe re-vas.cullf1SolhOn 
PfOCtout! IS r•De"Cttd to brt d~ the outet ume hmnlor uch level represents. the 
mt111mum lctept.Jble w•rhn; peuod ICH Pll•ent.s •u.•;r'\ed lhll urgency r.Jtrn; 
no latency of effect si.z.e-ie, that the benefit of surgery after a delay 
of seven) m'">nths would be the same as that of ~rgery ~t the outset. 
Morulity ~-as the sole outcome analysed in the re\·icv•; panelists 
wc:re asked to usc their o~o~.n judgment a.s ·to 51mptom burden and 
risk of other morbid events. 
Statistical methods 
The incomplc:tc: f•ctorial dc-sign. of thc: que-stionnaire allm•:ed use 
of least-squares regression to dc:tennine the: v.·cights for various 
factors ._..;thin e~ch of the five: angina cla.sse:s.. Panelist rating1 of 
"questionable" and "inAppropriate" were excluded, and only 
urgency ra~ wen cunsidercd. Factors sc:= not 10 be imponant 
urgency dc:tc:nninants were then assessed for impact as 
appropriateness dc:tc:nn.inants. This .entailed an analysis of how 
ofien changc:s in a gi\·c::n factor led to changc:s in panelist's ratings 
from urgent {gndc:s 1-7) !0 "questionable" or "inappropriate:". 
A scoring syston \\"aS also dc:ri\·ed from the regression model. To 
reduce outlier influences, the highest and lowc-st one-eighth of 
rc-sponses were trimmed, and the trimmed mean rating1 were 
analysed. Rl-gression coc:fficients for the major urgency 
d.:tcrminants "'·ere thc::n combined to proJuce a score tlut 
qu.antiulively sllllliTUJi!-Cd the consensus principks adopted by the 
panel. 
-
Results 
lnterpractitioner disagreement 
For only 1% of c:asc:s was there agreement by at least 
12 "16 panelists on the ratings. However, when the scale ~-as 
TABLE II-MAJOR FACTORS AFFECTING URGENCY RANKING 
A Presenlm9 p•m syndrome and th~r~peuttC response 
I. St.at'lk ..ngm~ on n:::>.o,on,;al--k mcdacl thr:nry: m1IJ '" modcn1c tCaru.il;m 
CMdio\-aSC\JI.a.r Socict\' ch.s scs 1-11". 
~- St.at'llc =~ on ~•~••Nl--lc mNicl therapy: scH"TC ~ CzNdim 
C..UJaN·:>.cul.a.r 5.-.:icry cbss Ill . 
i . l"n•l~hk :ltlJ:'ITU. ~in r'""'h·t"J .,.;lh imct'l'afit"J mnJicl thcr.~py.mJ """". 
<ut'lk on "nllll<"\.li..:>t>Un p>nd rb-. 1\"-A . 
~ - l"n,l.ll->1.: >r~~ru. on onl th.-nr~· . ·~=r~txns llllP""·cd l:>ut .an!;iru -.,th 
rrununal rn•n'CIU<>n rund d~-. 1\"-B . 
5. S~mptClOlS nN rn:uu~l:>lc on on.l ther-apy. requires comrur~: c:uc: 
monuonn~; .lt\J parm1cnl mNicrion. rruy be h.ocrnod~=cll~· 
unst.a!>lc JW>cl cbss 1\"-C. 
8 Coronary arTery d1sease defined by an;;tography rm<ot~r>•al ~ncm~ 
1--<:lnw nr n.tull-.lcnt•' 
I . Lc.·ft 01Jtn,h-rn ,h,Th .... , ... ''II h ••r \\'Uh,-ut 'h."Tl'~' ,-£ ''lh\.•r n."'-'>(..'1'. 
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divid~ into three broad clinical categories (re\·asculari_g_ 
promptly, levels 1-4; place on a -...-airing list;;;: 5-7; and 
no mage I questionable or inappropriate}), e::nt by at 
least 12/16 panelists was rc:ached for 60% of casc::s. Panems 
of &s.agrecrncnt are explored elsewhere} 
Major factors in urgency rankings 
----The three key determinants of urgency ranking werc;.liJZ> 
symptom starus and rcsp~mse to mCilic::aJ thera~~~ 
coronary anatomy; and (iii) results of non-m\-asJve tests lor 
tsd1ac:rmc nsk a-;IVTs). 
Stable angina S\Tnptoms were defmed acrording to the 
Canadian Cardio,·as.cular Socie~sses I-II~~ 
v.ith stable angina were presumed to be on standard medical 
ihcrapy y,,fh tolerable s1dc-dfccts. For unstable angina, tbs 
panel defiried thiee subgroups of mcreasing snoerity ordered 
accorrung to the response of symptoms to medical therapy 
,._pane) classes I V-A;:B,C; table 11); ih~ Should be pertinent 
to triage practices anywhere. 
Five anatomical p.anems of coronary disease were defined 
ublc Ill). A 50% reduction in lumin.al diameter was 
suggested to be clinically significant for left mainstem 
d.i!>C3se. Although more severe stenoses were o:pected to 
upgnde urgency ratings, no thresholds were set for other 
Y~sels, since th.: clinic:aJ significance of obstrUction is often 
dt:tennine-d in the COnteXt of ooth S~Tnptorns and results of 
non-in\·asivc im·cstigations for ri!.k of ischacmic damage (ie, 
o::x.:rcisc.- d.:ctrocardiography [ECG] and nuclear imaging 
procedures). 
Since patients being assessed for priority for treaone::nt 
wouJd have angiographically documented clisease, th~ 
4pplic:ation of non-invasi\'e tests is not to detenn.inc 
rrc.:'!'cncc or absence of clinicaLCl:iD._buuailicuhc.dcgJ:tS: 
,,j mk of i~har:mia anJ th .. · risks of dr:lay. :\ simph: Ji,·ision 
&rv..·een "h1gh nsk" and "not high risk" was accordingl~­
adopted. ~on-in\·asi\·c results were not includ .. 'CI in rating 
ratients in unstOlbk angina classes IV-B and JV-C, which 
c::~.rry high risk of an =rly myocardial infarction. E':unples 
of "high-risk" non-invasive test results are as follows: a 
high-risk score on the three-variable formal o;ercise ECG 
scoring system o( Mark et al; 11 early and striking ST-
scgmcnt . depression ( ~ 2 rnm) on exercise ECG; 
hypotension during exercise testing; 12 and nuclear imaging 
\ '·\ rt 
'l.\,..;UU1.1U\.;) Ul4L )..11\1'"'\:U JiiUILJ~1(\,.- dJI"'U \. • t "''"'.'"''' ·• •· .... --·-- .. - ._ ,. 
c:xcmsc or o..iipyridamolt: thallium ~imip-:~phy . ' 11 • 
Other factors 
Two further factors were incorporated into all case-
histories: left \·enuicular function (gr<~ .. :ks I to 4 ); and 
cq:>e\.IN pi"C'<:e'dure-related morbidity and mortality (high 
\'C:~us low.a\'c:ragc) bas.cd on features oth~r than \'entricular 
dysfunctiol'l---<:g, renal failure, and chronic airflow 
l~tation. Statistical modelling showed the effects of 
changing gr.~des of left ventricular function on urgency 
ratings to be consistent but small. According to ranki.ngs 
made by panelists and to their consensus recommendation, a 
high risk of procedure-related morbidity and mortality has 
little influence on urgency but a large one on decisions about 
whether it is appropriate to proceed--ie, whether the 
risk-benefit ratio of revascularisation is satisfactory. 
Two other factors were inrorporated into the case-history 
questionnaire only for cases of unstable angina .,.,;th 
incomplete therapeutic respOnse (panel class.cs IV-B and 
lV-C)-prcvious CABS, and recent myocardial infarction. 
Pre\;ous CABS was included because of practical 
constraints in providing urgent surgery, given the increased 
technical demands and operative time required for repeat 
procedures. Although these two factors had a definite 
impact on appropriateness ratings, ncithcr had a consistent 
or large influence on urgency scores. The panelists 
recommended, howe'\'er, that recent myocardial infarction 
should be considered on an individual basis, because of its 
potential to upgrade urg~cy in special cases (cg, post-
thrombolysis). 
Summary of consensus recommendations of the panel 
The full text of the panel's cons~us statement is 
available (from C. D. N.) on request. SomEpcninent points 
are discussed here. -
Any triage guidelines must complement the prudent 
c:xert:iS:C: of clinical judgment, not supersede or supplant it. 
Fundamental to the Ontario system is the asswnption that 
those at greater temporal risk of ischaemia-related adverse. 
e\'ents deser.·e prioriry. The scheme is oriented only to 
rating the urgency of cases; it remains incumbent upon the 
pracr:itionc:r to ensure that there are appropriate indications 
for surgery. 
S}mptom starus is the key urgency determinant, .,..;th 
precedence also being given to patients v.1th coronar;.· 
stenoses that put large amounts of myoc:ardiwn at risk of 
ischacmic dam.agc, esp<.."Cially whL'Tl com)boratcd by results 
of non-invasive: tests. Impaired left \'enuicular function 
upgrades urgency slightly, albeit potentially affecting 
appropriateness of intervention by influencing the risk-
benefit ratios. Other things being equal, higher-gr<~dc 
stenoses of affected vessels v..ill take priority over lesser 
dcgre.!S of stenoses, but indi\;dual jud~ents are needed. 
Although high risk of proccdure-rclatl.-d morbidity and 
mon.ali~· is a minor urgency determinant, it may well affect 
timing because of practical constraints (eg, when post-. 
opc:rari\'c intensi\'e care unit [I CU] beds arc in such short 
supply that a prolonged ICC stay could cause cancdlation of 
procedures for other persons at the same urgency ranking). 
Intef'\'al changes in any of the factors obviously necessitate 
re-ranking of the affected patient. 
Emergency revascularisation (level I) may apply to class 
IV-C unstable patients who present with recurrent 
JL,pitL' m:tx1murn pa rr:ntcral thr:rapy anu or U!>(' 111 .u, 
int..rJ-~onic balloon pump. Level 2 ratinp :withm 2~ h ·· 
apply primaril~· to patil.'TltS with brcakthrnugh ischacmic 
symptoms despite parenteral therapy, pa.nicularly if thr: 
coronary anawmical panem suggest~ major risk of 
ischar:mic iniur}. Patients pr~nting v..ith unstable angina 
who rL~pond wdlto mr:dical therapy (panc:l class 1\'-A ·, \ '31\' 
bc:twc:t:n "semi-urgent" and "delayed" catt'gori~ 
dt:f'<."nding largdy on the anatomical panr:m and results of 
non-in\'asive h.:sts (see table Ill). 
For stable angina, if s~mptoms interfere v..ith quali~· of 
life such that benefits of re\'ascularis.ation clearly outv•eigh 
the risks, waiting times of more than 3 mcmths arc 
undesirable. However, if necessary, ratings moq: toward i 
(ic, up to 6 months' wait) for patients with Canadian 
Cardiovascular Society class I-II S>mptoms, low risk as 
indicated by results of non-invasive tests, normal left 
ventricular funcr:ion, and limited coron311· disease; most of 
these patients were deemed questionable or inappropriate 
candicbtes for surgic:~l therapy by v311·ing numbers of 
panelists. 
Scoring system for urgency rating 
A simple: sroring table (table III) was developed as 
described above; it closely parallels the specific 
recommendations of the panel for parricul.ar angina classes. 
The summary srore combines the regression constant for 
each angina class .,.,;th the coefficients for anatomy. These 
srores clearly show the expected pancms for differences in 
severity or stabili~· of angina classes and potential 
importance of anatomical lesions. To take accoW1t of 
high-risk of ischacmic event as indicated hy non-in\·asi\·c 
tests, the score should be upgraded by subtracting the 
coefficient shown for each angina class. 
Left \'cntricular function can also be added to thr: schl."'llC: 
altht-.ugh tht' ma.ximum possible difference in any case 
anributable to changes in left ventricular grade was 0·-Hl. 
Thus prcsc:ncc of an impaired ventricle (grade 3 or 4) v..ill 
upgrade the urgency score by no more than 0·20, whereas 
normal left \'entricular function (grade I) exerts an opposite 
eff c:ct of similar magnirudc. 
The standard error.. anL-st to the precision of the scorL"S 
v.ith rl"SfX.'Ct to the case-history ratings, and the: good fits 
bc:rwC'Cn the \'alucs predicted from the scoring table and 
acrual trimmed means are shov.n by the magnirudr: of the 
~-rica! and ma:ximum residuals. 
Discussion 
Amc:ric:an2" and British 15 R..A1-.I'D panc:ls ha\'e prc\'iously 
gr.~ded the appropriateness of indications for C.-\BS, but not 
Wl.;ghcd issues of urgency and uiage. Triage practices for 
p_at.tc:n~q~;Jiring coronar;.· bypass surgcryorangJOplast) 
han: nc\'er l:x:cn ~ m a randomJsea ·controlkd-rri!il. 
;\ \orco\·c:r, obsr:rYatlunal srud1cs to dr:tennmr: pir:d1ctors of 
QCll~ram·e and postoperative complicauons -from 
CABS'" •• do not take wanmg tunes mto account; llie key 
outcomes m such srudJes==<:lc:aih or mlarct1on--v.1ili1dm 
any case be: t:XfX."ClL'd to occur prl."'pcrati\'cly when waiting 
Uines are excess1ve. I 'hetonna::J consensus processaescribed 
aoo\'e was iJ1ciTIOre the best possible means of deriving 
guiding principles in this uncertain area of practice. 
Ideally, the· panel's approach should be \'alidated by_ 
ranCfomising patients either to conventional care or iO 
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insrirutinnal qucuc·s l'rdl . ."n.-d 0n the h:l~1~ of nur n.' 'SL'd 
~y~ti!JTI . owcvcr, such a trial i~ nnt ~·J:o-1hk . Oh~·rYational 
t.: · arc: nuncthck~s und~:rway, dr:J" mg in pan on the 
experience of a triaf!c referral programme in Toronto that 
U!'(."S the scoring system .outlin~-d abon:. 
The panelists sought to create a \'cry simple systt.m 
inu)TTX1rating only ess(.:mial obit.'Ctin: clinical data. All 
things tx:ing equal, a doctor's rcspon~ to a 65-year-old 
retired person ~ith moderate angina of effort may be 
different from that to a .W-ycar-vld latx)ura who is dis.ablcd 
' by similar S)mptoms. However, such issues seem best left to 
the: fiduciary judgment of the parties involved. Some 
interpra.:titioner variability in factor interpretation is also 
inc\itahlt.'--ie, one cardiologist's class I II angina may be 
anothc:r 's class I I. •• The chances of these ,-agaries are 
p.."Thaps small for the unstable angina cate-gories dc:,·doped 
by the pand (IV-A,.B,C), which app;:ared practical and 
appropriate to triage decision-making. Nonetheless, the 
system is ob .. iously dcpcndt!nt on the doctors' informed 
appraisals of patients' s)mptoms, and on reasonable trials of 
medical therapy for s~mptom control. 
For some doctors an urgency rating system may be 
etluc::a:Jiy disromhung. However, for a ryptcil case-btstol'}·, 
1m dtscrepancy E>erween the panelists' hi!iliesr and lowest 
urgency ratin was uivalcnt to differences in tirnin of 2 
wee for patients with scvcrclv unsU!blc angina, and of at 
least 3 months for those with stable s)mptoms. 7 Thus 
pracn~mg v,,thout such a s ema in laces where there are 
ong v.-airing lisrs for CABS or PTCA coyjd be an erhjcaJ.. 
tssue. \X'ith no corrun'On terminology and no urgency 
~g system, inter-practitioner and interinstitutional 
diffcrc:nccs arc inC\·iU~blc, cannot be identified for planning 
purposes, may be harmful to patients, and raise the issue of 
whcthcr uuly informed consent has tx~ obtained from 
those who await revascul.arisation- pr~ures. ,\1oreover, 
the: panel's goal Y."35 to cope with th~ realip· of Ijmirc:d 
resources, Y.ithout in an\' way countenanCin the conce t of 
en y waiting lists for rc:rasotlarisarian prrx·edur~ 
Is our systt."m applicable in other counuies? .The 1988 
Ontario CABS rate of 42 per 100 000 r<rsons is Jess than 
half the American national rare but about double the British 
rare, and international differt.-nces in dOctors' viev.'S on 
surgical indiCltions ha\'e been rC"COrdt.-d." Thus variability 
among nations c.."Xist in both the tYP<-~ of p:llit.-nts awaiting 
n:\'a!>cul:uisauon :md their waiting tim~~- Our concern was 
the \·ariabili!)' in queue-forming practices v.ithin a gi\·en 
health Cln: system. 'l\:c,ncthek-ss. our exp.:rience shows how 
a form.a..l consensus proc~.-ss c::m help set guidclinc."S for 
id~:ntifying patimts who dL'SL'r\'C priori[}· for 
rc\'ascularisarion. Our schcmc can he modified for usc 
ds.L'\\·herc b\· altering the: time-frames anachc.-d m the 
urgmcy ratin or b\' n:taining only the scoring system to 
lie p sckct order of priority in surg1ca qUl.."UI:s ITTCS{Xctl\'e of 
an:rage or target wanmg umc:. 
R<"'""'"'\JI..!ru.Jthon P:md- <-..rJ,•i<•~:s,t> : R. S. B.u1=n.:. Sunnyl'zrn•l< Hc:.olth 
Sucr)CC' l.<.'Tltr.: · cn-cil~lnn:ltl; n .. r .. Jd S. fk:ml.mJ<. L"nin'T\II'Y of Otu><'3 
H.::lll ln<lllutr: :-,:<,1 &mun. Tutur~w 'X'c"Slcm H,..,r,ul; D.-·id Sons. Pc·d 
. \\crTK"n~l Hnl'flll~l. Hl':ltTiptun: John:\ . Ulm~. HJ.mthon G<.,...c"T:ll Hospll~l 
.,,.,·h~•= : D:.~, · ~oJ H . F11dl~u. R··~· ~l \'tnor•~ H•"f'll:.tl . . \\,>nlrol; Amm 
H~ ... Toronto '1).-estcm Hoo;piul jdc-n"2"--dl; Allm H<-ss. York u>unty 
Hospiul, Scv.'TTlal'lc.ct; William Hughc-;, Pcterborou~ Ch·ic Hosrutal; Jamcs 
5><"21'1. Sarborough Cmtc:ru.T)' Hospiut; Allan Tirunouth: Sc:arroruu~ 
Ci<.:ncnl Huspiul. C:mliac surgrons: B. S. Guldrrun, Sunnybruul:: Haith 
Scicnc:r Cc:n1rc (co-dwrmanl; John Gunstcmcn. Hamilton Galen! 
Hospiul; S. V. Lic:htcnstcin, St .\l.ic:hacl's Hospn-21: D;•·id 541tcr, Toru.oto 
'X"rncm HospiLJ.J; Richard D. \l:'eiscl, Toronto Go'lc-,.J Hospital. 
l.N'!'<T'I<U' ,'\\C"lllOO< lJ~J'C\'IITC"\" ·" - :VIuc-r.«l, ~rtmcnl -· 
H..,llh C.orr :anJ EpoJC'TTII01.~, l'nl\ CT'oll~ of Hnu-.h ('A•Iumhu .. \\;aru C. 
R.>...-chu,, Tnrronw H•"ru-21. A. Ua"n...l-.1. SUIV"Iyhn•nl Clmtol cpz..larunlc-g)· 
L'rut anJ Tomnt•• 'X'c-<IC'ITI Hn<p1ul. Llfl~ Humcr, Torunll' CuJJrn-a<.eulu 
T ~c and R co:i st ry P'n op-vn; J 'ona than L.c>rru.. • G:n 1 rc fur H c::al th 
E.n"n<"O<nlc and Puhc:-· Aru.lym .. \lc.\u"C"'' L'ru•·c-nity; Ouutorhc-r D . 
. \1<•~. Sunnyl'zn-.:ll: Haith Sclmcr Ccntn:: C. D . :-.;;ylor "ch.>Jmunl, 
Su,,,,,~· t.n>nl< Hclth s.._,tTIC"C' Cmtn:, }cm1 Olll. Dc"'J"anmcr)l of 1"1'10nClc 
Sur~:rry. L'ni\·CTSsty ofTun:onto; M . . \\. FUdlhs. ronsuh..ant 111 cp1dc:rruok>i:Y 
and progr.un c·nJu:mon. 
The- panC'I v.-r; n'!fl•·mn:! und<'T the ~u'p1~ of the- .\lnn'{''lit.an Toronto 
CudJ,,.·as...-ular Tnage anJ RC"-gmr:o· P'n'l!r.un S!'ll'l"-'rcd by the Cun1na.ry 
Care L'nn directoi"S' dul:o of .\-\C'U'C>pOiiun Toronto; the .\ktropotit= 
Toronto District Hollh CounCll; the- dJ,,sions of c:ardion~lar ~- and 
.:a.rd.CIIogy of the- dq>artmcnts of surgery and mediCine, l'nm:niry of 
T,~h' mc-d.tal f:an~lry; 31'\d the- Ontano ,\linistn· of Haith. '\t'c- t.lunlt Ms 
LydJa Hokt.ich. ,\in .'-uy Talr.er •. \in &th Rnt<.:n~. md ,\\n Karen 
FI"21Tl!'dcn fur =C't.arial ~urron. C. D. ~ . i~ supponed hy a carttT sacntist 
~><"2rd fn.wn thr: Onuno .\iinlstr:o· of Haith . 
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CABG Priority Score 
Anatomical Equivalent Stable Angina Unstable Angina• 
Class I/Class II Class III Class IV A Class IV B Class IV C 
Left main disese 5.40 4.85 4.75 3.40 2.15 
2 vessel, 3 vessel + prox LAD 6.15 6.00 5.50 3.90 2.55 
3 vessel disease (without prox LAD) 6.45 6.35 5.80 3.90 2.65 
1 vessel + prox LAD 6.80 6.55 5.80 4.05 2.90 
1 vessel, 2 vessel (without prox LAD) 6.95 6.65 6.15 4.15 3.05 
Non-invasive testing** -0.9 -0.75 -0.75 n/a n/a 
• Oass rv A- resolved with increased therapy; Oass rv B- resolved with increased therapy, recurrs with minimal activity; Class rv C - requires intravenous therapy for pain control 
''high risk exercise EKG, high risk nuclear medicine study 
Score: Priority 
1 - Immediately 
2- $24 hours 
3- $72 hours 
4- $14 days (same admission) 
5- $6 weeks 
6- $3 months 
7- $6 months 
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Coronary artery bypass graft surgery 
in Newfoundland and Labrador 
George A. Fox, MD, MSc; Jonathan O'Dea, BSc; 
Patrick S. Parfrey, MD 
Abstract 
Background: Newfoundland and Labrador, like other health care jurisdictions, is 
faced with widening gaps between the demands for health care and a strained 
ability to supply the necessary resources. The authors carried out a study to de-
termine the rates of appropriate and inappropriate coronary artery bypass graft-
ing (CABG) in the province and the waiting times for this surgery. 
Methods: This retrospective cohort study was performed in the tertiary care hospi-
tal that receives all referrals for coronary angiography and coronary artery revas-
cularization for Newfoundland and Labrador. By reviewing the hospital records, 
the authors identified 2 groups of patients: those in whom critical coronary 
artery disease was diagnosed on the basis of coronary angiography and who 
were referred for CABG between Apr. 1, 1994, and Mar. 31, 1995, and those 
who actually underwent the procedure during that period. By applying specific 
criteria developed by the RAND Corporation, the authors determined the appro-
priateness and necessity of CABG in each case. They also compared waiting 
times for CABG with optimal waiting times, as determined by a consensus-
based priority score. 
Results: A total of 338 patients underwent CABG during the study period. The 
cases were characterized by multivessel disease and late-stage angina symp-
toms. Almost all of the patients had high appropriateness scores (7-9), and 
nearly 95% had high necessity scores (7-9). However, during the study period, 
the waiting list increased by about 20%, because a total of 391 patients were re-
ferred by the weekly cardiovascular surgery conference; the authors identified 
these and an additional 31 patients as having necessity scores of 7 or more. 
Only 7 (23%) of 31 patients for whom CABG was considered very urgent un-
derwent surgery within the recommended 24 hours, and only 30 (24%) of the 
1 22 patients for whom CABG was considered urgent underwent surgery within 
the recommended 72 hours. 
Interpretation: These results provide evidence that the cardiac surgery program in 
Newfoundland and Labrador is performing CABG in patients for whom surgical 
revascularization is highly appropriate and necessary. Access to CABG is less 
than ideal, however, since the waiting list continues to expand, and many pa-
tients wait beyond the recommended time for surgery. 
Resume 
Contexte: Dans le domaine des soins de sante, Terre-Neuve et le Labrador font 
face, comme les autres provinces et territoires, a des ecarts qui se creusent entre 
Ia demande et une capacite grevee de fournir les ressources necessaires. Les au-
teurs ont realise une etude pour determiner les taux de pontages aortocorona-
riens (PAC) appropries et inutiles dans Ia province et Ia duree des periodes d'at-
tente ecou lees avant de subir cette intervention chirurgicale. 
Methodes: Cette etude retrospective de cohorte a ete realisee dans l'hopital de 
soins tertiaires qui rec;oit tous les patients que l'on envoie subir une coronaro-
graphie et une revascularisation de l'artere coronaire a Terre-Neuve et au 
Labrador. En etudiant les dossiers de l'hopital, les auteurs ont defini deux 
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groupes de patients : ceux chez lesquels on a diagnostique une coronaropat 
critique a Ia suite d'une angiographie coronarienne et que l'on a envoye SL 
un PAC entre le 1•' avri I 1 994 et le 31 mars 1995, et ceux qui ont vraiment s1 
!'intervention au cours de Ia meme periode. En utilisant des criteres particuli 
mis au point par Ia RAND Corporation, les auteurs ont determine Ia pertiner 
et Ia necessite du PAC dans chaque cas. lis ont aussi compare les periodes d' 
tente aux periodes d'attente optimales determinees en fonction de priori 
etablies par consensus. 
Resultats :Au total, 338 patients ant subi un PAC pendant Ia periode d'etude. L 
multiples vaisseaux atteints et les symptomes angineux au stade f inal caract€ 
saient les cas. Chez presque tous les patients, les resultats de pertinence etaiE 
eleves (7-9) et dans presque 95 % des cas, !'intervention etait tres necessai 
(7-9). Au cours de Ia periode d'etude, toutefois, Ia liste d'attente s'est allong1 
d'environ 20% parce qu'au total, 391 patients ant ete presentes a Ia suite de 
table ronde hebdomadaire sur Ia chirurgie cardiovasculaire; les auteurs o 
determine que chez ces patients et chez 31 autres, Ia cote de necessite c: 
teignait 7 ou plus. Seulement 7 (23 %) des 31 patients chez lesquels on a ju~ 
qu'un PAC etait tres urgent ant subi !' intervention chirurgicale dans le del. 
recommande de 24 heures et 30 (24 %) seulement des 1 22 patients chE 
lesquels on a juge le PAC urgent ont subi !'intervention chirurgicale dans I 
delai recommande de 72 heures. 
Interpretation : Ces resultats demontrent que dans le cadre du programme d 
chirurgie cardiaque a Terre-Neuve et au Labrador, on pratique des PAC che 
des patients pour lesquels Ia revascularisation chirurgicale est tres pertinente £ 
necessaire. L'acces au PAC n'est toutefois pas ideal, car les listes d'attente con 
tinuent de s'allonger et beaucoup de patients ati:endent plus longtemps que !I 
delai recommande pour subir une intervention ch irurgica le. 
D espite the evidence supporting coronary revascu-larization, controversy exists regarding the ap-propriate use of coronary artery bypass grafting 
(CABG) in clinical practice. This debate relates to overuse 
in some regions and underuse in others and is the result of 
inconsistent descriptions of patient outcomes, 1 observed 
variations in practice,u different ratings of appropriate-
ness," escalating costs,\ rationing of health care services6•7 
and recent media attention. 8 
Patient selection 
We reviewed the records of the tertiary care hospita 
that receives all referrals for coronary angiography anc 
coronary artery revascularization for Newfoundland anc 
Labrador. We identified 2 groups of patients: those wid 
a diagnosis of critical coronary artery disease establishec 
by coronary angiographt who were referred for CABG 
between Apr. 1,1994, and Mar. 31, 1995, and those who 
actually underwent the procedure during that period 
(many of whom were already on the waiting list for 
CABG at the beginning of the study period). We ob-
tained the patients' medical records, including pertinent 
documents from referring hospitals, from the Health 
Care Corporation of St. John's. We used a modified 
medical record abstraction formQ to capture the data re-
quired to determine the appropriateness, necessity and 
priority of CABG. The data were collected by experi-
enced research nurses and data abstractors trained to use 
the form. The information collected included demo-
graphic characteristics such as age, sex and date of coro-
nary angiography. Additional data included angina symp-
toms, cardiovascular history, cardiac medications and 
coronary artery anatomy. We also coUected data on non-
invasive testing, such as exercise stress testing and assess-
ments of left ventricular function. 
The province of Newfoundland and Labrador, like 
other health care jurisdictions, is faced with widening gaps 
between the demands for health care and a strained ability 
to supply the necessary resources. Effective delivery of 
CABG to the community implies that the surgery be per-
formed in appropriate patients, that waiting periods be 
reasonable and that the patients who need the procedure 
actually receive it. We carried out a study to determine 
the rates of appropriate and inappropriate CABG and the 
waiting times for this surgery in Newfoundland and 
Labrador over a 12-month period. 
Methods 
The study protocol was approved by the Human In-
vestigation Committee at Memorial University of New-
foundland, St. John's. 
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We classified angina symptoms, coronary artery 
anatomy and indications for CABG on the basis of the 
data collected and subsequently reviewed these classifica-
tions for accuracy. All abstracted records were reviewed by 
2 of us (G.A.F and P.S.P.) for completeness and consis-
tency. In addition, these 2 authors independently scored 
each record for the appropriateness and necessity of 
CABG according to the RAND Corporation criteria. 9 
The appropriateness and necessity scores were subse-
quently compared, and discrepancies were settled by con-
sensus. 
Whenever possible, for each case we obtained photo-
copies of notes from the cardiac catheterization procedure, 
the cardiovascular surgery conference and the surgery it-
self and attached these documents to the data record form. 
In addition, discharge summaries and letters of consulta-
tion as well as results of investigations such as stress tests 
and echocardiography were attached to the form. 
Definitions 
The definitions for unstable angina, angina class, 
asymptomatic coronary artery disease, significant coro-
nary artery disease, maximum medical therapy, results of 
noninvasive tests, levels of operative risk and contraindi-
cations to CABG were those approved by the Canadian 
panel that developed the scoring instrurnent.9•10 
Scoring of appropriateness and necessity 
After collecting the data, we assessed each case for the 
appropriateness and necessity of CABG using a predeter-
mined criterion-based, validated scoring system devel-
oped by the RAND Corporation and adapted for the 
Canadian population.9 
A procedure was deemed appropriate if the expected 
health benefits ·exceeded the expected negative conse-
quences by a margin that would lead the physician to re-
gard the procedure as worth doing, exclusive of mone-
tary costs. 9 A procedure was deemed necessary if the 
physician would feel obligated to recommend this pro-
cedure as the best clinical option available, given the 
high probability of a clinically important benefit in pa-
tients with that presentation.9 Thus, the necessity ratings 
include a more stringent risk-benefit assessment than do 
the appropriateness ratings, and, by definition, if a pro-
cedure is considered necessary it must first be consid-
ered appropriate. 
Appropriateness was scored on an ordinal scale from 1 
(eA.'tremely inappropriate) to 9 (extremely appropriate). In 
general terms, a score of 1 to 3 indicates inappropriate, 4 
to 6 b."'ltermediate and 7 to 9 appropriate. The same rat-
ings were used for the necessity scores. 
Priority scoring 
Using a priority score developed by consensus/ 1•12 we 
ranked patients waiting for CABG according to need. 
The priority ranking was determined by the pattern or 
severity of angina symptoms, the coronary artery anatomy 
and the results of noninvasive tests of ischemic risk. 11 The 
cases were categorized as follows: very urgent (patient 
should undergo surgery within 24 hours), urgent (should 
undergo surgery within 72 hours), semi-urgent (should 
undergo surgery within 14 days during the same hospital 
stay), short elective list (should undergo surgery within 6 
weeks) and delayed elective list (should undergo surgery 
within 6 months). 
By comparing this categorization with the length of 
time the patients actually waited for CABG, we were able 
to make an indirect assessment of the efficiency with 
which the cardiac surgery program delivers CABG in the 
provrnce. 
Results 
Study population 
Coronary angiography was performed in 1604 patients 
during the study period. Of these, 1082 had critical coro-
nary artery disease involving at least one artery. Percuta-
neous transluminal coronary angioplasty (PTCA) was 
performed in 266 of these patients. Of the 816 patients 
with critical coronary artery disease who did not undergo 
PTCA, 58 had a contraindication to surgery, and 9 had 
incomplete medical records. Of the remaining 749 pa-
tients, 391 (279 men and 112 women with a mean age of 
61.9 [SD 10.2] years) were referred for CABG, and 358 
(252 men and 106 women with a mean age of 57.6 [SD 
11.2] years) were treated medically. The clinical charac-
teristics of the 2 groups are shown in Table 1. 
The average waiting time for CABG among the 391 
patients referred for this procedure during the study pe-
riod was 33 (SD 63.5) days (range less than 1 hour to 397 
days). The last CABG procedure for this group was per-
formed on Oct. 14, 1995. Of the 391 patients, 301 
(77.0%) had symptoms compatible with class IV angina, 
and 71 (18.2%) had class ill angina symptoms. A total of 
328 patients (83.9%) were receiving maximum medical 
therapy at the time of coronary angiography. Over half 
(222 [56.8%]) had triple-vessel disease, and 61 (15.6%) 
had disease of the left main coronary artery. 
During the 12-month study period only 338 patients 
(242 men and 96 women with a mean age of 61.0 [SD 
1 0.6] years) actually underwent CABG (Table 2). Of 
these, 2 08 had been on the waiting list before Apr. 1, 
1994. Most presented with unstable angina (252 [74.6%]) 
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or had persistent ischemia following myocardial infarction 
(33 [9.8%]). A total of 252 (74.6%) had left main artery or 
triple-vessel disease, and 289 (85.5%) were receiving max-
imal medical therapy. 
Appropriateness of CABG 
The appropriateness and necessity scores were high. 
Of the 338 procedures, 334 (98.8%) were considered ap-
propriate and 317 (93.8%) were considered necessary. 
There were no cases in which CABG was considered in-
appropriate (Table 2). 
Referred for Medical 
CABG surgery treatment 
Characteristic n=391 n =358 
Angina 
None 9 (2.3) 54 (15 .1) 
Class I 2 (0.5) 54 (15.1) 
Class II 8 (2.0) 35 (9 .8) 
Class Ill 71 (18 .2) 42 (11.7) 
Class IVA 77 (19.7) 136 (38.0) 
Class IVB 81 (20.7) 26 (7.3) 
Class IVC 143 (36.6) 11 (3.1) 
Indication for CABG 
Stable angina 49 (12.5) 80 (22.3) 
Unstable angina 275 (70.3) 153 (42.7) 
Acute Ml 4 (1.0) 2 (0.6) 
Post Ml 43 (11.0) 91 (25.4) 
Asymptomatic 3 (0.8) 28 (7.8) 
Near sudden death (0.2) 3 (0.8) 
Complications of PTCA orCA 5 (1.3) 0 (0 .0) 
Valve surgery 11 (2.8) (0.3) 
Coronary anatomy 
Protected left main artery 1 (0.2) 2 (0.6) 
Unprotected left main artery 60 (15.3) 1 (0.3) 
3-vessel disease 222 (56 .8) 48 (13.4) 
2-vessel disease+ PLAD 52 (13.3) 46(12.8) 
2-vessel disease 35 (9.0) 67 (18.7) 
1-vessel disease + PLAD 15 (3.8) 46 (12.8) 
1-vessel disease 6 (1.5) 148 (41.3) 
Ejection fraction, % 
> 35 287 (73.4) 285 (79.6) 
15-35 80 (20.5) 63 (17.6) 
< 15 20 (5.1) 8 (2.2) 
No data 4 (1.0) 2 (0.6) 
Operative risk 
Normal or low 250 (63.9) 268 (74.9) 
Moderate or high 101 (25.8) 81 (22.6) 
Very high 40 (10.2) 9 (2.5) 
Note: CABG = coronary artery bypass grahing, Ml = myocardial infarction, PTCA = percuta-
neous transluminal coronary angioplasty, CA = coronary ang1ography, PLAD = proximal len 
anterior descending artery. 
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Waiting period 
Although 391 patients were referred for CABG dm 
the study period, only 3 3 8 underwent surgery; thus, 
waiting list increased by 53 patients. 
Characteristic 
Angina 
None 
Class I 
Class II 
Class Ill 
Class IVA 
Class IVB 
Class IVC 
Indication for CABG 
Stable angina 
Unstable angina 
Acute Ml 
PostMI 
Asymptomatic 
Near sudden death 
Complications of PTCA orCA 
Valve surgery 
Coronary anatomy 
Protected left main artery 
Unprotected left main artery 
3-vessel disease 
2-vessel disease +PLAD 
2-vessel disease 
1-vessel disease +PLAD 
1-vessel disease 
Ejection fraction, % 
> 35 
15-35 
< 15 
No data 
Stress test result 
Very positive 
Not very positive 
No data 
Operative risk 
Normal or low 
Moderate or high 
Very high 
Appropriateness score for CABGt 
1-3 
4-6 
7-9 
Necessity score for CABGt 
1-3 
4-6 
7-9 
No. (and %) of patients 
6 (1.8) 
(0.3) 
5 (1.5) 
50 (14.8) 
66 (19.5) 
67 (19.8) 
143 (42 .3) 
34 (10.1) 
252 (74.6) 
3 (0.9) 
33 (9.8) 
2 (0.6) 
1 (0.3) 
5 (1.5) 
8 (2.4) 
1 (0.3) 
62 (18.3) 
189 (55.9) 
49 (14.5) 
24 (7.1) 
11 (3.2) 
2 (0 .6) 
250 (74.0) 
63 (18.6) 
21 (6.2) 
4 (1.2) 
161 (47.6) 
28 (8.3) 
149 (44.1) 
217 (64.2) 
85 (25.1) 
36 (10.6) 
0 (0_0) 
4 (1.2) 
334 (98.8) 
4 (1.2) 
17 (5.0) 
317 (93 .8) 
'Of these patients, 289 (85 .5%) were receiving max1mum medical therapy at the time 
ofCABG. 
tl =extremely inappropriate or unnecessary, 9: extremely appropriate or necessary.! 
See Methods. 
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In addition, using the RAND Corporation criterion of 
a necessity score of 7 or higher as an indication for 
surgery,9 we identified another 31 patients (i.e., 422 in all) 
for whom CABG was considered necessary . 
The length of time spent on the waiting list for each 
category of patient is shown in Fig. 1 (for patients referred 
for CABG during the study period). On the basis of the 
priority scores, CABG was considered very urgent for 31 
patients, of whom 7 (23 %) underwent the surgery within 
the recommended time. The proportions of patients in 
the other groups who underwent CABG within the rec-
ommended time were as follows: 30/122 (24%) in the ur-
gent group, 56/87 (64%) in the semi-urgent group, 49/98 
(50%) in the short wait group and 40/53 (75%) in the de-
layed wait group. 
To our knowledge, 4 patients died while awaiting 
CABG during the study period. 
Interpretation 
We found that, for the period under review, the cardiac 
surgery program in Newfoundland and Labrador per-
formed CABG predominantly in patients with late-stage 
angina symptoms and multivessel coronary artery disease. 
In addition, bypass surgery was performed in patients for 
whom the surgery was considered highly appropriate and 
necessary. However, we did observe substantial delays rel-
ative to suggested waiting periods. 
Most of the patients in this study presented with ad-
vanced disease, 587 (78.4%) of the 749 with class ill or IV 
angina symptoms. Unfortunately, the inconsistent report-
ing of angina symptoms in the literature 13- 16 precludes 
valid comparisons of angina classification between studies. 
A total of 493 (65.8%) of the 749 patients in the study co-
hort had angiographic evidence of multivessel coronary 
artery disease involving the left main coronary artery or 
the proximal left anterior descending artery. This finding 
is similar to the 'proportion of patients with multivessel 
disease with or without left main or left anterior descend-
ing artery involvement reported in other studies (54% to 
62%).13-ll 
Among the 338 patients who underwent CABG, we 
did not observe any cases in which the surgery was con-
sidered inappropriate. In comparison, the reported rate of 
inappropriate procedures at other centres varies from 2% 
to 16%.9 Furthermore, 94% of the CABG procedures in 
our study were considered necessary according to RAND 
Corporation criteria. 9 This rate exceeds other Canadian 
and US reports of70% to 83%. 15 •17 
Despite the delivery of highly appropriate and neces-
sary surgery there were still delays for some patients 
awaiting CABG. We observed considerable discrepancies 
berv.reen recommended and actual waiting times for 
surgery. Although some patients underwent surge1 
within the optimal period, an average of about 50% of p: 
tientsin each category were still waiting for surgery at d 
end of their recommended waiting period. There was ev 
dence, however, that cases were given priority on the bas 
of urgency, since patients with class IV angina symptorr 
underwent the procedure sooner than patients with le: 
severe angma. 
The failure to acl-lleve optimal waiting times resulte< 
at least in part, from the constant addition of urgent cast 
to the top of the waiting list, thus consuming a limited rc 
source. In addition, the total number of CABG proce 
dures performed annually was far less than the number c 
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Fig. 1: length of time on waiting list for coronary artery by-
pass graft surgery for patients referred between Apr. 1, 1994, 
and Mar. 31, 1995, in Newfoundland and labrador. Thecate-
gories refer to the recommended priority of the cases: very ur-
gent, surgery should be performed within 24 hours; urgent, 
within 72 hours; semi-urgent, within 14 days during the same 
hospital stay; short elective, within 6 weeks; delayed elective, 
within 6 months. 
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patients who required surgery, as determined by either 
the cardiovascular surgery conference (3 91) or the RAND 
Corporation criteria (422). These factors select for pa-
tients with more advanced coronary artery disease and 
may delay access to CABG for others. Additional reasons 
for delays include economic restraint, lack of access to 
critical care beds, Jack of surgical assistants and a limited 
number of cardiac surgeons. 
Limitations 
The predominant limitation of our study arises from 
the use of a retrospective chart audit for data collection. 
The abstraction of data was therefore dependent on the 
accuracy of the informacion recorded at the time of the 
original consultation, coronary angiography, surgical pro-
cedure and foUow-up visits. To minimize these problems, 
we used properly trained data abstractors and a standard-
ized, validated data abstraction record adapted for d1e 
Canadian population. 
Conclusions 
The patient profile and indications for CABG in our 
study show that in 1994 and 1995, the cardiac surgery 
program in Newfoundland and Labrador was providing 
revascularization to patients with late-stage angina symp-
toms and advanced coronary artery disease. However, de-
spite the performance of appropriate and necessary 
surgery in patients with advanced disease, the waiting list 
for bypass surgery continued to expand, and optimal wait- · 
ing times for individual patients were often exceeded. 
This discrepancy has prompted the provincial govern-
ment to use specific criteria (i.e., RAND Corporation ne-
cessity score of 7 or higher) to estimate the annual needs 
for CABG. This policy warrants investigation to deter-
mine its effect on the delivery of CAB G. 
Failure to perform CABG quickly in urgent cases may 
contribute to excess illness, unnecessary hospital costs and 
patient dissatisfaction. Furthermore, there is likely a 
larger group of symptomatic patients with less advanced 
disease whose condition is stable for whom CABG may 
be delayed. The long-term effects on this subgroup in 
terms of death, illness and lost productivity are unknown. 
We thank Dr. C. David Naylor, of the Institute for Clinical Eval-
uative Sciences in Ontario, for providing the evaluation tools 
necessary to carry out this study. 
This work was funded by the Health Care Corporation of 
St. John's. 
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CLINICAL STUDIES 
Need for coronary artery bypass grafting 
in Newfoundland and Labrador: 
The impact of increased demand 
CM Kent RN1, L Power BSc1, OM Gregory MScl, BJ Barrett MBl, CC MacCallum MD2, 
EW Stone MD2, PS Parfrey MD1 
GM Kent, L Power, DM Gregory, et al. Need for coronary artery 
bypass grafting in Newfoundland and Labrador: The impact of 
increased demand. Can J Cardiol 2004;20(4):399-404. 
BACKGROUND: In the past dec;ade, growth of coronary revascu-
larization in Canada has been substantia( It was hypothesized that as 
coronary angiography (CA) rates increased, referral for necessary 
coronary artery bypass grafting (CABO) would also increase, and 
include patients with multi vessel disease and class I to III angina who 
required elective surgery. Furthermore, it was proposed that the num-
ber of CABO surgeries needed would increase at a similar rate to that 
of CA. 
METHODS: An incident cohort of patients who received CA in 
1998/1999 was identified, and the group referred for CABG was fol-
lowed. Clinical characteristics, appropriateness and necessity scores 
using specific criteria, and waiting times were evaluated and com-
pared with a similar cohort from 1994/1995. Utilization data for coro-
nary revascularization procedures from 1994 to 2002 were reviewed. 
RESULTS: Between 1994/1995 and 1998/1999, the number of CAs 
per year increased by 3 7%. The inappropriateness rate for CA was 4% 
in 1998/1999. The proportion of patients diagnosed with critical 
coronary artery disease increased from 68% in 1994/1995 to 74% in 
1998/1999. The number referred for CABO increased by 48%, and 
the number for percutaneous transluminal coronary angioplasty 
(PTCA) increased by 137%. The increase in the number referred for 
CABO was attributable to the increase in the number of patients 
with less severe symptoms who required delayed elective CABO. The 
necessity rate for CABO in the referred group was 94% in 1994/1995 
and 95% in 1998/1999. A further 91 patients were identified who 
needed CABO but did not receive it, 86% of whom had PTCA. From 
1999 to 2002, the annual growth rate in those referred for CABO was 
higher than the growth rate for CA. 
CONCLUSIONS: With the growth in CA. the rate of discovery of 
high risk coronary anatomy actually increased. Growth in CABO 
volume was attributable to growth in the need for elective surgery in 
patients with class I to III angina. The rate of CABO increased dis-
proportionately to the rate of CA, despite higher rates of PTCA with 
stenting. It is likely that the demand for CABO will continue to rise 
steadily, as expansion of angiography occurs, and may be higher than 
expected from the growth in CA. 
Key Words: Coronary angiography; Coronary artery bypass grafting; 
Medications; Necessity scores; Waiting times 
Les besoins de pontages aortocoronariens a 
Terre,Neuve et au Labrador : Les effets de 
!'augmentation de Ia demande 
HISTORIQUE: Depuis dix ans, les revascularisations coronariennesont 
connu une augmentation subsrantielle au Canada. On pustule qu'avec 
!'augmentation des taux d'angiographie coronarienne (AC), les 
aiguillages pour un pontage aortocoronarien (PAC) necessaire 
augmenteraient aussi, et incluraient des patients aneints d'une malalie 
pluritronculaire au d'une angine de classe I a lli qui auraient eu besoin 
d'une intervention non urgente. De plus, il est propose que le nombre 
d'operations pour un PAC necessaire augmenterait a un raux similaire a 
celui des AC. 
METHODOLOGIE : Des cohones incidentes de patients qui avair:nt 
subi une AC en 1998-1999 ont ete reperees, et le groupe aiguille pour un 
PAC a ete suivi. Les caracteristiques cliniques, Ia pertinence et les 
indices de necessite calcult!s a !'aide de criteres precis, de meme que les 
temps d'attente, ont ere evalues et compares a ceux d'une cohorte 
similaire de 1994-1995. Les donnees d'utilisation des interventions de 
revascularisation coronarienne effecruees entre 1994 et 2002 ont Ct.e 
examinees. 
RESULTATS : Entre 1994-1995 er 1998-1999, le nombre d'AC par 
annee a augmente de 37 %. Le taux de non-pertinence d'AC s'elevail a 
4 % en 1998-1999. La proportion de patients recevant un diagnostic de 
coronaropathie chronique est passee de 68 % en 1994-1995 a 74 % m 
1998-1999. Le nombre d'aiguillages pour un PAC a augmente de 48 %,et 
le nombre d'aiguillages pour angioplastie transluminale percutanee 
(ATP), de 13 7 %. L'augmenration du nombre de patients aiguilles pour «1 
PAC a ete attribuee a celle du nombre de patients presentant ~ 
symptomes moins graves et qui avaient besoin d'un PAC non urgent. I.e 
raux de necessite pour un PAC au sein du groupe aiguille s'elevait a 94 ~ 
en 1994-1995 et a 95 % en 1998-1999: On a repere 91 patients qui 
auraient eu besoin d'un PAC mais qui ne l'ont pas subi, mais 86 % d'entR 
eux avaient subi une ATP. Entre 1999 et 2002, le raux de croissana 
annuelle des personnes aiguillees pour un PAC etait plus eleve que le raux 
de croissance des AC. 
CONCLUSIONS : Etant donne Ia croissance des AC, le raux tit 
decouverte d'anatomie coronarienne a haut risque a augmente. La 
croissance du volume de PAC etait attribuable a Ia croissance du besaiin 
d'intervention non urgente chez des patients atteints d'angine de classes 
l a III. Le raux de PAC a augmente de maniere non proportionnelle :m 
raux d'AC, malgre des raux plus eleves d'ATP avec extenseur. II es 
probable que la demande de PAC continue d'augmenter regulieremel'll, 
randis que le nombre d'angiographies augmente, et il pourrait etre pl111 
eleve qu'on ne le prevoirait d'apres Ia croissance de l'AC. 
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I n 1994/1995, an eva luatio n of the cardiac surgery program in Newfoundland revealed that the coronary artery bypass 
grafts (CABGs) performed were highly appropriate and neces-
sary, but that access to CABG was not ideal, the waiting list 
was high and ma ny patients waited beyond the recommended 
time for surgery ( 1 ). A s a result, the government of 
Newfoundland and Labrador agreed to fund CABGs, based on 
need and the size of the waiting list. The number of CABGs to 
be funded was derived from the referral rate by cardiologists for 
CABG, and justified by the similarity with the rate based on 
the number of patients with high RAND Corporation neces-
sity scores for CABG identified after coronary angiography 
(CA) ( 1 ). The number was estimated at 422 per year, plus an 
additional 40 per year to reduce the waiting list, a combined 
rate of 116 per 100,000 individuals o lder than 20 years of age. 
Benchmarking needs for CABG may be rendered unreliable 
if the level of demand for CABG is itself inappropriate (2) . 
Demand may increase if more patients are referred for angiog-
raphy by internists and cardiologists, including patients with 
less advanced disease (2,3 ). !~creased capacity for performing 
CABG also has the potential, through supply-induced demand, 
to lead to inappropriate overuse. On the other hand, demand 
for CABG may decrease if new efficacious coronary revascular-
ization procedures are introduced, similar to what happened 
after 1995 when percutaneous transluminal coronary angio-
plasty (PTCA) with stenting started and dramatically changed 
practice ( 4). 
In view of the restricted access to CABG, the high propor-
tion of acutely ill patients and the high necessity rate in those 
referred for CABG in 1994/1995, we proposed the hypotheses 
that, as CA rates increased, rates of referral for CABG would 
also increase and the proportion of patients with less sympto-
matic disease would be higher, but the necessity scores would 
not deteriorate. These hypotheses were tested in an incident 
cohort who received CAin 1998/1999 using the same methods 
as in 1994/1995 (1). 
Need for CABG was again defined as the referral rate from 
cardiology, and this rate was compared to that based on an 
objective scale for necessity that was applied to patients after 
CA (5 ). We suggested that the number of CABGs needed 
would increase at the same rates as CA, and assessed CA and 
coronary revascularization utilization data from 1998 to 2002. 
METHODS 
The study protocol was approved by the Human Investigation 
Committee at Memorial University of Newfoundland, StJohn's. 
Utilization data 
The records on CA, PTCA and CABG at the Cardiac Program of 
the Health Care Corporation of StJohn's were reviewed to deter-
mine the referral rates, utilization rates and wait lists for these pro-
cedures from 1994 to 2002. This program is the sole intraprovincial 
source of these services in Newfoundland and Labrador, which had 
402,000 persons 20 years of age and older in 1999. · 
Data collection 
From August 1, 1998, to July 31, 1999, a research nurse attended 
the cardiac catheteiiza.tion laboratory, and an incident cohort of 
all patients having diagnostic CA during that year was identified. 
Demographic, clinical and diagnostic test data were collected to 
determine the appropriateness and necessity of CA (5). Records 
were kept of the decisions made at the weekly cardiovascular 
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conference by card iologists and cardiac surgeons regarding the type 
of intervention to be applied to patients with critical coronary 
artery disease. Priority for CABG was determined and waiting times 
for CABG were recorded. Patients who were referred for CABG 
were assessed for the appropriateness and necessity of CABG (6). 
Data from 1998/1999 were compared with those collected in 
1994/1995. 
The data were co llected by a trained, experienced research car-
diology nurse (GMK) and by a Masters student in clinical epi-
demiology (LP). The information collected included demographic 
characteristics such as age, sex and date of CA. Additional data 
included angina symptoms, cardiovascular history, cardiac medica-
tions and coronary artery anatomy. Data on non-invasive. testing, 
such as exercise stress testing and assessments of left ventricular 
function, were also collected. 
Angina symptoms, coronary artery anatomy and indications 
for CA or CABG were classified on the basis of the data collected, 
and each record was scored for the appropriateness and necessity 
of CA, CABG or PTCA according to the RAND Corporation cri-
teria (5,6). Appropriateness and necessity scores inconsistent with 
the clinical data were reviewed by the authors (GCM and PSP), 
and discrepancies were settled by consensus. 
Whenever possible, notes from the cardiac catheterization pro-
cedure, the cardiovascular surgery conference and the surgery 
itself, discharge summaries and letters of consultation, as well as 
results of investigations such as stress tests and echocardiography, 
were collected for review on the study data record form. 
Definitions 
The definitions for unstable angina, angina class, asymptomatic 
coronary artery disease, significant coronary artery disease, maxi-
mum medical therapy, results of noninvasive tests, level of opera-
tive risk and contraindications to CABG were approved by the 
Canadian panel that developed the scoring instrument (5,6). 
Scoring of appropriateness and necessity 
Data on each CA case were reviewed for appropriateness of 
angiography, and each case who had critical coronary artery dis-
ease was then scored for the appropriateness and necessity of 
CABG using predetermined criterion-based, validated scoring sys-
tems developed by the RAND Corporation and adapted for the 
Canadian population (5,6). 
A procedure was deemed appropriate if the expected health 
benefits exceeded the expected n_egative consequences by a mar-
gin that would lead a physician to regard the procedure as worth-
while, exclusive of monetary costs. A procedure was deemed 
necessary if a physician felt obligated to recommend this proce-
dure as the best clinical option available, given the high probabil-
ity of a clinically important benefit in patients with that 
presentation. Thus, the necessity ratings included a more stringent 
risk-benefit assessment than did the appropriateness ratings; by 
definition, if a procedure is considered necessary, it must first be 
considered appropriate. Appropriateness was scored on an ordinal 
scale from 1 (extremely inappropriate) to 9 (extremely appropri-
ate) . In general terms, a score of 1 to 3 indicates inappropriate, 
4 to 6 indicates intermediate, and 7 to 9 indicates appropriate. 
The same ratings were used for the necessity scores. 
Priority scoring 
Using a priority score developed by consensus, patients referred for 
CABG were ranked according to need (7). The priority ranking 
was determined by the pattern or severity of angina symptoms, the 
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TABLE 1 
Characteristics of patients who underwent diagnostic 
coronary catheterization- considered appropriate, 
uncertain or inappropriate- in 1998/1999 
Appropriate Uncertain Inappropriate 
(n=1534) (n=457) (n=80) 
Characteristic N(%) N(%) N(%) 
Age > 75 years 57 (4) 126 (28) 2 (3) 
Maximal medical therapy 1236 (80) 198 (43) 34 (43) 
Exercise stress test 
Very positive 335 (22) 31 (7) 0 (0) 
Positive 550 (36) 194 (42) 8 (11) 
Indication for CA 
Chronic stable angina 472 (31) 174 (38) 27 (34) 
Unstable angina 642 (42) 117 (26) 2 (3) 
Acute Ml/post Ml angina 321 (21) 49 (11) 2 (3) 
Chest pain (uncertain origin) 24 (2) 24 (5) 48 (60) 
Silent ischemia 25 (2) 4 (1) 0 (0) 
Other 50 (3) • 89 (19) 1 (1) 
Ejection fraction 
>35% 1216 (88) 331 (79) 70 (95) 
15-35% 143 (10) 63 (14) 3 (4) 
<15% 23 (2) 23 (6) 1 (1) 
Coronary anatomy 
Protected left main 7 (1) 6 (1) 0 (0) 
Unprotected left main 83 (5) 18 (4) 0 (0) 
3-vessel disease 417 (27) 108 (24) 6 (8) 
2-vessel disease with 125 (8) 34 (7) 2 (3) 
proximal LAD 
2 vessels, no proximal LAD 194 (13) 60 (13) 3 (4) 
1 vessel with proximal LAD 129 (8) 20 (4) 1 (1) 
1 vessel, no proximal LAD 269 (18) 63 (14) 8 (10) 
No critical CAD 309 (20) 147 (32) 60 (75) 
CA Coronary angiography; CAD Coronary artery disease; LAD Left anterior 
descending artery; Ml Myocardial infarction 
coronary artery anatomy and the results of noninvasive tests of 
ischemic risk. The cases were categorized as follows: very urgent 
(patient should undergo surgery within 24 h), urgent (should 
undergo surgery within 72 h), semi-urgent (should undergo surgery 
within 14 days during the same hospital stay), short elective list 
(should undergo surgery within six weeks) and delayed elective list 
(should undergo surgery within six months). By comparing this 
categorization with the length of time the patients actually waited 
for CABG, it was possible to make an indirect assessment of the 
efficiency with which the cardiac surgery program delivers CABG 
in the province of Newfoundland and Labrador. 
RESULTS 
CA 
Between 1994/199 5 and 1998/1999, the number of diagnostic 
CAs increased by 37% (from 1604 to 2196) and there were 
134 persons on the waiting list for CA at the end of 
September 1999. By 1999, the cardiac catheterization labora-
tory was working at full capacity, which explains why the 
annual number of CAs done in 2000/2001(N=2258) 
increased by only 2.8% over 1998/1999, but the waiting list 
had increased to 343. A second cardiac catheterization labo-
ratory was opened in 2002, with funding approved because of 
the increased wait list. 
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TABLE 2 
Clinical characteristics of patients diagnosed by coronary 
angiography with critical coronary artery disease in 
1994/1995 and 1998/1999 
1995 1999 
(N=1073) (N=1625) 
Mean (SO) Mean (SO) p 
Age, years 60 (±11) 61 (±11) NS 
N(%) N(%) 
Male 760 (71) 1152 (71) NS 
Diabetes mellitus 452 (28) 
Angina class 
No angina/uncertain 69 (6.4) 117 (7) NS 
Class I to II 108 (11 .9) 131 (8) NS 
Class Ill 146 (13.5) 534 (33) <0.0001 
Class IV 750 (69.3) 843 (52) <0.0001 
Very positive stress test 436 (40) 326 (20) <0.0001 
Ejection fraction <35% 268 (25) 226 (14) <0.0001 
Coronary anatomy 
Left main 72 (7) 119 (7) NS 
3 vessels 328 (30) 568 (35) NS 
2 vessels 314 (29) 438 (27) NS 
1 vessel 359 (33) 500 (31) NS 
Of 2071 CAs assessed for appropriateness using the RAND 
criteria in 1998/1999, 74% (N=1534) were appropriate, 22% 
(N=457) were uncertain and 4% (N=80) were inappropriate. 
The criteria could not be applied in 125 patients. In the inap-
propriate group, the majority (60%) were CAs for chest pain of 
uncertain etiology (Table 1). Cases in the uncertain group, 
compared with the appropriate group, were more likely to be 
over 75 years of age (28% versus 4%), less likely to have unsta-
ble angina as the indication for CA (26% versus 42%), more 
likely to have other reasons (particularly heart failure) as the 
indication for CA (19% versus 3%), and less likely to have a 
very positive stress test (12% versus 35%) and to be on maxi-
mal medical therapy ( 4 3% versus 81%). 
By 1998/1999, the threshold for CA had been lowered to 
include more patients with class I to III angina, although the 
proportion with critical coronary disease, a measure of prudent 
use of CA, was a little higher than in 1994/1995: 1082 of 1604 
(68%) CA patients were diagnosed with critical disease in 
1994/1995, whereas the proportion had increased to 74% 
(1625 o£2196) in 1998/1999. Comparison of these two groups 
of patients with critical stenoses revealed that, although age, 
proportion of males and coronary anatomy was the same, the 
later cohort was characterized by significantly higher propor-
tions with class III angina (33% versus 14%), lower propor-
tions with very positive stress tests (20% versus 40%) and 
lower proportions with ejection fractions less than 0.35 ( 14% 
versus 25%) (Table 2). 
Management of critical coronary artery disease 
In 1994/1995, 391 of 1073 (36%) patients with critical coro-
nary disease were referred for CABG, 25% (N=266) were 
referred for PTCA, revascularization was contraindicated in 
5% (N=58) and 33% (N=358) were treated with medical ther-
apy. Charts were not available for nine patients. By 1998/1999, 
practice patterns had changed -of 1625 patients with critical 
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TABLE 3 
Clinical characteristics of patients referred for coronary 
artery bypass graft (CABG) in 1994/1995 and 1998/1999 
199411995 1998/1999 
(N=391) (N=578*) 
Mean (SO) Mean (SO) p 
Age (years) 62 (10) 62 (9) NS 
N(%) N(%) 
Male 279 (71) 445 (77) 0.05 
Angina class 
No, lorll 19 (5) 67 (12) 0.05 
Ill 71 (18) 248 (43) <0.0001 
IVa 77 (20) 24 (4) <0.0001 
IV b or c 224 (57) 239 (41) <0.0001 
Very positive stress test 198 (51) 154 (27) <0.0001 
Ejection fraction <0.35 100 (26) 90 (16) 0.0001 
Maximal medical therapy 289 (86) 439 (76) NS 
Coronary anatomy 
Left main 61' (16) 97 (17) NS 
3 vessels 222 (57) 348 (60) NS 
2 vessels with PLAD 52 (13) 71 (12) NS 
2 vessels without PLAD 35 (9) 39 (7) NS 
1 vessel with PLAD 15 (4) 11 (2) NS 
1 vessel without PLAD 6 (1) 12 (2) NS 
Delayed elective priority 53 (14) 201 (41) <0.0001 
for surgery 
*This includes 61 patients who had repeat coronary angiographies because 
they were on the CABG wait list for longer than six months. PLAD Proximal 
left anterior descending artery 
disease, the proportion referred for PTCA increased to 39% 
(N=631), only 24% (N=397) were primarily treated with med-
ical therapy, and revascularization was contraindicated in a fur-
ther 7% (N=117), who were then treated medically. The 
proportion referred for CABG remained the same (36%; 
N=578), although repeat CAs for patients delayed on the 
CABG wait list for longer than six months accounted for 
91 cases. 
The clinical characteristics of the 1998/1999 cohort 
referred for CABG differed from the 1994/1995 cohort 
(Table 3) in that there was a shift toward patients who were 
less acutely ill: the proportion with class Ill angina was higher 
(43% versus 18%), the proportion on maximal therapy was 
lower (76% versus 86%) and the proportion considered elec-
tive ( CABG to be performed between six weeks and six 
months) was higher (41% versus 14%).ln fact, the increase in 
the number of patients referred for CABG could be attributed 
to the increase in the number of patients recommended for 
elective surgery. 
This shift toward the less acutely ill was facilitated by the 
growth in PTCA. In 1998/1999, PTCA was used predomi-
nantly to treat the more acutely ill: 64% (N=405) of those 
referred for PTCA had unstable angina and 81% were on max-
imal medical therapy. A substantial number with less limited 
disease received PTCA: 26% (N=170) had left main, triple 
vessel, two vessel with proximal LAD disease. The comparable 
figures in 1994/1995 were as follows: 86% (N=289) who had a 
PTCA procedure had unstable angina, 86% (N=249) were on 
maximal medical therapy and 31% (N= 141) had less limited 
coronary disease~ 
402 
TABLE 4 
Waiting times of patients referred for coronary artery 
bypass graft in 1994/1995 and 1998/1999 by priority and 
recommended waiting time 
1994/1995 1998/1999 
Recommended Total Target Target Total Target Target 
Priority waiting time (N) (N) (%) (N) (N) (%) 
Very urgent <24 h 31 7 23 24 5 21 
Urgent <72 h 122 30 24 141 42 30 
Semi-urgent <2 weeks 87 56 64 68 33 49 
Short wait <6 weeks 98 49 50 59 42 71 
Delayed wait >6 weeks 53 40 75 201 71 35 
<6 months 391 493* 
*Of 578 patients referred, 61 were repeat cardiac catheterizations; they were 
excluded from this analysis. A further 24 were unassignable because they did 
not have angina. 'Target' refers to patients who received surgery within the 
recommended waiting time 
An assessment of all patients with critical coronary disease 
who were not repeat CAs suggested that CABG was neces-
sary in 491 (95%) patients referred for CABG in 1998/1999. 
Thirty-eight of 491 patients were scored as needing PTCA, 
but coronary anatomy precluded PTCA, and CABG was 
undertaken instead. A further 91 patients needed CABG but 
were not referred . Of the latter group, 86% (N=78) were actu-
ally treated with PTCA. This could reflect new indications for 
PTCA and stenting determined after RAND cri teria were 
developed (4,8) . Thus, the referral rate from cardiology 
(N=517) was similar to the necessity rate identified by objec-
tive criteria (N=504). 
Waiting times for CABG 
Table 4 shows the waiting times according to priority and rec-
ommended waiting time. In 1998/1999, only 39% of patients 
received CABG within the recommended waiting time, com-
pared with 47% in 1994/1995. The biggest deterioration in 
efficiency (proportion who received surgery within the rec-
ommended waiting time) occurred in those designated 
delayed wait priority. 
Utilization data from 1998 to 2002 
In 1999/2000, the annual growth in CA was 3.3%, but the 
growth in those referred for CABG was 6.0% (Table 5). This 
was partly influenced by inclu~ion of patients who had repeat 
CA while waiting for CABG and by a reduction in the rate of 
PTCA. The number of CABGs actually performed was less 
than the number referred and the wait list increased. In 
2000/2001, for the first time the number of CABG performed 
exceeded the number referred and the wait list decreased. 
However, the number referred for CABG increased dramati-
cally, by 14.2%, in the following year, substantially higher than 
the growth rate in CA. 
In 1995, the annual number of CABGs recommended per 
year was 462, but this was not achieved until 1999/2000 
(N=473). This was not related to inadequate funding but 
caused by the need to build a cardiovascular intensive care 
unit, and by problems in ensuring adequate numbers of perfu-
sionists, anesthetists and cardiac surgeons. In the previous 
years, the number ofCABGs performed was 375 in 1995/1996, 
460 in 1997/1998 and 437 in 1998/1999. During this time, the 
number of new patients referred for CABG increased from 391 
in 1994/1995 to 517 in 1998/1999, an increase of 8% per 
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TABLE 5 
Coronary revascularization utilization data for 1998 to 2002 
199811999 1999/2000 200012001 200112002 
Coronary catheterization + 2196 2269 2258 2389 
Referred for CABG (%) 578 (26) 613 (27) 628 (28) 717 (30) 
PTCA(%) 631 (29) 536 (24) 529 (23) 550 (23) 
CABG done 437 473 641 626 
CABG wait list 227 308 223 243 
Annual growth in 
CA(%) 9.2* 3.3 -0.5 5.8 
CABG(%) 12.0* 6.0 2.4 14.2 
PTCA(%) 39.0* -15.1 -1.3 4.0 
*Derived from increase from 199411995. +Includes patients who had repeat 
coronary angiography (CA) while on the coronary artery bypass graft (CABG) 
wail list. PTCA Perr;utaneous transluminal coronary angioplasty 
year. This constant deficit between demand for CABG and 
actual supply of CABG increased the wait list to 308 in 
1999/2000 (Table 5) . -' 
The proportion of patients referred for CABG in 
1994/1995 was 24% of CAs performed, whereas in 2001/2002, 
it was 30%. Part of this increase was related to repeat CAs for 
patients already on the CABG wait list (2.8% of total CAs in 
1998/1999). 
DISCUSSION 
The government of Newfoundland and Labrador agreed to 
fund CABG numbers according to need and the size of the 
waiting list, but the health care delivery system was slow in 
providing the capacity to meet the demand. This failure was 
exacerbated by the continued annual growth in the number of 
incident cases needing CABG. This growth was the result of 
greater use of CA and referral of patients with stable coronary 
syndromes than had occurred in 1994/1995. The disparity 
between supply and demand led to a longer waiting list and 
further deterioration in waiting times for CABG. 
The present report demonstrates that the proportion of 
patients diagnosed with critical coronary artery disease, among 
those who had CA performed, increased from 68% in 
1994/1995 to 74% in 1998/1999; the proportion of inappropri-
ate CA was low (4%); the necessity rate in those referred for 
CABG was high (95%); and the proportion referred for 
CABG with limited disease (one- or two-vessel disease with-
out involvement of the proximal left anterior descending 
artery) was low in 1994/1995 (10%) and in 1998/1999 (9%). 
This is compatible with the belief that growth in CABG uti-
lization increased from a relatively low baseline rate and would 
not be expected to be associated with a large increase in 
unnecessary surgeries (3 ). These data confirm that clinical 
decision-making continued to be acceptable and that 
increased use of public funds was necessary to meet the needs 
of the community. 
Despite the fact that the RAND methodology was pub-
lished in 1993, and that indications for catheterization and 
revascularization changed in the mid 1990s, high levels of 
necessity and appropriateness were nonetheless observed in 
the 1998/1999 cohort. 
From the patients' perspective, the deterioration in wait list 
times for CABG was probably a source of frustration, dissatis-
faction with the health care system, morbidity and perhaps an 
increased risk of death (9). However, when compared with 
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thousands of other patients living with coronary artery disease, 
such as those who had survived for six months after a myocardial 
infarction, they are at a similar O! decreased risk of death 
(10,11). 
From the doctors' perspective, the government's decision to 
fund the program according to the referral rate from cardiology 
was welcomed. The difference between the number of patients 
referred by cardiologists and the number projected by objective 
criteria was small. The government wants a reliable method to 
benchmark the numbers that they will need to fund, and will 
not interfere with clinical decision-making unless the disparity 
between objective need and demand widens. 
From the provincial government's perspective, the continu-
ing growth in the need for CABG, in a publicly funded health 
care system, induces substantial stress on the provincial budget, 
and raises questions concerning the capacity to fund such 
growth. Of particular concern to the payer is the unpredictable 
growth rate. 
The volume of patients receiving catheterization and revas-
cularization procedures have increased rapidly in other 
Canadian provinces since the mid 1990s, although rates are 
higher in Newfoundland. In Ontario, the rate of cardiac 
catheterization in 2000/2001 was 458 per 100,000 adults (12), 
whereas in Newfoundland it was 562 per 100,000 adults. 
During the same time period, the rate of percutaneous coro-
nary interventions in Ontario was 120 per I 00,000 versus 132 
per 100,000 in Newfoundland (12). In Ontario, the rate of 
CABGs performed in 1999 was 104 per 100,000 adults (13), 
whereas it was higher (118 per 100,000) in Newfoundland. 
The change in target number of CABGs required in 
Newfoundland increased from 462 ( 115 per 100,000 adults) in 
1995/1996 to 717 (178 per 100,000) in 2001/2002. 
CONCLUSIONS 
We conclude that the referral rate by cardiologists for CABG, 
which takes into account changes in clinical practice, is cur-
rently a reasonable way in which to plan the funding of the 
CABG program in Newfoundland. The increased growth in 
acceptable demand for CABG, induced by referrals with class I 
to III angina for more elective surgery, must be taken into 
account in predicting future benchmarks. However, changes in 
clinical practice, which may occur quickly and may be influ-
enced by barriers to revascularization, will make these predic-
tions difficult. The enormous increase in target number of 
CABGs required is stressful to a publicly funded health care 
delivery system, which has agreed to benchmark funding the 
number of CABGs based on need. 
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